Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Abortion, Spontaneous
Functional single nucleotide polymorphisms of matrix metalloproteinase 7 and 12 genes in idiopathic recurrent spontaneous abortion.
Acquired Immunodeficiency Syndrome
Application of MMP-7 and MMP-10 in assisting the diagnosis of malignant pleural effusion.
Acute Coronary Syndrome
Role of matrix metalloproteinases in coronary artery disease.
Acute Coronary Syndrome
[Changes in proinflammatory cytokine and destructive metalloproteinase levels during formation of unstable atherosclerotic plaque]
Acute Coronary Syndrome
[Inflammatory-destructive biomarkers of atherosclerotic plaques instability. Study of arterial wall and blood].
Acute Kidney Injury
Matrix metalloproteinase-7 protects against acute kidney injury by priming renal tubules for survival and regeneration.
Acute Kidney Injury
Measurement of urinary matrix metalloproteinase-7 for early diagnosis of acute kidney injury based on an ultrasensitive immunomagnetic microparticle-based time-resolved fluoroimmunoassay.
Acute Kidney Injury
The Many Faces of Matrix Metalloproteinase-7 in Kidney Diseases.
Acute Lung Injury
Matrilysin shedding of syndecan-1 regulates chemokine mobilization and transepithelial efflux of neutrophils in acute lung injury.
Adenocarcinoma
A Panel of Tumor-associated Autoantibodies for the Detection of Early-stage Breast Cancer.
Adenocarcinoma
Analyses of matrix metalloproteinases and their inhibitors in cyst fluid of serous ovarian tumors.
Adenocarcinoma
Association between expression of MMP-7 and MMP-9 and pelvic lymph node and para-aortic lymph node metastasis in early cervical cancer.
Adenocarcinoma
Association of matrilysin expression with progression and poor prognosis in human pancreatic adenocarcinoma.
Adenocarcinoma
Association of matrilysin mRNA expression with K-ras mutations and progression in pancreatic ductal adenocarcinomas.
Adenocarcinoma
Beta-catenin up-regulates the expression of cyclinD1, c-myc and MMP-7 in human pancreatic cancer: relationships with carcinogenesis and metastasis.
Adenocarcinoma
Citrus auraptene targets translation of MMP-7 (matrilysin) via ERK1/2-dependent and mTOR-independent mechanism.
Adenocarcinoma
Clarification of the active gelatinolytic sites in human ovarian neoplasms using in situ zymography.
Adenocarcinoma
Clinicopathologic and prognostic significance of matrix metalloproteinases in rectal cancer.
Adenocarcinoma
Correlation between the immunohistochemical expressions of MMP-1, MMP-7 and VEGF and prognostic factors in colorectal adenocarcinoma.
Adenocarcinoma
Differential expression of matrix metalloprotease-7 in each component of uterine carcinosarcoma.
Adenocarcinoma
EGF induces the expression of matrilysin in the human prostate adenocarcinoma cell line, LNCaP.
Adenocarcinoma
Expression and localization of matrix-degrading metalloproteinases during colorectal tumorigenesis.
Adenocarcinoma
Expression of gelatinase A, tissue inhibitor of metalloproteinases-2, matrilysin, and trypsin(ogen) in lung neoplasms: an immunohistochemical study.
Adenocarcinoma
Expression of matrix metalloproteinases 7 and 9 in non-small cell lung cancer Relation to clinicopathological factors, beta-catenin and prognosis.
Adenocarcinoma
Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human pancreatic adenocarcinomas: clinicopathologic and prognostic significance of matrilysin expression.
Adenocarcinoma
Expression of metalloproteinase genes in human prostate cancer.
Adenocarcinoma
Expression of MMP-7, MMP-9, TIMP-1 and TIMP-2 mRNA in lung tissue of patients with non-small cell lung cancer (NSCLC) and benign pulmonary disease.
Adenocarcinoma
Expression of mRNA MMP-7 and mRNA TIMP-1 in non-small cell lung cancer.
Adenocarcinoma
Expression of tissue levels of matrix metalloproteinases and tissue inhibitors of metalloproteinases in gastric adenocarcinoma.
Adenocarcinoma
Expression of urokinase-type plasminogen activator, stromelysin 1, stromelysin 3, and matrilysin genes in lung carcinomas.
Adenocarcinoma
Expressions of Matrix Metalloproteinases 2, 7, and 9 in Carcinogenesis of Pancreatic Ductal Adenocarcinoma.
Adenocarcinoma
Immunohistochemical study of fibrosis and adenocarcinoma in dominant-negative p53 transgenic mice exposed to chrysotile asbestos and benzo(a)pyrene.
Adenocarcinoma
Immunohistochemical study of vascular endothelial growth factor (VEGF) and matrilysin (MMP-7) in T1 adenocarcinoma of the colon and rectum to predict lymph node metastases or distant metastases.
Adenocarcinoma
Interleukin-17 promotes prostate cancer via MMP7-induced epithelial-to-mesenchymal transition.
Adenocarcinoma
Intraductal papillary mucinous neoplasms of the pancreas: an analysis of protein expression and clinical features.
Adenocarcinoma
Matrilysin-1 (MMP-7) and MMP-19 are expressed by Paget's cells in extramammary Paget's disease.
Adenocarcinoma
Matrix metalloproteinase (MMP)-7 in Barrett's esophagus and esophageal adenocarcinoma: expression, metabolism, and functional significance.
Adenocarcinoma
Matrix metalloproteinase 7 is required for tumor formation, but dispensable for invasion and fibrosis in SMAD4-deficient intestinal adenocarcinomas.
Adenocarcinoma
Matrix metalloproteinase matrilysin (MMP-7) participates in the progression of human gastric and esophageal cancers.
Adenocarcinoma
Matrix metalloproteinase-7 is expressed by pancreatic cancer precursors and regulates acinar-to-ductal metaplasia in exocrine pancreas.
Adenocarcinoma
Metalloproteinase-1, metalloproteinase-7, and p53 immunoexpression and their correlation with clinicopathological prognostic factors in colorectal adenocarcinoma.
Adenocarcinoma
MT1-MMP and MMP-7 in invasion and metastasis of human cancers.
Adenocarcinoma
Multiplex Soluble Biomarker Analysis from Pleural Effusion.
Adenocarcinoma
Overexpression of matrix metalloproteinase-7 (MMP-7) correlates with tumor proliferation, and a poor prognosis in non-small cell lung cancer.
Adenocarcinoma
Predictive value of MMP-7 expression for response to chemotherapy and survival in patients with non-small cell lung cancer.
Adenocarcinoma
Serum CA19-9, cathepsin D, and matrix metalloproteinase-7 as a diagnostic panel for pancreatic ductal adenocarcinoma.
Adenocarcinoma
Significance of matrix metalloproteinase-7 [correction of matrix metalloproteinase-2], -11 and tissue inhibitor of metalloproteinase-1 expression in normal, hyperplastic and neoplastic endometrium.
Adenocarcinoma
The expression of mmp-7 messenger-RNA in primary and metastatic human colorectal adenocarcinoma.
Adenocarcinoma
The functional polymorphism in the matrix metalloproteinase-7 promoter increases susceptibility to esophageal squamous cell carcinoma, gastric cardiac adenocarcinoma and non-small cell lung carcinoma.
Adenocarcinoma
Tumorigenesis and phenotypic characteristics of mucin-producing bile duct tumors: an immunohistochemical approach.
Adenocarcinoma
Upregulation and differential expression of matrilysin (MMP-7) and metalloelastase (MMP-12) and their inhibitors TIMP-1 and TIMP-3 in Barrett's oesophageal adenocarcinoma.
Adenocarcinoma
Urachal Carcinoma of the Bladder: Impact of Clinical and Immunohistochemical Parameters on Patient Prognosis.
Adenocarcinoma
[The significance of beta-catenin and matrix metalloproteinase-7 expression in colorectal adenoma and carcinoma]
Adenocarcinoma of Lung
Antisense oligonucleotide targeting matrix metalloproteinase-7 (MMP-7) changes the ultrastructure of human A549 lung adenocarcinoma cells.
Adenocarcinoma of Lung
Chronic exposure to exogenous matrilysin induces chemoresistance and enhances Bcl-2 expression in A549 lung adenocarcinoma cells.
Adenocarcinoma of Lung
Matrilysin inhibits proliferation and modulates sensitivity of lung cancer cells to FasL-mediated apoptosis.
Adenocarcinoma of Lung
MiR-22-3p Expression is down-regulated in lung adenocarcinoma.
Adenocarcinoma of Lung
MMP-7 is upregulated by COX-2 and promotes proliferation and invasion of lung adenocarcinoma cells.
Adenocarcinoma of Lung
Pericellular activation of proMMP-7 (promatrilysin-1) through interaction with CD151.
Adenocarcinoma of Lung
Rapid detection of matrix metalloproteinase-7 and carcinoembryonic antigen mRNA expression in intraoperative pleural lavage samples using the reverse transcriptase loop-mediated isothermal amplification method.
Adenocarcinoma, Mucinous
Distinct clinicopathologic characteristics of lung mucinous adenocarcinoma with KRAS mutation.
Adenocarcinoma, Mucinous
Intraductal papillary mucinous neoplasms of the pancreas: an analysis of protein expression and clinical features.
Adenocarcinoma, Mucinous
Tumorigenesis and phenotypic characteristics of mucin-producing bile duct tumors: an immunohistochemical approach.
Adenoma
Analyses of matrix metalloproteinases and their inhibitors in cyst fluid of serous ovarian tumors.
Adenoma
Detection of colorectal adenomas using a bioactivatable probe specific for matrix metalloproteinase activity.
Adenoma
Differential gene expression between flat adenoma and normal mucosa in the colon in a microarray analysis.
Adenoma
E1A-F is overexpressed early in human colorectal neoplasia and associated with cyclooxygenase-2 and matrix metalloproteinase-7.
Adenoma
Enhanced secretion and activation of matrilysin during malignant conversion of human colorectal epithelium and its relationship with invasive potential of colon cancer cells.
Adenoma
Examining the role of Paneth cells in the small intestine by lineage ablation in transgenic mice.
Adenoma
Expression and localization of matrix-degrading metalloproteinases during colorectal tumorigenesis.
Adenoma
Expression of matrilysin mRNA in colorectal adenomas and its induction by truncated fibronectin.
Adenoma
Expression of matrix metalloproteinase matrilysin (MMP-7) was induced by activated Ki-ras via AP-1 activation in SW1417 colon cancer cells.
Adenoma
Expression of matrix metalloproteinases and related tissue inhibitors in the cyst fluids of ovarian mucinous neoplasms.
Adenoma
Expression of matrix metalloproteinases in benign and malignant follicular thyroid lesions.
Adenoma
Expression of putative anticancer targets in familial adenomatous polyposis and its association with the APC mutation status.
Adenoma
Immunohistochemical expression of matrix metalloproteinase-7 in human colorectal adenomas using specified automated cellular image analysis system: a clinicopathological study.
Adenoma
Interplay of insulin-like growth factor-II, insulin-like growth factor-I, insulin-like growth factor-I receptor, COX-2, and matrix metalloproteinase-7, play key roles in the early stage of colorectal carcinogenesis.
Adenoma
Intestinal tumorigenesis is suppressed in mice lacking the metalloproteinase matrilysin.
Adenoma
Intraductal papillary mucinous neoplasms of the pancreas: an analysis of protein expression and clinical features.
Adenoma
Matrilysin gene expression in sporadic and familial colorectal adenomas.
Adenoma
Matrilysin is associated with progression of colorectal tumor.
Adenoma
Matrix metalloproteases expression in different histological types of colorectal polyps.
Adenoma
Matrix metalloproteinase-9 contributes to intestinal tumourigenesis in the adenomatous polyposis coli multiple intestinal neoplasia mouse.
Adenoma
Mutated K-ras(Asp12) promotes tumourigenesis in Apc(Min) mice more in the large than the small intestines, with synergistic effects between K-ras and Wnt pathways.
Adenoma
Overexpression of poly(ADP-ribose) polymerase-1 (PARP-1) in the early stage of colorectal carcinogenesis.
Adenoma
Prognostic and predictive potential molecular biomarkers in colon cancer.
Adenoma
Relationship between matrix metalloproteinase-7 and pit pattern in early stage colorectal cancer.
Adenoma
Role of matrix metalloproteinase-7 in colorectal adenomas.
Adenoma
Role of matrix metalloproteinases in colorectal carcinogenesis.
Adenoma
Sulindac treatment alters collagen and matrilysin expression in adenomas of ApcMin/+ mice.
Adenoma
The behavior of MMP-2, MMP-7, MMP-9 and their inhibitors TIMP-1, TIMP-2 in adenoma-colorectal cancer sequence.
Adenoma
The metalloproteinase matrilysin is a target of beta-catenin transactivation in intestinal tumors.
Adenoma
The PEA3 subfamily of Ets transcription factors synergizes with beta-catenin-LEF-1 to activate matrilysin transcription in intestinal tumors.
Adenoma
Truncated mouse adenomatous polyposis coli reduces connexin32 content and increases matrilysin secretion from Paneth cells.
Adenoma
[The significance of beta-catenin and matrix metalloproteinase-7 expression in colorectal adenoma and carcinoma]
Adenoma, Liver Cell
Distinction of hepatocellular adenoma from hepatocellular carcinoma with and without cirrhosis using E-cadherin and matrix metalloproteinase immunohistochemistry.
Adenoma, Villous
Role of matrix metalloproteinase-7 in colorectal adenomas.
Adenomatous Polyposis Coli
Correlation between beta-catenin widespread nuclear expression and matrix metalloproteinase-7 overexpression in sporadic desmoid tumors.
Adenomatous Polyposis Coli
Differential expression of matrilysin and cyclooxygenase-2 in intestinal and colorectal neoplasms.
Adenomatous Polyposis Coli
Matrilysin gene expression in sporadic and familial colorectal adenomas.
Adenomatous Polyposis Coli
Matrix metalloproteinase-9 contributes to intestinal tumourigenesis in the adenomatous polyposis coli multiple intestinal neoplasia mouse.
Adenomatous Polyposis Coli
Nestin positively regulates the Wnt/?-catenin pathway and the proliferation, survival and invasiveness of breast cancer stem cells.
Adenomatous Polyposis Coli
Truncated mouse adenomatous polyposis coli reduces connexin32 content and increases matrilysin secretion from Paneth cells.
Adenomatous Polyps
Enhanced expression of MMP-7 and MMP-13 in inflammatory bowel disease: a precancerous potential?
Adenomyosis
Polymorphisms in the promoter regions of the matrix metalloproteinases-7, -9 and the risk of endometriosis and adenomyosis in China.
Adenomyosis
[Expression of the small molecular weight matrix metalloproteinase in adenomyosis of the mouse uterus]
Adrenal Cortex Neoplasms
MicroRNA signature in massive macronodular adrenocortical disease and implications for adrenocortical tumorigenesis.
Aggressive Periodontitis
Matrix metalloproteinase -7, -8, -9 and -13 in gingival tissue of patients with type 1 diabetes and periodontitis.
Aggressive Periodontitis
The in vivo expression of the collagenolytic matrix metalloproteinases (MMP-2, -8, -13, and -14) and matrilysin (MMP-7) in adult and localized juvenile periodontitis.
AIDS Dementia Complex
Matrix metalloproteinase activity stimulates N-cadherin shedding and the soluble N-cadherin ectodomain promotes classical microglial activation.
Albuminuria
Canonical Wnt/?-catenin signaling mediates transforming growth factor-?1-driven podocyte injury and proteinuria.
Alzheimer Disease
Analysis of Matrix Metallo-Proteases and the Plasminogen System in Mild Cognitive Impairment and Alzheimer's Disease Cerebrospinal Fluid.
Alzheimer Disease
MMP-7 cleaves amyloid ? fragment peptides and copper ion inhibits the degradation.
Ameloblastoma
Immunohistochemical expression of matrilysins (MMP-7 and MMP-26) in ameloblastomas and adenomatoid odontogenic tumors.
Ameloblastoma
MMP-7, -8, -9, E-cadherin, and beta-catenin expression in 34 ameloblastoma cases.
Amyotrophic Lateral Sclerosis
Characterization of gene regulation and protein interaction networks for Matrin 3 encoding mutations linked to amyotrophic lateral sclerosis and myopathy.
Amyotrophic Lateral Sclerosis
Genetic analysis of matrin 3 gene in French amyotrophic lateral sclerosis patients and frontotemporal lobar degeneration with amyotrophic lateral sclerosis patients.
Amyotrophic Lateral Sclerosis
Heterogeneity of Matrin 3 in the developing and aging murine central nervous system.
Amyotrophic Lateral Sclerosis
Knockdown of genes involved in axonal transport enhances the toxicity of human neuromuscular disease-linked MATR3 mutations in Drosophila.
Amyotrophic Lateral Sclerosis
Matrin 3 Is a Component of Neuronal Cytoplasmic Inclusions of Motor Neurons in Sporadic Amyotrophic Lateral Sclerosis.
Amyotrophic Lateral Sclerosis
Mutant MATR3 mouse model to explain multisystem proteinopathy.
Amyotrophic Lateral Sclerosis
Mutations in the Matrin 3 gene cause familial amyotrophic lateral sclerosis.
Amyotrophic Lateral Sclerosis
Subcellular Localization of Matrin 3 Containing Mutations Associated with ALS and Distal Myopathy.
Aneurysm
Aneurysm Severity is Increased by Combined Mmp-7 Deletion and N-cadherin Mimetic (EC4-Fc) Over-Expression.
Aneurysm
The expression of MMP-7 in serum and aneurysm tissues of patients with abdominal aortic aneurysm associated with hypertension and the clinical efficacy of endovascular exclusion.
Angina, Stable
Role of matrix metalloproteinases in coronary artery disease.
Aortic Aneurysm, Abdominal
The expression of MMP-7 in serum and aneurysm tissues of patients with abdominal aortic aneurysm associated with hypertension and the clinical efficacy of endovascular exclusion.
Arthritis
Metalloproteinase-7 contributes to joint destruction in Staphylococcus aureus induced arthritis.
Arthritis, Infectious
Metalloproteinase-7 contributes to joint destruction in Staphylococcus aureus induced arthritis.
Arthritis, Rheumatoid
Expression of ADAM15 in rheumatoid synovium: up-regulation by vascular endothelial growth factor and possible implications for angiogenesis.
Arthritis, Rheumatoid
Immunolocalisation studies on six matrix metalloproteinases and their inhibitors, TIMP-1 and TIMP-2, in synovia from patients with osteo- and rheumatoid arthritis.
Asbestosis
Serum concentrations of Krebs von den Lungen-6, surfactant protein D, and matrix metalloproteinase-2 as diagnostic biomarkers in patients with asbestosis and silicosis: a case-control study.
Asthma
Divergent functions for airway epithelial matrix metalloproteinase 7 and retinoic acid in experimental asthma.
Asthma
IL-13 and TH2 cytokine exposure triggers matrix metalloproteinase 7-mediated Fas ligand cleavage from bronchial epithelial cells.
Astrocytoma
Association between the functional polymorphism in the matrix metalloproteinase-7 promoter and susceptibility to adult astrocytoma.
Astrocytoma
Expression of MMP-2, MMP-7, MMP-9, MMP-10 and MMP-11 in human astrocytic and oligodendroglial gliomas.
Astrocytoma
Matrix metalloproteinase-9 interplays with the IGFBP2-IGFII complex to promote cell growth and motility in astrocytomas.
Astrocytoma
[Correlations of polymorphisms in matrix metalloproteinase-3 and -7 promoters to susceptibility to brain astrocytoma]
Atherosclerosis
Apolipoprotein A-IV is a novel substrate for matrix metalloproteinases.
Atherosclerosis
Associations of D-dimer with CT Lung Abnormalities, Serum Biomarkers of Lung Injury, and Forced Vital Capacity: MESA Lung Study.
Atherosclerosis
Cholesterol, lipoproteins and subclinical interstitial lung disease: the MESA study.
Atherosclerosis
Elevated Plasma Levels of MMP-12 Are Associated With Atherosclerotic Burden and Symptomatic Cardiovascular Disease in Subjects With Type 2 Diabetes.
Atherosclerosis
Serum Matrix Metalloproteinase-7, Respiratory Symptoms, and Mortality in Community-dwelling Adults: The Multi-Ethnic Study of Atherosclerosis.
Atrial Fibrillation
Effect of matrix metalloproteinase and their inhibitors on atrial myocardial structural remodeling.
Bacterial Infections
Matrilysin (MMP-7) catalytic activity regulates ?-catenin localization and signaling activation in lung epithelial cells.
Bacterial Infections
Stimulation of MMP-7 (matrilysin) by Helicobacter pylori in human gastric epithelial cells: role in epithelial cell migration.
Barrett Esophagus
Matrix metalloproteinase (MMP)-7 in Barrett's esophagus and esophageal adenocarcinoma: expression, metabolism, and functional significance.
Biliary Atresia
Current Concepts of Biliary Atresia and Matrix Metalloproteinase-7: A Review of Literature.
Biliary Atresia
Diagnostic Accuracy of Serum Matrix Metalloproteinase-7 for Biliary Atresia.
Biliary Atresia
Increased MMP-7 expression in biliary epithelium and serum underpins native liver fibrosis after successful portoenterostomy in biliary atresia.
Biliary Atresia
Large-scale proteomics identifies MMP-7 as a sentinel of epithelial injury and of biliary atresia.
Biliary Atresia
Matrilysin (MMP-7) is a major matrix metalloproteinase upregulated in biliary atresia-associated liver fibrosis.
Biliary Atresia
Predicting native liver injury and survival in biliary atresia.
Biliary Atresia
Serum MMP-7 in the Diagnosis of Biliary Atresia.
Biliary Tract Diseases
Detection of serum MMP-7 and MMP-9 in cholangiocarcinoma patients: evaluation of diagnostic accuracy.
Biliary Tract Diseases
Prospective study of MMP7 serum levels in the diagnosis of cholangiocarcinoma.
Bone Diseases
A loss of host-derived MMP-7 promotes myeloma growth and osteolytic bone disease in vivo.
Bone Diseases
Matrilysin/MMP-7 Cleavage of Perlecan/HSPG2 Complexed with Semaphorin 3A Supports FAK-Mediated Stromal Invasion by Prostate Cancer Cells.
Bowen's Disease
Matrix metalloproteinase-7 activates heparin-binding epidermal growth factor-like growth factor in cutaneous squamous cell carcinoma.
Bowen's Disease
Transformation-specific matrix metalloproteinases (MMP)-7 and MMP-13 are expressed by tumour cells in epidermolysis bullosa-associated squamous cell carcinomas.
Brain Injuries, Traumatic
Blood-brain barrier dysfunction significantly correlates with serum matrix metalloproteinase-7 (MMP-7) following traumatic brain injury.
Brain Neoplasms
MMP-7 (matrilysin) expression in human brain tumors.
Brain Neoplasms
Production of recombinant human matrix metalloproteinase 7 (Matrilysin) with potential role in tumor invasion by refolding from Escherichia coli inclusion bodies and development of sandwich ELISA of MMP-7.
Breast Neoplasms
ADAM28 is overexpressed in human breast carcinomas: implications for carcinoma cell proliferation through cleavage of insulin-like growth factor binding protein-3.
Breast Neoplasms
Alcohol Stimulates Activation of Snail, Epidermal Growth Factor Receptor Signaling, and Biomarkers of Epithelial-Mesenchymal Transition in Colon and Breast Cancer Cells.
Breast Neoplasms
beta-Catenin and p53 analyses of a breast carcinoma tissue microarray.
Breast Neoplasms
Breast Heterogeneity: Obstacles to Developing Universal Biomarkers of Breast Cancer Initiation and Progression.
Breast Neoplasms
CCR10 activation stimulates the invasion and migration of breast cancer cells through the ERK1/2/MMP-7 signaling pathway.
Breast Neoplasms
Coagulation factor VIIa-mediated protease-activated receptor 2 activation leads to ?-catenin accumulation via the AKT/GSK3? pathway and contributes to breast cancer progression.
Breast Neoplasms
Common MMP-7 polymorphisms and breast cancer susceptibility: a multistage study of association and functionality.
Breast Neoplasms
Delphinidin suppresses breast carcinogenesis through the HOTAIR/microRNA-34a axis.
Breast Neoplasms
Estrogen-deficient osteoporosis enhances the recruitment and activity of osteoclasts by breast cancer cells.
Breast Neoplasms
Expression of gelatinases A and B, stromelysin-3 and matrilysin genes in breast carcinomas: clinico-pathological correlations.
Breast Neoplasms
Expression of metalloproteases and their inhibitors in different histological types of breast cancer.
Breast Neoplasms
Expression of tissue levels of matrix metalloproteinases and their inhibitors in breast cancer.
Breast Neoplasms
Genetic polymorphisms in the MMP-7 gene and breast cancer survival.
Breast Neoplasms
Hypoxia-induced gene expression in human macrophages: implications for ischemic tissues and hypoxia-regulated gene therapy.
Breast Neoplasms
IL-18 immunoadjuvanted xenogeneic canine MMP-7 DNA vaccine overcomes immune tolerance and supresses the growth of murine mammary tumor.
Breast Neoplasms
Inhibitors of polyamine biosynthesis decrease the expression of the metalloproteases meprin alpha and MMP-7 in hormone-independent human breast cancer cells.
Breast Neoplasms
Investigating the regulation mechanism of baicalin on triple negative breast cancer's biological network by a systematic biological strategy.
Breast Neoplasms
LEF-1 regulates proliferation and MMP-7 transcription in breast cancer cells.
Breast Neoplasms
Matrilysin over-expression in MCF-7 cells enhances cellular invasiveness and pro-gelatinase activation.
Breast Neoplasms
Matrix metalloproteinase single-nucleotide polymorphisms and haplotypes predict breast cancer progression.
Breast Neoplasms
MMP-7 A-181G Polymorphism in Breast Cancer Patients from Western Iran.
Breast Neoplasms
MT1-MMP and MMP-7 in invasion and metastasis of human cancers.
Breast Neoplasms
Plasma Concentrations of Matrilysins MMP-7 and MMP-26 as Diagnostic Biomarkers in Breast Cancer.
Breast Neoplasms
Protein kinase D1 regulates matrix metalloproteinase expression and inhibits breast cancer cell invasion.
Breast Neoplasms
Silencing of KIF3B Suppresses Breast Cancer Progression by Regulating EMT and Wnt/?-Catenin Signaling.
Breast Neoplasms
Study of the topographic distribution of ets-1 protein expression in invasive breast carcinomas in relation to tumor phenotype.
Breast Neoplasms
Targeting matrilysin and its impact on tumor growth in vivo: the potential implications in breast cancer therapy.
Breast Neoplasms
The Contribution of Matrix Metalloproteinase-7 Promoter Genotypes in Breast Cancer in Taiwan.
Breast Neoplasms
The multifunctional role of the immunohistochemical expression of MMP-7 in invasive breast cancer.
Breast Neoplasms
Tumor suppressive function of Matrin 3 in the basal-like breast cancer.
Breast Neoplasms
[Expressions of FOXC1 and MMP-7 in molecular subtypes of breast cancer and their association with clinicopathological characteristics].
Bronchiectasis
Matrix metalloproteinase activation by free neutrophil elastase contributes to bronchiectasis progression in early cystic fibrosis.
Bronchiectasis
Matrix Metalloproteinases Vary with Airway Microbiota Composition and Lung Function in Non-Cystic Fibrosis Bronchiectasis.
Carcinogenesis
A study on angiogenesis-related matrix metalloproteinase networks in primary hepatocellular carcinoma.
Carcinogenesis
Achaete-scute complex homolog-1 promotes DNA repair in the lung carcinogenesis through matrix metalloproteinase-7 and O(6)-methylguanine-DNA methyltransferase.
Carcinogenesis
Association of Ets-related transcriptional factor E1AF expression with overexpression of matrix metalloproteinases, COX-2 and iNOS in the early stage of colorectal carcinogenesis.
Carcinogenesis
Beta-catenin up-regulates the expression of cyclinD1, c-myc and MMP-7 in human pancreatic cancer: relationships with carcinogenesis and metastasis.
Carcinogenesis
Charge-Triggered Membrane Insertion of Matrix Metalloproteinase-7, Supporter of Innate Immunity and Tumors.
Carcinogenesis
Colorectal carcinoma: from tumorigenesis to treatment.
Carcinogenesis
Correlation of polymorphism of IL-8 and MMP-7 with occurrence and lymph node metastasis of early stage cervical cancer.
Carcinogenesis
Development of in situ zymography to localize active matrix metalloproteinase-7 (matrilysin-1).
Carcinogenesis
Differential expression of matrilysin and cyclooxygenase-2 in intestinal and colorectal neoplasms.
Carcinogenesis
E1A-F is overexpressed early in human colorectal neoplasia and associated with cyclooxygenase-2 and matrix metalloproteinase-7.
Carcinogenesis
Enhanced expression of MMP-7 and MMP-13 in inflammatory bowel disease: a precancerous potential?
Carcinogenesis
Epidermal growth factor upregulates matrix metalloproteinase-7 expression through activation of PEA3 transcription factors.
Carcinogenesis
ETS variant 1 regulates matrix metalloproteinase-7 transcription in LNCaP prostate cancer cells.
Carcinogenesis
Expression and localization of matrix-degrading metalloproteinases during colorectal tumorigenesis.
Carcinogenesis
Expression of matrilysin mRNA in colorectal adenomas and its induction by truncated fibronectin.
Carcinogenesis
Expression of matrix metalloproteinase-7 involving in growth, invasion, metastasis and angiogenesis of gastric cancer.
Carcinogenesis
Helicobacter pylori potentiates epithelial:mesenchymal transition in gastric cancer: links to soluble HB-EGF, gastrin and matrix metalloproteinase-7.
Carcinogenesis
Helicobacter pylori upregulates matrilysin (MMP-7) in epithelial cells in vivo and in vitro in a Cag dependent manner.
Carcinogenesis
High gene expression of matrix metalloproteinase-7 is associated with early stages of oral cancer.
Carcinogenesis
Interplay of insulin-like growth factor-II, insulin-like growth factor-I, insulin-like growth factor-I receptor, COX-2, and matrix metalloproteinase-7, play key roles in the early stage of colorectal carcinogenesis.
Carcinogenesis
Intestinal tumorigenesis is suppressed in mice lacking the metalloproteinase matrilysin.
Carcinogenesis
Matrilysin (matrix metalloproteinase-7) expression in ulcerative colitis-related tumorigenesis.
Carcinogenesis
Matrilysin gene expression in sporadic and familial colorectal adenomas.
Carcinogenesis
Matrilysin in early stage intestinal tumorigenesis.
Carcinogenesis
Matrix metalloproteinase 7 mediates mammary epithelial cell tumorigenesis through the ErbB4 receptor.
Carcinogenesis
Matrix metalloproteinase-7 and premalignant host responses in Helicobacter pylori-infected mice.
Carcinogenesis
MMP-7 is upregulated by COX-2 and promotes proliferation and invasion of lung adenocarcinoma cells.
Carcinogenesis
MMP7 as a potential biomarker of colon cancer and its prognostic value by bioinformatics analysis.
Carcinogenesis
New insights into the roles of matrix metalloproteinases in colorectal cancer development and progression.
Carcinogenesis
Overexpression of poly(ADP-ribose) polymerase-1 (PARP-1) in the early stage of colorectal carcinogenesis.
Carcinogenesis
Overexpression of SOX18 correlates with accelerated cell growth and poor prognosis in human pancreatic ductal adenocarcinoma.
Carcinogenesis
p120 and Kaiso regulate Helicobacter pylori-induced expression of matrix metalloproteinase-7.
Carcinogenesis
Physiological activities of carbon monoxide-releasing molecules: Ca ira.
Carcinogenesis
Polyamine-dependent expression of the matrix metalloproteinase matrilysin in a human colon cancer-derived cell line.
Carcinogenesis
Role of matrix metalloproteinase-7 (matrilysin) in human cancer invasion, apoptosis, growth, and angiogenesis.
Carcinogenesis
Role of matrix metalloproteinases in colorectal carcinogenesis.
Carcinogenesis
Role of PTEN and MMP-7 expression in growth, invasion, metastasis and angiogenesis of gastric carcinoma.
Carcinogenesis
Roles of matrix metalloproteinase-7 (MMP-7) in cancer.
Carcinogenesis
Simultaneous determination of matrix metalloproteinase (MMP)-7, MMP-1, -3, and -13 gene expression by multiplex PCR in colorectal carcinomas.
Carcinogenesis
The Contribution of MMP-7 Genotypes to Colorectal Cancer Susceptibility in Taiwan.
Carcinogenesis
The detection of Helicobacter pylori cag pathogenicity islands (PAIs) and expression of matrix metalloproteinase-7 (MMP-7) in gastric epithelial dysplasia and intramucosal cancer.
Carcinogenesis
The influence of matrix metalloproteinase-7 on early mammary tumorigenesis in the multiple intestinal neoplasia mouse.
Carcinogenesis
The matrix metalloproteinase matrilysin influences early-stage mammary tumorigenesis.
Carcinogenesis
The metalloproteinase matrilysin is a target of beta-catenin transactivation in intestinal tumors.
Carcinogenesis
The PEA3 subfamily of Ets transcription factors synergizes with beta-catenin-LEF-1 to activate matrilysin transcription in intestinal tumors.
Carcinogenesis
Up-regulation of TRPM-2, MMP-7 and ID-1 during sex hormone-induced prostate carcinogenesis in the Noble rat.
Carcinoid Tumor
Expression of gelatinase A, tissue inhibitor of metalloproteinases-2, matrilysin, and trypsin(ogen) in lung neoplasms: an immunohistochemical study.
Carcinoid Tumor
Increased gastric expression of MMP-7 in hypergastrinemia and significance for epithelial-mesenchymal signaling.
Carcinoma
A one-step sandwich enzyme immunoassay for human matrix metalloproteinase 7 (matrilysin) using monoclonal antibodies.
Carcinoma
A Panel of Tumor-associated Autoantibodies for the Detection of Early-stage Breast Cancer.
Carcinoma
A subset of high-grade pulmonary neuroendocrine carcinomas shows up-regulation of matrix metalloproteinase-7 associated with nuclear beta-catenin immunoreactivity, independent of EGFR and HER-2 gene amplification or expression.
Carcinoma
Achaete-scute complex homolog-1 promotes DNA repair in the lung carcinogenesis through matrix metalloproteinase-7 and O(6)-methylguanine-DNA methyltransferase.
Carcinoma
Activation of gelatinase-tissue-inhibitors-of-metalloproteinase complexes by matrilysin.
Carcinoma
Active matrix metalloproteinase-7 is associated with invasion in buccal squamous cell carcinoma.
Carcinoma
Activin A enhances MMP-7 activity via the transcription factor AP-1 in an esophageal squamous cell carcinoma cell line.
Carcinoma
ADAM28 is overexpressed in human non-small cell lung carcinomas and correlates with cell proliferation and lymph node metastasis.
Carcinoma
Adhesion molecules, extracellular matrix, and proteases in prostate carcinoma.
Carcinoma
An integrated clinical-genomics approach identifies a candidate multi-analyte blood test for serous ovarian carcinoma.
Carcinoma
Association of matrilysin expression with progression and poor prognosis in human pancreatic adenocarcinoma.
Carcinoma
Association of matrilysin expression with recurrence and poor prognosis in human esophageal squamous cell carcinoma.
Carcinoma
Association of matrilysin mRNA expression with K-ras mutations and progression in pancreatic ductal adenocarcinomas.
Carcinoma
Association of matrix metalloproteinase-7 (-181A>G) polymorphism with risk of esophageal squamous cell carcinoma in Kashmir Valley.
Carcinoma
Associations of Promoter Methylations and mRNA Expressions of MMP-2, MMP-7 and MMP-9 with Primary Fallopian Tube Carcinoma.
Carcinoma
Autoantibodies against MMP-7 as a novel diagnostic biomarker in esophageal squamous cell carcinoma.
Carcinoma
Bacterial exposure induces and activates matrilysin in mucosal epithelial cells.
Carcinoma
Beta-catenin up-regulates the expression of cyclinD1, c-myc and MMP-7 in human pancreatic cancer: relationships with carcinogenesis and metastasis.
Carcinoma
Binding of alpha5 monoclonal antibody to cell surface alpha5beta1 integrin modulates MMP-2 and MMP-7 activity in B16F10 melanoma cells.
Carcinoma
Binding of matrilysin-1 to human epithelial cells promotes its activity.
Carcinoma
Changes in the expression of matrix proteases and of the transcription factor c-Ets-1 during progression of precancerous bronchial lesions.
Carcinoma
Circulating Anti-Matrix Metalloproteinase-7 Antibodies May Be a Potential Biomarker for Oral Squamous Cell Carcinoma.
Carcinoma
Cleavage of beta 4 integrin by matrilysin.
Carcinoma
Clinical significance of matrix metalloproteinase-7 expression in esophageal carcinoma.
Carcinoma
Clinical significance of mucin phenotype, beta-catenin and matrix metalloproteinase 7 in early undifferentiated gastric carcinoma.
Carcinoma
Clinical significance of serum MMP-2 and MMP-7 in patients with ovarian cancer.
Carcinoma
Clinicopathologic and prognostic significance of matrilysin expression at the invasive front in human colorectal cancers.
Carcinoma
Clinicopathologic and prognostic significance of matrix metalloproteinases in rectal cancer.
Carcinoma
Clinicopathological significance of MMP-7, laminin ?2 and EGFR expression at the invasive front of gastric carcinoma.
Carcinoma
Coexpression of matrix metalloproteinase-7 (MMP-7) and epidermal growth factor (EGF) receptor in colorectal cancer: an EGF receptor tyrosine kinase inhibitor is effective against MMP-7-expressing cancer cells.
Carcinoma
Combined detection of serum autoantibodies as diagnostic biomarkers in esophagogastric junction adenocarcinoma.
Carcinoma
Correlation among 16 biological factors [p53, p21(waf1), MIB-1 (Ki-67), p16(INK4A), cyclin D1, E-cadherin, Bcl-2, TNF-?, NF-?B, TGF-?, MMP-7, COX-2, EGFR, HER2/neu, ER, and HIF-1?] and clinical outcomes following curative chemoradiation therapy in 10 patients with esophageal squamous cell carcinoma.
Carcinoma
COX-2, MMP-7 expression in oral lichen planus and oral squamous cell carcinoma.
Carcinoma
CYR61 downregulation correlates with tumor progression by promoting MMP-7 expression in human gastric carcinoma.
Carcinoma
Cysteine-rich protein 61 suppresses cell invasion via down-regulation of matrix metalloproteinase-7 expression in the human gastric carcinoma cell line MKN-45.
Carcinoma
Detection of Matrilysin Activity Using Polypeptide Functionalized Reduced Graphene Oxide Field-Effect Transistor Sensor.
Carcinoma
Development of in situ zymography to localize active matrix metalloproteinase-7 (matrilysin-1).
Carcinoma
Difference in responsiveness of human esophageal squamous cell carcinoma lines to epidermal growth factor for MMP-7 expression.
Carcinoma
Differential expression of c-jun and c-fos mRNAs in squamous cell carcinoma of the head and neck: associations with uPA, gelatinase B, and matrilysin mRNAs.
Carcinoma
Differential expression of matrilysin-1 (MMP-7), 92 kD gelatinase (MMP-9), and metalloelastase (MMP-12) in oral verrucous and squamous cell cancer.
Carcinoma
Differential expression of MMP and uPA systems and prognostic relevance of their expression in esophageal squamous cell carcinoma.
Carcinoma
Ductal origin of pancreatic adenocarcinomas induced by conditional activation of a human Ha-ras oncogene in rat pancreas.
Carcinoma
E1A-F is overexpressed early in human colorectal neoplasia and associated with cyclooxygenase-2 and matrix metalloproteinase-7.
Carcinoma
Effusion cytodiagnosis of carcinosarcoma derived from the female genital tract: immunohistochemical features of MMP-7 and Ki-67 and immunofluorescence double staining analyses of eight cases.
Carcinoma
EGF induces the expression of matrilysin in the human prostate adenocarcinoma cell line, LNCaP.
Carcinoma
Elevated matrix metalloproteinase 7 expression promotes the proliferation, motility and metastasis of tongue squamous cell carcinoma.
Carcinoma
Elevated matrix metalloproteinase-7 expression promotes metastasis in human lung carcinoma.
Carcinoma
Enhanced production and activation of matrix metalloproteinase-7 (matrilysin) in human endometrial carcinomas.
Carcinoma
Epidermal growth factor induces FoxO1 nuclear exclusion to activate MMP7-mediated metastasis of larynx carcinoma.
Carcinoma
Evaluation of matrix metalloproteinase 7 in plasma and pancreatic juice as a biomarker for pancreatic cancer.
Carcinoma
Expression and localization of the matrix metalloproteinase pump-1 (MMP-7) in human gastric and colon carcinomas.
Carcinoma
Expression and significance of IGF-2, PCNA, MMP-7, and ?-actin in gastric carcinoma with Lauren classification.
Carcinoma
Expression and tissue localization of matrix metalloproteinase 7 (matrilysin) in human gastric carcinomas. Implications for vessel invasion and metastasis.
Carcinoma
Expression of gelatinase A, tissue inhibitor of metalloproteinases-2, matrilysin, and trypsin(ogen) in lung neoplasms: an immunohistochemical study.
Carcinoma
Expression of heparanase gene, CD44v6, MMP-7 and nm23 protein and their relationship with the invasion and metastasis of gastric carcinomas.
Carcinoma
Expression of matrilysin in vascular endothelial cells adjacent to matrilysin-producing tumors.
Carcinoma
Expression of matrix metalloproteinase-7 and tissue inhibitor of metalloproteinase-1 in human prostate.
Carcinoma
Expression of matrix metalloproteinase-7 correlates with the invasion of T1 colorectal carcinoma.
Carcinoma
Expression of matrix metalloproteinase-7 on cancer cells and tissue endothelial cells in renal cell carcinoma: prognostic implications and clinical significance for invasion and metastasis.
Carcinoma
Expression of matrix metalloproteinases 3, 10 and 11 (stromelysins 1, 2 and 3) and matrix metalloproteinase 7 (matrilysin) by cancer cells in non-small cell lung neoplasms. Clinicopathologic studies.
Carcinoma
Expression of matrix metalloproteinases 7 and 2 in human renal cell carcinoma.
Carcinoma
Expression of matrix metalloproteinases and related tissue inhibitors in the cyst fluids of ovarian mucinous neoplasms.
Carcinoma
Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human pancreatic adenocarcinomas: clinicopathologic and prognostic significance of matrilysin expression.
Carcinoma
Expression of matrix metalloproteinases in benign and malignant follicular thyroid lesions.
Carcinoma
Expression of matrix metalloproteinases in human transitional cell carcinoma of the urinary bladder.
Carcinoma
Expression of matrix metalloproteinases in supraglottic carcinoma and its clinical implication for estimating lymph node metastases.
Carcinoma
Expression of metalloproteases and their inhibitors in different histological types of breast cancer.
Carcinoma
Expression of metalloproteinase genes in human prostate cancer.
Carcinoma
Expression of MMP-7 and MT1-MMP in oral squamous cell carcinoma as predictive indicator for tumor invasion and prognosis.
Carcinoma
Expression of MMP-7, MMP-9, TIMP-1 and TIMP-2 mRNA in lung tissue of patients with non-small cell lung cancer (NSCLC) and benign pulmonary disease.
Carcinoma
Expression of mRNA MMP-7 and mRNA TIMP-1 in non-small cell lung cancer.
Carcinoma
Expression of the matrix metalloproteinase promatrilysin in coculture of prostate carcinoma cell lines.
Carcinoma
Expression of the metalloproteinase matrilysin in DU-145 cells increases their invasive potential in severe combined immunodeficient mice.
Carcinoma
Expression of urokinase-type plasminogen activator, stromelysin 1, stromelysin 3, and matrilysin genes in lung carcinomas.
Carcinoma
Expressions of Matrix Metalloproteinase-7 and -9 and their Prognostic Significances in Rectal Cancer.
Carcinoma
Gene Expression Profiling of the Leading Edge of Cutaneous Squamous Cell Carcinoma: IL-24-Driven MMP-7.
Carcinoma
Heregulin-beta promotes matrix metalloproteinase-7 expression via HER2-mediated AP-1 activation in MCF-7 cells.
Carcinoma
High gene expression of matrix metalloproteinase-7 is associated with early stages of oral cancer.
Carcinoma
In silico trials to design potent inhibitors against matrilysin (MMP-7).
Carcinoma
In vitro method for diagnosing and monitoring renal cell carcinoma using matrix metalloprotease-7 as humoral biomarker.
Carcinoma
Increased expression of matrix metalloproteinase 7 and 9 and membrane type 1-matrix metalloproteinase in esophageal squamous cell carcinomas.
Carcinoma
Integrin- and cadherin-mediated induction of the matrix metalloprotease matrilysin in cocultures of malignant oral squamous cell carcinoma cells and dermal fibroblasts.
Carcinoma
Interleukin-1beta secreted from monocytic cells induces the expression of matrilysin in the prostatic cell line LNCaP.
Carcinoma
Interrelation between expression of matrix metalloproteinase 7 and beta-catenin in esophageal cancer.
Carcinoma
Inverse relationship between matrilysin expression and proliferative activity of cells in advanced gastric carcinoma.
Carcinoma
Matrilsin expression is a useful marker of submucosal invasion and lymph node metastasis in early stage signet ring cell carcinoma of the stomach.
Carcinoma
Matrilysin (matrix metalloproteinase-7) expression in ulcerative colitis-related tumorigenesis.
Carcinoma
Matrilysin (MMP-7) catalytic activity regulates ?-catenin localization and signaling activation in lung epithelial cells.
Carcinoma
Matrilysin (MMP-7) induces homotypic adhesion of human colon cancer cells and enhances their metastatic potential in nude mouse model.
Carcinoma
Matrilysin (MMP-7) is a novel broadly expressed tumor antigen recognized by antigen-specific T cells.
Carcinoma
Matrilysin (MMP-7) promotes invasion of ovarian cancer cells by activation of progelatinase.
Carcinoma
Matrilysin (PUMP) correlates with dermal invasion during appendageal development and cutaneous neoplasia.
Carcinoma
Matrilysin 1 influences colon carcinoma cell migration by cleavage of the laminin-5 beta3 chain.
Carcinoma
Matrilysin expression in human prostate carcinoma.
Carcinoma
Matrilysin-1 (MMP-7) and MMP-19 are expressed by Paget's cells in extramammary Paget's disease.
Carcinoma
Matrilysin-specific antisense oligonucleotide inhibits liver metastasis of human colon cancer cells in a nude mouse model.
Carcinoma
Matrix metalloproteinase 7 (matrilysin) from human rectal carcinoma cells. Activation of the precursor, interaction with other matrix metalloproteinases and enzymic properties.
Carcinoma
Matrix metalloproteinase 7 and perlecan in oral epithelial dysplasia and carcinoma in situ: an aid for histopathologic recognition of their cell proliferation centers.
Carcinoma
Matrix metalloproteinase 7 expression in ampullary carcinoma.
Carcinoma
Matrix metalloproteinase matrilysin (MMP-7) participates in the progression of human gastric and esophageal cancers.
Carcinoma
Matrix metalloproteinase-7 activates heparin-binding epidermal growth factor-like growth factor in cutaneous squamous cell carcinoma.
Carcinoma
Matrix metalloproteinase-7 and matrix metalloproteinase-25 in oral tongue squamous cell carcinoma.
Carcinoma
Matrix metalloproteinase-7 and matrix metalloproteinase-9 are associated with unfavourable prognosis in superficial oesophageal cancer.
Carcinoma
Matrix metalloproteinase-7 expression in gastric carcinoma.
Carcinoma
Matrix metalloproteinase-7 mRNA and protein expression in gastric carcinoma: a meta-analysis.
Carcinoma
Matrix metalloproteinase-7, -8, -9, -15, and -25 in minor salivary gland adenoid cystic carcinoma.
Carcinoma
Matrix metalloproteinase-9 from bone marrow-derived cells contributes to survival but not growth of tumor cells in the lung microenvironment.
Carcinoma
Matrix metalloproteinases (MMPs) and inhibitor of metalloproteinases (TIMP) mRNA and protein expression in laryngeal squamous cell carcinoma.
Carcinoma
Matrix Metalloproteinases and Their Tissue Inhibitors in Blood Serum of Patients with Endometrial Cancer: Clinical and Morphological Correlations.
Carcinoma
Matrix metalloproteinases contribute distinct roles in neuroendocrine prostate carcinogenesis, metastasis, and angiogenesis progression.
Carcinoma
MiRNA-34a inhibits EGFR-signaling-dependent MMP7 activation in gastric cancer.
Carcinoma
MMP and TIMP gene expression in head and neck squamous cell carcinomas and adjacent tissues.
Carcinoma
MMP-7 expression may influence the rate of distant recurrences and disease-specific survival in HPV-positive oropharyngeal squamous cell carcinoma.
Carcinoma
MMP-7 is a highly specific negative marker for benign and malignant mesothelial cells in serous effusions.
Carcinoma
MMP-7, MMP-8, and MMP-9 in oral and cutaneous squamous cell carcinomas.
Carcinoma
Modulation of matrilysin levels in colon carcinoma cell lines affects tumorigenicity in vivo.
Carcinoma
Modulation of matrix metalloproteinase-7 (matrilysin) secretion in coculture of human colon carcinoma cells with fibroblasts from orthotopic and ectopic organs.
Carcinoma
Monensin induces cell death by autophagy and inhibits matrix metalloproteinase 7 (MMP7) in UOK146 renal cell carcinoma cell line.
Carcinoma
MT1-MMP and MMP-7 in invasion and metastasis of human cancers.
Carcinoma
Multistep carcinogenesis of perihilar cholangiocarcinoma arising in the intrahepatic large bile ducts.
Carcinoma
Overexpression of matrix metalloproteinase-7 (MMP-7) correlates with tumor proliferation, and a poor prognosis in non-small cell lung cancer.
Carcinoma
Overexpression of matrix metalloproteinase-7 mRNA in human colon carcinomas.
Carcinoma
Paracrine factor and cell-cell contact-mediated induction of protease and c-ets gene expression in malignant keratinocyte/dermal fibroblast cocultures.
Carcinoma
Pericellular activation of proMMP-7 (promatrilysin-1) through interaction with CD151.
Carcinoma
Plasma matrix metalloproteinase-7 as a metastatic marker and survival predictor in patients with renal cell carcinomas.
Carcinoma
Polymorphisms of matrix metalloproteinase-7 and -9 are associated with oral tongue squamous cell carcinoma.
Carcinoma
Predictive value of MMP-7 expression for response to chemotherapy and survival in patients with non-small cell lung cancer.
Carcinoma
Preoperative estimation of neural invasion in rectal carcinoma.
Carcinoma
Preoperative levels of matrix metalloproteinase-7 and -9 and tissue inhibitor of matrix metalloproteinase-1 relation to pathologic parameters in bladder carcinoma patients.
Carcinoma
Prognostic significance of matrix metalloproteinase-7 (MMP-7) expression at the invasive front in gastric carcinoma.
Carcinoma
Prognostic value of matrix metalloproteinases in oral squamous cell carcinoma.
Carcinoma
Purification and characterization of extracellular matrix-degrading metalloproteinase, matrin (pump-1), secreted from human rectal carcinoma cell line.
Carcinoma
Quantitative immunohistochemical analysis of matrilysin 1 (MMP-7) in various renal cell carcinoma subtypes.
Carcinoma
Regulation of matrilysin expression in cells of squamous cell carcinoma by E-cadherin-mediated cell-cell contact.
Carcinoma
Relationship between E-cadherin, matrix metalloproteinase-7 gene expression and clinicopathological features in gastric carcinoma.
Carcinoma
Role of matrix metalloproteinases in colorectal carcinogenesis.
Carcinoma
Role of PTEN and MMP-7 expression in growth, invasion, metastasis and angiogenesis of gastric carcinoma.
Carcinoma
SLC12A5 interacts and enhances SOX18 activity to promote bladder urothelial carcinoma progression via upregulating MMP7.
Carcinoma
The Contribution of MMP-7 Promoter Polymorphisms in Renal Cell Carcinoma.
Carcinoma
The expression and clinical significance of matrix metalloproteinase 7 and tissue inhibitor of matrix metalloproteinases 2 in clear cell renal cell carcinoma.
Carcinoma
The functional polymorphism in the matrix metalloproteinase-7 promoter increases susceptibility to esophageal squamous cell carcinoma, gastric cardiac adenocarcinoma and non-small cell lung carcinoma.
Carcinoma
The matrix metalloprotease pump-1 (MMP-7, Matrilysin): A candidate marker/target for ovarian cancer detection and treatment.
Carcinoma
Tumor and host factors that may limit efficacy of chemotherapy in non-small cell and small cell lung cancer.
Carcinoma
Urachal Carcinoma of the Bladder: Impact of Clinical and Immunohistochemical Parameters on Patient Prognosis.
Carcinoma
Urokinase receptor, MMP-1 and MMP-9 are markers to differentiate prognosis, adenoma and carcinoma in thyroid malignancies.
Carcinoma
[beta-Catenin induces invasive growth by activating matrix metalloproteinases in colorectal carcinoma]
Carcinoma
[Correlation between expression of MMP-7 in gastric submucosal invasive carcinoma and lymph node micrometastasis]
Carcinoma
[Expression and clinical significance of Ang-2 and MMP-7 in laryngeal carcinoma]
Carcinoma
[Expression of ETV5 and MMP-7 in Early Stage Cervical Squamous Cell Carcinoma and Its Role in Lymphatic Metastasis.]
Carcinoma
[Matrix metalloproteinases and their tissue inhibitors in malignancies of the female genital tract]
Carcinoma
[Prognostic significance of the molecular markers in human gastrointestinal cancer]
Carcinoma
[Relationship of matrilysin with invasion, metastasis, and prognosis in laryngeal cancer]
Carcinoma
[The expression of matrix metalloproteinases and tissue inhibitor of metalloproteinases in transplanted tumor of salivary adenoid cystic carcinoma cell lines]
Carcinoma
[The significance of beta-catenin and matrix metalloproteinase-7 expression in colorectal adenoma and carcinoma]
Carcinoma in Situ
Changes in the expression of matrix proteases and of the transcription factor c-Ets-1 during progression of precancerous bronchial lesions.
Carcinoma in Situ
Matrix metalloproteinase 7 and perlecan in oral epithelial dysplasia and carcinoma in situ: an aid for histopathologic recognition of their cell proliferation centers.
Carcinoma, Adenoid Cystic
Matrix metalloproteinase-7, -8, -9, -15, and -25 in minor salivary gland adenoid cystic carcinoma.
Carcinoma, Adenoid Cystic
[The expression of matrix metalloproteinases and tissue inhibitor of metalloproteinases in transplanted tumor of salivary adenoid cystic carcinoma cell lines]
Carcinoma, Adenosquamous
Association between expression of MMP-7 and MMP-9 and pelvic lymph node and para-aortic lymph node metastasis in early cervical cancer.
Carcinoma, Basal Cell
Matrilysin (PUMP) correlates with dermal invasion during appendageal development and cutaneous neoplasia.
Carcinoma, Ductal
MMP-7 A-181G Polymorphism in Breast Cancer Patients from Western Iran.
Carcinoma, Hepatocellular
Assessing matrix metalloproteinase expression and activity in hepatocellular carcinomas.
Carcinoma, Hepatocellular
Association of E-cadherin, matrix metalloproteinases, and tissue inhibitors of metalloproteinases with the progression and metastasis of hepatocellular carcinoma.
Carcinoma, Hepatocellular
c-Myc transactivates GP73 and promotes metastasis of hepatocellular carcinoma cells through GP73-mediated MMP-7 trafficking in a mildly hypoxic microenvironment.
Carcinoma, Hepatocellular
Distinction of hepatocellular adenoma from hepatocellular carcinoma with and without cirrhosis using E-cadherin and matrix metalloproteinase immunohistochemistry.
Carcinoma, Hepatocellular
Expression of matrix metalloproiteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in hepatocellular carcinoma tissue, compared with the surrounding non-tumor tissue.
Carcinoma, Hepatocellular
Expression of matrix metalloproteinases (MMPs) in cultured hepatocellular carcinoma (HCC) cells and surgically resected HCC tissues.
Carcinoma, Hepatocellular
Fibulin-5 inhibits hepatocellular carcinoma cell migration and invasion by down-regulating matrix metalloproteinase-7 expression.
Carcinoma, Hepatocellular
Involvement of the Ets-1 gene in overexpression of matrilysin in human hepatocellular carcinoma.
Carcinoma, Hepatocellular
Isofraxidin, a coumarin component from Acanthopanax senticosus, inhibits matrix metalloproteinase-7 expression and cell invasion of human hepatoma cells.
Carcinoma, Hepatocellular
Messenger RNA expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human hepatocellular carcinoma.
Carcinoma, Hepatocellular
microRNA-489 Plays an Anti-Metastatic Role in Human Hepatocellular Carcinoma by Targeting Matrix Metalloproteinase-7.
Carcinoma, Hepatocellular
No association of MMP-7, MMP-8, and MMP-21 polymorphisms with the risk of hepatocellular carcinoma in a Chinese population.
Carcinoma, Hepatocellular
Relation of enhanced secretion of active matrix metalloproteinases with tumor spread in human hepatocellular carcinoma.
Carcinoma, Hepatocellular
[Expressions of MDM2 and MMP-7 in normal liver, cirrhosis, hepatocellular carcinoma tissues]
Carcinoma, Intraductal, Noninfiltrating
Study of matrix metalloproteinases and their tissue inhibitors in ductal in situ carcinomas of the breast.
Carcinoma, Lewis Lung
Matrix metalloproteinase-9 from bone marrow-derived cells contributes to survival but not growth of tumor cells in the lung microenvironment.
Carcinoma, Lobular
MMP-7 A-181G Polymorphism in Breast Cancer Patients from Western Iran.
Carcinoma, Mucoepidermoid
Matrix metalloproteinase (MMP)-7 in salivary gland cancer.
Carcinoma, Neuroendocrine
A subset of high-grade pulmonary neuroendocrine carcinomas shows up-regulation of matrix metalloproteinase-7 associated with nuclear beta-catenin immunoreactivity, independent of EGFR and HER-2 gene amplification or expression.
Carcinoma, Non-Small-Cell Lung
Beyond Conventional: The New Horizon of Anti-Angiogenic microRNAs in Non-Small Cell Lung Cancer Therapy.
Carcinoma, Non-Small-Cell Lung
Clinical significance of immunohistochemical expression of insulin-like growth factor-1 receptor and matrix metalloproteinase-7 in resected non-small cell lung cancer.
Carcinoma, Non-Small-Cell Lung
Correlation Between MMP-7 and bFGF Expressions in Non-small Cell Lung Cancer Tissue and Clinicopathologic Features.
Carcinoma, Non-Small-Cell Lung
Effect of Osimertinib on the expression of serum mmp-7 and mmp-9 in patients with non-small cell lung cancer.
Carcinoma, Non-Small-Cell Lung
Expression of matrix metalloproteinases 3, 10 and 11 (stromelysins 1, 2 and 3) and matrix metalloproteinase 7 (matrilysin) by cancer cells in non-small cell lung neoplasms. Clinicopathologic studies.
Carcinoma, Non-Small-Cell Lung
Expression of matrix metalloproteinases 7 and 9 in non-small cell lung cancer Relation to clinicopathological factors, beta-catenin and prognosis.
Carcinoma, Non-Small-Cell Lung
Expression of MMP-7, MMP-9, TIMP-1 and TIMP-2 mRNA in lung tissue of patients with non-small cell lung cancer (NSCLC) and benign pulmonary disease.
Carcinoma, Non-Small-Cell Lung
Expression of mRNA MMP-7 and mRNA TIMP-1 in non-small cell lung cancer.
Carcinoma, Non-Small-Cell Lung
Fibulin-3 promoter methylation alters the invasive behavior of non-small cell lung cancer cell lines via MMP-7 and MMP-2 regulation.
Carcinoma, Non-Small-Cell Lung
Overexpression of matrix metalloproteinase-7 (MMP-7) correlates with tumor proliferation, and a poor prognosis in non-small cell lung cancer.
Carcinoma, Non-Small-Cell Lung
Predictive value of MMP-7 expression for response to chemotherapy and survival in patients with non-small cell lung cancer.
Carcinoma, Non-Small-Cell Lung
Prognostic value of matrix metalloproteinase-7 expression in patients with non-small cell lung cancer.
Carcinoma, Non-Small-Cell Lung
Roles of osteopontin and matrix metalloproteinase-7 in occurrence, progression, and prognosis of nonsmall cell lung cancer.
Carcinoma, Non-Small-Cell Lung
The Contribution of MMP-7 Promoter Polymorphisms to Taiwan Lung Cancer Susceptibility.
Carcinoma, Non-Small-Cell Lung
The functional polymorphism in the matrix metalloproteinase-7 promoter increases susceptibility to esophageal squamous cell carcinoma, gastric cardiac adenocarcinoma and non-small cell lung carcinoma.
Carcinoma, Ovarian Epithelial
Clinical utility of circulating matrix metalloproteinase-7 (MMP-7), CC chemokine ligand 18 (CCL18) and CC chemokine ligand 11 (CCL11) as markers for diagnosis of epithelial ovarian cancer.
Carcinoma, Ovarian Epithelial
Expression of MMP-2, -7, -9, MT1-MMP and TIMP-1 and -2 has no prognostic relevance in patients with advanced epithelial ovarian cancer.
Carcinoma, Ovarian Epithelial
Inhibition of matrilysin expression by antisense or RNA interference decreases lysophosphatidic acid-induced epithelial ovarian cancer invasion.
Carcinoma, Ovarian Epithelial
Matrilysin (MMP-7) promotes invasion of ovarian cancer cells by activation of progelatinase.
Carcinoma, Ovarian Epithelial
Plasma levels of MMP-7 and TIMP-1 in laboratory diagnostics and differentiation of selected histological types of epithelial ovarian cancers.
Carcinoma, Ovarian Epithelial
Prognostic significance of matrix metalloproteinase-7 in epithelial ovarian cancer and its relation to beta-catenin expression.
Carcinoma, Papillary
MT1-MMP and MMP-7 in invasion and metastasis of human cancers.
Carcinoma, Renal Cell
Bio-informatics analysis of renal carcinoma gene matrix metalloproteinase-7.
Carcinoma, Renal Cell
Expression of matrix metalloproteinase-7 on cancer cells and tissue endothelial cells in renal cell carcinoma: prognostic implications and clinical significance for invasion and metastasis.
Carcinoma, Renal Cell
Expression of matrix metalloproteinases 7 and 2 in human renal cell carcinoma.
Carcinoma, Renal Cell
In vitro method for diagnosing and monitoring renal cell carcinoma using matrix metalloprotease-7 as humoral biomarker.
Carcinoma, Renal Cell
Matrilysin (MMP-7) is a novel broadly expressed tumor antigen recognized by antigen-specific T cells.
Carcinoma, Renal Cell
Monensin induces cell death by autophagy and inhibits matrix metalloproteinase 7 (MMP7) in UOK146 renal cell carcinoma cell line.
Carcinoma, Renal Cell
Plasma matrix metalloproteinase-7 as a metastatic marker and survival predictor in patients with renal cell carcinomas.
Carcinoma, Renal Cell
Prognostic Role of Matrix Metalloproteinases 2, 7, 8, 9 and Their Type 1 Tissue Inhibitor in Blood Serum of Patients with Kidney Cancer.
Carcinoma, Renal Cell
Quantitative immunohistochemical analysis of matrilysin 1 (MMP-7) in various renal cell carcinoma subtypes.
Carcinoma, Renal Cell
The Contribution of MMP-7 Promoter Polymorphisms in Renal Cell Carcinoma.
Carcinoma, Renal Cell
The expression and clinical significance of matrix metalloproteinase 7 and tissue inhibitor of matrix metalloproteinases 2 in clear cell renal cell carcinoma.
Carcinoma, Renal Cell
Validation of the diagnostic and prognostic relevance of serum MMP-7 levels in renal cell cancer by using a novel automated fluorescent immunoassay method.
Carcinoma, Small Cell
Expression of gelatinase A, tissue inhibitor of metalloproteinases-2, matrilysin, and trypsin(ogen) in lung neoplasms: an immunohistochemical study.
Carcinoma, Squamous Cell
Active matrix metalloproteinase-7 is associated with invasion in buccal squamous cell carcinoma.
Carcinoma, Squamous Cell
Association of matrilysin expression with recurrence and poor prognosis in human esophageal squamous cell carcinoma.
Carcinoma, Squamous Cell
Differential expression of c-jun and c-fos mRNAs in squamous cell carcinoma of the head and neck: associations with uPA, gelatinase B, and matrilysin mRNAs.
Carcinoma, Squamous Cell
Elevated matrix metalloproteinase 7 expression promotes the proliferation, motility and metastasis of tongue squamous cell carcinoma.
Carcinoma, Squamous Cell
Expression of gelatinase A, tissue inhibitor of metalloproteinases-2, matrilysin, and trypsin(ogen) in lung neoplasms: an immunohistochemical study.
Carcinoma, Squamous Cell
Expression of matrix metalloproteinases 3, 10 and 11 (stromelysins 1, 2 and 3) and matrix metalloproteinase 7 (matrilysin) by cancer cells in non-small cell lung neoplasms. Clinicopathologic studies.
Carcinoma, Squamous Cell
Gene Expression Profiling of the Leading Edge of Cutaneous Squamous Cell Carcinoma: IL-24-Driven MMP-7.
Carcinoma, Squamous Cell
Increased expression of matrix metalloproteinase 7 and 9 and membrane type 1-matrix metalloproteinase in esophageal squamous cell carcinomas.
Carcinoma, Squamous Cell
Integrin- and cadherin-mediated induction of the matrix metalloprotease matrilysin in cocultures of malignant oral squamous cell carcinoma cells and dermal fibroblasts.
Carcinoma, Squamous Cell
Interrelation between expression of matrix metalloproteinase 7 and beta-catenin in esophageal cancer.
Carcinoma, Squamous Cell
Matrilysin (PUMP) correlates with dermal invasion during appendageal development and cutaneous neoplasia.
Carcinoma, Squamous Cell
Matrix metalloproteinase matrilysin (MMP-7) participates in the progression of human gastric and esophageal cancers.
Carcinoma, Squamous Cell
Matrix metalloproteinase-7 activates heparin-binding epidermal growth factor-like growth factor in cutaneous squamous cell carcinoma.
Carcinoma, Squamous Cell
Matrix metalloproteinase-7 and matrix metalloproteinase-25 in oral tongue squamous cell carcinoma.
Carcinoma, Squamous Cell
MMP and TIMP gene expression in head and neck squamous cell carcinomas and adjacent tissues.
Carcinoma, Squamous Cell
MMP-7, MMP-8, and MMP-9 in oral and cutaneous squamous cell carcinomas.
Carcinoma, Squamous Cell
Overexpression of matrix metalloproteinase-7 (MMP-7) correlates with tumor proliferation, and a poor prognosis in non-small cell lung cancer.
Carcinoma, Squamous Cell
Paracrine factor and cell-cell contact-mediated induction of protease and c-ets gene expression in malignant keratinocyte/dermal fibroblast cocultures.
Carcinoma, Squamous Cell
Polymorphisms of matrix metalloproteinase-7 and -9 are associated with oral tongue squamous cell carcinoma.
Carcinoma, Squamous Cell
Predictive value of MMP-7 expression for response to chemotherapy and survival in patients with non-small cell lung cancer.
Carcinoma, Squamous Cell
Regulation of matrilysin expression in cells of squamous cell carcinoma by E-cadherin-mediated cell-cell contact.
Carcinoma, Squamous Cell
Tumor and host factors that may limit efficacy of chemotherapy in non-small cell and small cell lung cancer.
Carcinoma, Squamous Cell
[Expression of ETV5 and MMP-7 in Early Stage Cervical Squamous Cell Carcinoma and Its Role in Lymphatic Metastasis.]
Carcinoma, Squamous Cell
[The expression of tumor related macrophages and matrix solution element in laryngeal squamous carcinoma tissue and the relationship with tumor microvascular density].
Carcinoma, Transitional Cell
Expression of matrix metalloproteinases in human transitional cell carcinoma of the urinary bladder.
Carcinosarcoma
Differential expression of matrix metalloprotease-7 in each component of uterine carcinosarcoma.
Carcinosarcoma
Effusion cytodiagnosis of carcinosarcoma derived from the female genital tract: immunohistochemical features of MMP-7 and Ki-67 and immunofluorescence double staining analyses of eight cases.
Cardiomegaly
Matrix metalloproteinase-7 and ADAM-12 (a disintegrin and metalloproteinase-12) define a signaling axis in agonist-induced hypertension and cardiac hypertrophy.
Cardiomegaly
MMP-2 mediates angiotensin II-induced hypertension under the transcriptional control of MMP-7 and TACE.
Cardiovascular Diseases
Cholesterol, lipoproteins and subclinical interstitial lung disease: the MESA study.
Cardiovascular Diseases
Elevated Plasma Levels of MMP-12 Are Associated With Atherosclerotic Burden and Symptomatic Cardiovascular Disease in Subjects With Type 2 Diabetes.
Cardiovascular Diseases
MMP-7 and cardiovascular disease: not so surprising!
Cardiovascular Diseases
Serum tissue-degrading proteinases and incident cardiovascular disease events.
Carotid Artery Diseases
Matrix metalloproteinase 7 is associated with symptomatic lesions and adverse events in patients with carotid atherosclerosis.
Carotid Stenosis
Elevated circulating metalloproteinase 7 predicts recurrent cardiovascular events in patients with carotid stenosis: a prospective cohort study.
Cataract
Higher aqueous levels of matrix metalloproteinases indicated visual impairment in patients with retina vein occlusion after anti-VEGF therapy.
Cholangiocarcinoma
CX-4945 Induces Methuosis in Cholangiocarcinoma Cell Lines by a CK2-Independent Mechanism.
Cholangiocarcinoma
Detection of serum MMP-7 and MMP-9 in cholangiocarcinoma patients: evaluation of diagnostic accuracy.
Cholangiocarcinoma
Expression of matrix metalloproteinase 7 is an unfavorable postoperative prognostic factor in cholangiocarcinoma of the perihilar, hilar, and extrahepatic bile ducts.
Cholangiocarcinoma
Expression of Matrix Metalloproteinase-7 is an Unfavorable Prognostic Factor in Intrahepatic Cholangiocarcinoma.
Cholangiocarcinoma
Expression pattern of matrix metalloproteinases in human liver.
Cholangiocarcinoma
Matrix metalloproteinase-7 expression and biologic aggressiveness of cholangiocellular carcinoma.
Cholangiocarcinoma
Measurement of serum carcinoembryonic antigen, carbohydrate antigen 19-9, cytokeratin-19 fragment and matrix metalloproteinase-7 for detecting cholangiocarcinoma: a preliminary case-control study.
Cholangiocarcinoma
Plasma hydroxyproline, MMP-7 and collagen I as novel predictive risk markers of hepatobiliary disease-associated cholangiocarcinoma.
Cholangiocarcinoma
Prospective study of MMP7 serum levels in the diagnosis of cholangiocarcinoma.
Cholangitis, Sclerosing
Serum Matrix Metalloproteinase 7 Is a Diagnostic Biomarker of Biliary Injury and Fibrosis in Pediatric Autoimmune Liver Disease.
Cholestasis
Diagnostic Accuracy of Serum Matrix Metalloproteinase-7 for Biliary Atresia.
Cholestasis
Increased MMP-7 expression in biliary epithelium and serum underpins native liver fibrosis after successful portoenterostomy in biliary atresia.
Cholestasis
Large-scale proteomics identifies MMP-7 as a sentinel of epithelial injury and of biliary atresia.
Cholestasis
Predicting native liver injury and survival in biliary atresia.
Cholestasis
Quantification of Serum Matrix Metallopeptide 7 Levels May Assist in the Diagnosis and Predict the Outcome for Patients with Biliary Atresia.
Cholesteatoma
Evaluation of significant gene expression changes in congenital and acquired cholesteatoma.
Chondrosarcoma
By activating matrix metalloproteinase-7, shear stress promotes chondrosarcoma cell motility, invasion and lung colonization.
Chondrosarcoma
Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human chondrosarcomas.
Choroidal Neovascularization
Role of matrix metalloproteinase-7 in angiogenesis associated with age-related macular degeneration.
Chronic Periodontitis
Study of the participation of MMP-7, EMMPRIN and cyclophilin A in the pathogenesis of periodontal disease.
Colitis
Cellular sources of MMP-7, MMP-13 and MMP-28 in ulcerative colitis.
Colitis
Expression profiles of matrix metalloproteinases and their inhibitors in colonic inflammation related to pediatric inflammatory bowel disease.
Colitis, Ulcerative
Cellular sources of MMP-7, MMP-13 and MMP-28 in ulcerative colitis.
Colitis, Ulcerative
Enhanced expression of matrilysin, collagenase, and stromelysin-1 in gastrointestinal ulcers.
Colitis, Ulcerative
Enhanced expression of MMP-7 and MMP-13 in inflammatory bowel disease: a precancerous potential?
Colitis, Ulcerative
Enhanced secretion and activation of matrilysin during malignant conversion of human colorectal epithelium and its relationship with invasive potential of colon cancer cells.
Colitis, Ulcerative
Expression of matrilysin mRNA in colorectal adenomas and its induction by truncated fibronectin.
Colitis, Ulcerative
Expressions of Matrix Metalloproteinases (MMP-2, MMP-7, and MMP-9) and Their Inhibitors (TIMP-1, TIMP-2) in Inflammatory Bowel Diseases.
Colitis, Ulcerative
Matrilysin (matrix metalloproteinase-7) expression in ulcerative colitis-related tumorigenesis.
Colitis, Ulcerative
Matrix metalloproteinases cleave membrane-bound PD-L1 on CD90+ (myo-)fibroblasts in Crohn's disease and regulate Th1/Th17 cell responses.
Colitis, Ulcerative
The expression of matrix metalloproteinase matrilysin indicates the degree of inflammation in ulcerative colitis.
Colonic Neoplasms
Association of ets-related transcriptional factor E1AF expression with tumour progression and overexpression of MMP-1 and matrilysin in human colorectal cancer.
Colonic Neoplasms
Association of trypsin expression with tumour progression and matrilysin expression in human colorectal cancer.
Colonic Neoplasms
Binding of active matrilysin to cell surface cholesterol sulfate is essential for its membrane-associated proteolytic action and induction of homotypic cell adhesion.
Colonic Neoplasms
Cancer chemopreventive effects of lycopene: suppression of MMP-7 expression and cell invasion in human colon cancer cells.
Colonic Neoplasms
Cancer invasion regulates vascular complexity in a three-dimensional biomimetic model.
Colonic Neoplasms
Construction of a novel DNA decoy that inhibits the oncogenic beta-catenin/T-cell factor pathway.
Colonic Neoplasms
Contribution of matrilysin (MMP-7) to the metastatic pathway of human colorectal cancers.
Colonic Neoplasms
Conversion of highly malignant colon cancer from an aggressive to a controlled disease by oral administration of a metalloproteinase inhibitor.
Colonic Neoplasms
Decreased synthesis of matrix metalloproteinase-7 and adhesion to the extracellular matrix proteins of human colon cancer cells treated with troglitazone.
Colonic Neoplasms
Detection of regional lymph node metastases in colon cancer by using RT-PCR for matrix metalloproteinase 7, matrilysin.
Colonic Neoplasms
Dimerumic Acid Inhibits SW620 Cell Invasion by Attenuating H(2)O(2)-Mediated MMP-7 Expression via JNK/C-Jun and ERK/C-Fos Activation in an AP-1-Dependent Manner.
Colonic Neoplasms
Distinct expression pattern of the full set of secreted phospholipases A2 in human colorectal adenocarcinomas: sPLA2-III as a biomarker candidate.
Colonic Neoplasms
Effect of preoperative radiotherapy on matrilysin gene expression in rectal cancer.
Colonic Neoplasms
Effect of sulindac sulfide on metallohydrolases in the human colon cancer cell line HT-29.
Colonic Neoplasms
Elevated expressions of MMP7, TROP2, and survivin are associated with survival, disease recurrence, and liver metastasis of colon cancer.
Colonic Neoplasms
Enhanced secretion and activation of matrilysin during malignant conversion of human colorectal epithelium and its relationship with invasive potential of colon cancer cells.
Colonic Neoplasms
Epidermal growth factor upregulates matrix metalloproteinase-7 expression through activation of PEA3 transcription factors.
Colonic Neoplasms
Expression of matrix metalloproteinase matrilysin (MMP-7) was induced by activated Ki-ras via AP-1 activation in SW1417 colon cancer cells.
Colonic Neoplasms
Expressions of TIMP-1, COX-2 and MMP-7 in Colon Polyp and Colon Cancer.
Colonic Neoplasms
Farnesoid X receptor represses matrix metalloproteinase 7 expression, revealing this regulatory axis as a promising therapeutic target in colon cancer.
Colonic Neoplasms
FGF-1/-3/FGFR4 signaling in cancer-associated fibroblasts promotes tumor progression in colon cancer through Erk and MMP-7.
Colonic Neoplasms
Global gene expression analysis of rat colon cancers induced by a food-borne carcinogen, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine.
Colonic Neoplasms
Identification of amino acid residues of matrix metalloproteinase-7 essential for binding to cholesterol sulfate.
Colonic Neoplasms
Identification of early-stage colorectal cancer patients at risk of relapse post-resection by immunobead reverse transcription-PCR analysis of peritoneal lavage fluid for malignant cells.
Colonic Neoplasms
Inhibitory effect of matrilysin antisense oligonucleotides on human colon cancer cell invasion in vitro.
Colonic Neoplasms
Integrin- and cadherin-mediated induction of the matrix metalloprotease matrilysin in cocultures of malignant oral squamous cell carcinoma cells and dermal fibroblasts.
Colonic Neoplasms
Interleukin-1? promotes extracellular shedding of syndecan-2 via induction of matrix metalloproteinase-7 expression.
Colonic Neoplasms
Knockdown of MMP-7 inhibits cell proliferation and enhances sensitivity to 5-fluorouracil and X-ray irradiation in colon cancer cells.
Colonic Neoplasms
Matrilysin (matrix metalloprotease-7) cleaves membrane-bound annexin II and enhances binding of tissue-type plasminogen activator to cancer cell surfaces.
Colonic Neoplasms
Matrilysin (MMP-7) induces homotypic adhesion of human colon cancer cells and enhances their metastatic potential in nude mouse model.
Colonic Neoplasms
Matrilysin as a target for chemotherapy for colon cancer: use of antisense oligonucleotides as antimetastatic agents.
Colonic Neoplasms
Matrilysin stimulates DNA synthesis of cultured vascular endothelial cells and induces angiogenesis in vivo.
Colonic Neoplasms
Matrilysin-specific antisense oligonucleotide inhibits liver metastasis of human colon cancer cells in a nude mouse model.
Colonic Neoplasms
Matrix metalloproteinase-7 induces homotypic tumor cell aggregation via proteolytic cleavage of the membrane-bound Kunitz-type inhibitor HAI-1.
Colonic Neoplasms
Matrix metalloproteinase-7-catalyzed release of HB-EGF mediates deoxycholyltaurine-induced proliferation of a human colon cancer cell line.
Colonic Neoplasms
Matrix-degrading metalloproteinases in tumor progression.
Colonic Neoplasms
MMP7 as a potential biomarker of colon cancer and its prognostic value by bioinformatics analysis.
Colonic Neoplasms
Modulation of matrilysin levels in colon carcinoma cell lines affects tumorigenicity in vivo.
Colonic Neoplasms
NOX1 to NOX2 switch deactivates AMPK and induces invasive phenotype in colon cancer cells through overexpression of MMP-7.
Colonic Neoplasms
Oncogenic beta-catenin and MMP-7 (matrilysin) cosegregate in late-stage clinical colon cancer.
Colonic Neoplasms
Overexpression of Reg4, alone or combined with MMP-7 overexpression, is predictive of poor prognosis in colorectal cancer.
Colonic Neoplasms
Peroxisome proliferator-activated receptor gamma agonists inhibit the proliferation and invasion of human colon cancer cells.
Colonic Neoplasms
Polyamine-dependent expression of the matrix metalloproteinase matrilysin in a human colon cancer-derived cell line.
Colonic Neoplasms
Polymorphisms in MMP-1, MMP-2, MMP-7, MMP-13 and MT2A do not contribute to breast, lung and colon cancer risk in polish population.
Colonic Neoplasms
Processing of syndecan-2 by matrix metalloproteinase-14 and effect of its cleavage on VEGF-induced tube formation of HUVECs.
Colonic Neoplasms
Prognostic significance of the TNM system criteria, levels of serum insulin-like growth factors and their transport proteins, VEGF and MMP-7 in colorectal cancer.
Colonic Neoplasms
Proliferative effects of apical, but not basal, matrix metalloproteinase-7 activity in polarized MDCK cells.
Colonic Neoplasms
Radixin enhances colon cancer cell invasion by increasing MMP-7 production via Rac1-ERK pathway.
Colonic Neoplasms
Retinoic acids reduce matrilysin (matrix metalloproteinase 7) and inhibit tumor cell invasion in human colon cancer.
Colonic Neoplasms
Simultaneous determination of matrix metalloproteinase (MMP)-7, MMP-1, -3, and -13 gene expression by multiplex PCR in colorectal carcinomas.
Colonic Neoplasms
Suppression of matrilysin inhibits colon cancer cell invasion in vitro.
Colonic Neoplasms
Syndecan-2 cytoplasmic domain upregulates Matrix Metalloproteinase-7 expression via Protein KinaseC? mediated FAK/ERK signaling pathway in colon cancer.
Colonic Neoplasms
Syndecan-2 enhances E-cadherin shedding and fibroblast-like morphological changes by inducing MMP-7 expression in colon cancer cells.
Colonic Neoplasms
Syndecan-2 functions as a docking receptor for pro-matrix metalloproteinase-7 in human colon cancer cells.
Colonic Neoplasms
Synergistic cooperation between the AP-1 and LEF-1 transcription factors in activation of the matrilysin promoter by the src oncogene: implications in cellular invasion.
Colonic Neoplasms
The matrix metalloproteinase-7 regulates the extracellular shedding of syndecan-2 from colon cancer cells.
Colonic Neoplasms
Tissue factor/activated factor VIIa induces matrix metalloproteinase-7 expression through activation of c-Fos via ERK1/2 and p38 MAPK signaling pathways in human colon cancer cell.
Colonic Neoplasms
Tungsten Oxide Nanoplates; the Novelty in Targeting Metalloproteinase-7 Gene in Both Cervix and Colon Cancer Cells.
Colonic Neoplasms
Tyrosine 51 residue of the syndecan-2 extracellular domain is involved in the interaction with and activation of pro-matrix metalloproteinase-7.
Colonic Neoplasms
Wnt/?-catenin signaling mediates the antitumor activity of magnolol in colorectal cancer cells.
Colonic Neoplasms
[Expression and clinical significance of survivin and matrix metalloproteinase-7 in colon cancer.]
Colorectal Neoplasms
(-)-Epigallocatechin-3-gallate promotes pro-matrix metalloproteinase-7 production via activation of the JNK1/2 pathway in HT-29 human colorectal cancer cells.
Colorectal Neoplasms
A/G Polymorphism of the MMP-7 Gene Promoter Region in Colorectal Cancer.
Colorectal Neoplasms
Aluminum exposure promotes the metastatic proclivity of human colorectal cancer cells through matrix metalloproteinases and the TGF-?/Smad signaling pathway.
Colorectal Neoplasms
Andrographolide could inhibit human colorectal carcinoma Lovo cells migration and invasion via down-regulation of MMP-7 expression.
Colorectal Neoplasms
Association of ets-related transcriptional factor E1AF expression with tumour progression and overexpression of MMP-1 and matrilysin in human colorectal cancer.
Colorectal Neoplasms
ASSOCIATION OF MMP-7 -181A>G POLYMORPHISM WITH COLORECTAL CANCER AND GASTRIC CANCER SUSCEPTIBILITY: A SYSTEMATIC REVIEW AND META-ANALYSIS.
Colorectal Neoplasms
Association of trypsin expression with tumour progression and matrilysin expression in human colorectal cancer.
Colorectal Neoplasms
beta-catenin regulates the expression of the matrix metalloproteinase-7 in human colorectal cancer.
Colorectal Neoplasms
Cancer chemopreventive effects of lycopene: suppression of MMP-7 expression and cell invasion in human colon cancer cells.
Colorectal Neoplasms
Clinical impact of matrix metalloproteinase-7 mRNA expression in the invasive front and inner surface of tumor tissues in patients with colorectal cancer.
Colorectal Neoplasms
Clinical Significance of MMP-7 and PTEN Expression in Colorectal Cancer.
Colorectal Neoplasms
Clinical utility of grading criteria for submucosal invasion in the prognosis of T1 colorectal carcinomas.
Colorectal Neoplasms
Clinicopathologic and prognostic significance of matrilysin expression at the invasive front in human colorectal cancers.
Colorectal Neoplasms
Clinicopathological assessment and quantitative estimation of the matrix metalloproteinases MMP-2 and MMP-7 and the inhibitors TIMP-1 and TIMP-2 in colorectal carcinoma tissue samples.
Colorectal Neoplasms
Clinicopathological significance of the gene expression of matrix metalloproteinase-7, insulin-like growth factor-1, insulin-like growth factor-2 and insulin-like growth factor-1 receptor in patients with colorectal cancer: insulin-like growth factor-1 receptor gene expression is a useful predictor of liver metastasis from colorectal cancer.
Colorectal Neoplasms
Co-expression of matrix metalloproteinase-7 (MMP-7) and phosphorylated insulin growth factor receptor I (pIGF-1R) correlates with poor prognosis in patients with wild-type KRAS treated with cetuximab or panitumumab: a GEMCAD study.
Colorectal Neoplasms
Coexpression of matrilysin and laminin-5 gamma2 chain may contribute to tumor cell migration in colorectal carcinomas.
Colorectal Neoplasms
Coexpression of matrix metalloproteinase-7 (MMP-7) and epidermal growth factor (EGF) receptor in colorectal cancer: an EGF receptor tyrosine kinase inhibitor is effective against MMP-7-expressing cancer cells.
Colorectal Neoplasms
Coexpression of p-IGF-1R and MMP-7 Modulates Panitumumab and Cetuximab Efficacy in RAS Wild-Type Metastatic Colorectal Cancer Patients.
Colorectal Neoplasms
Colorectal carcinoma susceptibility and metastases are associated with matrix metalloproteinase-7 promoter polymorphisms.
Colorectal Neoplasms
Contribution of matrilysin (MMP-7) to the metastatic pathway of human colorectal cancers.
Colorectal Neoplasms
Diagnostic values of MMP-7, MMP-9, MMP-11, TIMP-1, TIMP-2, CEA, and CA19-9 in patients with colorectal cancer.
Colorectal Neoplasms
Differential expression of matrilysin and cyclooxygenase-2 in intestinal and colorectal neoplasms.
Colorectal Neoplasms
E-cadherin and metalloproteinase-1 and -7 polymorphisms in colorectal cancer.
Colorectal Neoplasms
E-cadherin, beta-catenin adhesion complex and relation to matrilysin expression in pT3 rectosigmoid cancers.
Colorectal Neoplasms
Effect of preoperative radiotherapy on matrilysin gene expression in rectal cancer.
Colorectal Neoplasms
Enhanced expression of MMP-7 and MMP-13 in inflammatory bowel disease: a precancerous potential?
Colorectal Neoplasms
Enhanced secretion and activation of matrilysin during malignant conversion of human colorectal epithelium and its relationship with invasive potential of colon cancer cells.
Colorectal Neoplasms
Evaluation of alpha 1-antitrypsin and the levels of mRNA expression of matrix metalloproteinase 7, urokinase type plasminogen activator receptor and COX-2 for the diagnosis of colorectal cancer.
Colorectal Neoplasms
Evaluation of the correlation of KAI1/CD82, CD44, MMP7 and ?-catenin in the prediction of prognosis and metastasis in colorectal carcinoma.
Colorectal Neoplasms
Expression and activity levels of matrix metalloproteinase-7 and in situ localization of caseinolytic activity in colorectal cancer.
Colorectal Neoplasms
Expression and prognostic value of matrix metalloproteinase-7 in colorectal cancer.
Colorectal Neoplasms
Expression of matrilysin in vascular endothelial cells adjacent to matrilysin-producing tumors.
Colorectal Neoplasms
Expression of matrix metalloproteinase 7, laminin and type IV collagen-associated liver metastasis in human colorectal cancer: immunohistochemical approach.
Colorectal Neoplasms
Expression of matrix metalloproteinase matrilysin (MMP-7) was induced by activated Ki-ras via AP-1 activation in SW1417 colon cancer cells.
Colorectal Neoplasms
Expression of matrix metalloproteinase-7 correlates with the invasion of T1 colorectal carcinoma.
Colorectal Neoplasms
Expression of matrix metalloproteinases 2, 7 and 9 in patients with colorectal cancer.
Colorectal Neoplasms
Expression of MMP-7(PUMP-1) mRNA in human colorectal cancers.
Colorectal Neoplasms
Expression of p16 in lymph node metastases of adjuvantly treated stage III colorectal cancer patients identifies poor prognostic subgroups: a retrospective analysis of biomarkers in matched primary tumor and lymph node metastases.
Colorectal Neoplasms
Fecal cyclooxygenase 2 plus matrix metalloproteinase 7 mRNA assays as a marker for colorectal cancer screening.
Colorectal Neoplasms
High expression of matrix metalloproteinases: MMP-2 and MMP-9 predicts poor survival outcome in colorectal carcinoma.
Colorectal Neoplasms
Immunohistochemical expression of MMP-7 protein and its serum level in colorectal cancer.
Colorectal Neoplasms
Immunohistochemical molecular markers as predictors of curability of endoscopically resected submucosal colorectal cancer.
Colorectal Neoplasms
Implications of Isoprostanes and Matrix Metalloproteinase-7 Having Potential Role in the Development of Colorectal Cancer in Males.
Colorectal Neoplasms
Inhibitory effect of matrilysin antisense oligonucleotides on human colon cancer cell invasion in vitro.
Colorectal Neoplasms
Interplay of insulin-like growth factor-II, insulin-like growth factor-I, insulin-like growth factor-I receptor, COX-2, and matrix metalloproteinase-7, play key roles in the early stage of colorectal carcinogenesis.
Colorectal Neoplasms
Intestinal tumorigenesis is suppressed in mice lacking the metalloproteinase matrilysin.
Colorectal Neoplasms
Knockdown of MMP-7 inhibits cell proliferation and enhances sensitivity to 5-fluorouracil and X-ray irradiation in colon cancer cells.
Colorectal Neoplasms
Malignant Potential of Gastrointestinal Cancers Assessed by Structural Equation Modeling.
Colorectal Neoplasms
Matrilysin (matrix metalloproteinase-7) expression in ulcerative colitis-related tumorigenesis.
Colorectal Neoplasms
Matrilysin (MMP-7) as a significant determinant of malignant potential of early invasive colorectal carcinomas.
Colorectal Neoplasms
Matrilysin (MMP-7) degrades VE-cadherin and accelerates accumulation of beta-catenin in the nucleus of human umbilical vein endothelial cells.
Colorectal Neoplasms
Matrilysin is associated with progression of colorectal tumor.
Colorectal Neoplasms
Matrix metalloproteinase 7 is a useful marker for 5-fluorouracil-based adjuvant chemotherapy in stage II and stage III colorectal cancer patients.
Colorectal Neoplasms
Matrix metalloproteinase 7 is required for tumor formation, but dispensable for invasion and fibrosis in SMAD4-deficient intestinal adenocarcinomas.
Colorectal Neoplasms
Matrix metalloproteinase-7 expression in colorectal cancer liver metastases: evidence for involvement of MMP-7 activation in human cancer metastases.
Colorectal Neoplasms
Matrix metalloproteinase-7 increases resistance to Fas-mediated apoptosis and is a poor prognostic factor of patients with colorectal carcinoma.
Colorectal Neoplasms
Matrix metalloproteinase/tissue inhibitors of matrix metalloproteinase phenotype identifies poor prognosis colorectal cancers.
Colorectal Neoplasms
Matrix metalloproteinases 7 and 9 and their types 1 and 4 tissue inhibitors in tumors and plasma of patients with colorectal cancer.
Colorectal Neoplasms
Matrix metalloproteinases may contribute compensationally to tumor invasion in T1 colorectal carcinomas.
Colorectal Neoplasms
Metalloproteinase-1, metalloproteinase-7, and p53 immunoexpression and their correlation with clinicopathological prognostic factors in colorectal adenocarcinoma.
Colorectal Neoplasms
MMP-7 (matrilysin) accelerated growth of human umbilical vein endothelial cells.
Colorectal Neoplasms
MMP-7 and SGCE as distinctive molecular factors in sporadic colorectal cancers from the mutator phenotype pathway.
Colorectal Neoplasms
MMP-7 as a prognostic marker in colorectal cancer.
Colorectal Neoplasms
MMP7 Modulation by Short- and Long-term Radiotherapy in Patients with Rectal Cancer.
Colorectal Neoplasms
Modifying Effects of Dietary Factors on (-)-Epigallocatechin-3-gallate-induced Pro-matrix Metalloproteinase-7 Production in HT-29 Human Colorectal Cancer Cells.
Colorectal Neoplasms
Modulation of matrilysin levels in colon carcinoma cell lines affects tumorigenicity in vivo.
Colorectal Neoplasms
Modulation of matrix metalloproteinase-7 (matrilysin) secretion in coculture of human colon carcinoma cells with fibroblasts from orthotopic and ectopic organs.
Colorectal Neoplasms
New insights into the roles of matrix metalloproteinases in colorectal cancer development and progression.
Colorectal Neoplasms
Nobiletin, a citrus flavonoid, down-regulates matrix metalloproteinase-7 (matrilysin) expression in HT-29 human colorectal cancer cells.
Colorectal Neoplasms
Novel octapeptide-DTX prodrugs targeting MMP-7 as effective agents for the treatment of colorectal cancer with lower systemic toxicity.
Colorectal Neoplasms
Observation of microvessels and invasion in early colorectal neoplasms on narrow band imaging: combination with CD34 and matrix metalloproteinase-7 expression.
Colorectal Neoplasms
Overexpression of matrix metalloproteinase-7 mRNA in human colon carcinomas.
Colorectal Neoplasms
Overexpression of MMP-13 gene in colorectal cancer with liver metastasis.
Colorectal Neoplasms
Overexpression of poly(ADP-ribose) polymerase-1 (PARP-1) in the early stage of colorectal carcinogenesis.
Colorectal Neoplasms
Overexpression of Reg4, alone or combined with MMP-7 overexpression, is predictive of poor prognosis in colorectal cancer.
Colorectal Neoplasms
Overexpression of the thymosin beta-4 gene is associated with increased invasion of SW480 colon carcinoma cells and the distant metastasis of human colorectal carcinoma.
Colorectal Neoplasms
Peritoneal expression of Matrilysin helps identify early post-operative recurrence of colorectal cancer.
Colorectal Neoplasms
Prediction of distant metastasis by using reverse transcriptase-polymerase chain reaction for epithelial and variant CD44 mRNA in the peripheral blood of patients with colorectal cancer.
Colorectal Neoplasms
Prognostic significance of matrix metalloproteinase 7 immunohistochemical expression in colorectal cancer: a meta-analysis.
Colorectal Neoplasms
Prognostic significance of MMP-7 expression in colorectal cancer: A meta-analysis.
Colorectal Neoplasms
Prognostic significance of the TNM system criteria, levels of serum insulin-like growth factors and their transport proteins, VEGF and MMP-7 in colorectal cancer.
Colorectal Neoplasms
Prosurvival long noncoding RNA PINCR regulates a subset of p53 targets in human colorectal cancer cells by binding to Matrin 3.
Colorectal Neoplasms
Quantitative estimation of matrix metalloproteinases 2 and 7 (MMP-2, MMP-7) and tissue inhibitors of matrix metalloproteinases 1 and 2 (TIMP-1, TIMP-2) in colorectal carcinoma tissue samples.
Colorectal Neoplasms
Relationship between matrix metalloproteinase-7 and pit pattern in early stage colorectal cancer.
Colorectal Neoplasms
Relationship of serum MMP-7 levels for colorectal cancer: a meta-analysis.
Colorectal Neoplasms
Retraction Note to: Relationship of serum MMP-7 levels for colorectal cancer: a meta-analysis.
Colorectal Neoplasms
Role of matrix metalloproteinases (MMPs) in colorectal cancer.
Colorectal Neoplasms
Rosiglitazone and retinoic acid inhibit proliferation and induce apoptosis in the HCT-15 human colorectal cancer cell line.
Colorectal Neoplasms
Serum IGF-I, IGFBP-3, and matrix metalloproteinase-7 levels and acquired chemo-resistance in advanced colorectal cancer.
Colorectal Neoplasms
Serum levels of TIMP-1 and MMP-7 as potential biomarkers in patients with metastatic colorectal cancer.
Colorectal Neoplasms
Serum matrilysin correlates with poor survival independently of KRAS and BRAF status in refractory advanced colorectal cancer patients treated with irinotecan plus cetuximab.
Colorectal Neoplasms
Serum matrilysin levels predict outcome in curatively resected colorectal cancer patients.
Colorectal Neoplasms
Serum matrix metalloproteinase 7 levels identifies poor prognosis advanced colorectal cancer patients.
Colorectal Neoplasms
Simultaneous determination of matrix metalloproteinase (MMP)-7, MMP-1, -3, and -13 gene expression by multiplex PCR in colorectal carcinomas.
Colorectal Neoplasms
Single-pair fluorescence resonance energy transfer analysis of mRNA transcripts for highly sensitive gene expression profiling in near real time.
Colorectal Neoplasms
Stiff substrates increase YAP-signaling-mediated matrix metalloproteinase-7 expression.
Colorectal Neoplasms
Systematic analysis of proteins from different signaling pathways in the tumor center and the invasive front of colorectal cancer.
Colorectal Neoplasms
Systematic assessment of protein phenotypes characterizing high-grade tumour budding in mismatch repair-proficient colorectal cancer.
Colorectal Neoplasms
The Contribution of MMP-7 Genotypes to Colorectal Cancer Susceptibility in Taiwan.
Colorectal Neoplasms
The expression of mmp-7 messenger-RNA in primary and metastatic human colorectal adenocarcinoma.
Colorectal Neoplasms
TNM staging for GIT cancers is correlated with the level of MMPs and TGF-?1.
Colorectal Neoplasms
[beta-Catenin induces invasive growth by activating matrix metalloproteinases in colorectal carcinoma]
Colorectal Neoplasms
[Effects of tamoxifen on apoptosis and matrix metalloproteinase-7 expression in estrogen receptor beta-positive colorectal cancer cell line HT-29]
Colorectal Neoplasms
[Expression of LOX in Colorectal Cancer Tissues and Its Relationship with Progress and Prognosis].
Colorectal Neoplasms
[Expression of matrix metalloproteinases and tissue inhibitor of metalloproteinases in colorectal neoplasm]
Colorectal Neoplasms
[Function of MMP-7 in colorectal cancer]
Colorectal Neoplasms
[Genetic diagnosis of colorectal cancer]
Colorectal Neoplasms
[Prognostic significance of the molecular markers in human gastrointestinal cancer]
Colorectal Neoplasms
[The significance of beta-catenin and matrix metalloproteinase-7 expression in colorectal adenoma and carcinoma]
Coronary Artery Disease
Allele-specific regulation of matrix metalloproteinase-7 promoter activity is associated with coronary artery luminal dimensions among hypercholesterolemic patients.
Coronary Artery Disease
Analysis of MMP-7 and TIMP-2 gene polymorphisms in coronary artery disease and myocardial infarction: A Turkish case-control study.
Coronary Artery Disease
Changes in plasma levels of MMP-9, MMP-7 and their inhibitors in patients with coronary artery disease.
Coronary Artery Disease
Increased plasma concentration of matrix metalloproteinase-7 in patients with coronary artery disease.
Coronary Artery Disease
Role of matrix metalloproteinases in coronary artery disease.
Coronary Artery Disease
[Changes in proinflammatory cytokine and destructive metalloproteinase levels during formation of unstable atherosclerotic plaque]
Coronary Artery Disease
[Inflammatory-destructive biomarkers of atherosclerotic plaques instability. Study of arterial wall and blood].
Cough
Elevated matrilysin levels in bronchoalveolar lavage fluid do not distinguish idiopathic pulmonary fibrosis from other interstitial lung diseases.
COVID-19
Immunofibrotic drivers of impaired lung function in postacute sequelae of SARS-CoV-2 infection.
Crohn Disease
Enhanced expression of matrilysin, collagenase, and stromelysin-1 in gastrointestinal ulcers.
Crohn Disease
Enhanced expression of MMP-7 and MMP-13 in inflammatory bowel disease: a precancerous potential?
Crohn Disease
Expressions of Matrix Metalloproteinases (MMP-2, MMP-7, and MMP-9) and Their Inhibitors (TIMP-1, TIMP-2) in Inflammatory Bowel Diseases.
Cryptogenic Organizing Pneumonia
Is metalloproteinase-7 specific for idiopathic pulmonary fibrosis?
Cystic Fibrosis
Matrilysin expression and function in airway epithelium.
Cystic Fibrosis
Matrix metalloproteinase activation by free neutrophil elastase contributes to bronchiectasis progression in early cystic fibrosis.
Cystic Fibrosis
Matrix Metalloproteinases-7 and Kidney Fibrosis.
Cystic Fibrosis
Regulation of matrilysin expression in airway epithelial cells by Pseudomonas aeruginosa flagellin.
Cystitis
Molecular Basis of Acute Cystitis Reveals Susceptibility Genes and Immunotherapeutic Targets.
Cysts
Analyses of matrix metalloproteinases and their inhibitors in cyst fluid of serous ovarian tumors.
Cysts
Induction of matrix metalloprotease-7 is common in mucinous ovarian tumors including early stage disease.
Cysts
Matrilysin (MMP-7) Inhibition of BMP-7 Induced Renal Tubular Branching Morphogenesis Suggests a Role in the Pathogenesis of Human Renal Dysplasia.
Demyelinating Diseases
Matrix metalloproteinases MMP-9 and MMP-7 are expressed in experimental autoimmune neuritis and the Guillain-Barré syndrome.
Dermatomyositis
Expression of matrix metalloproteinases in the muscle of patients with inflammatory myopathies.
Dermatomyositis
Surfactant protein D is associated with 3-month mortality of anti-MDA5 antibody-interstitial lung disease.
Diabetes Complications
Serum MMP-7 is increased in diabetic renal disease and diabetic diastolic dysfunction.
Diabetes Mellitus
Changes in Activity of Matrix Metalloproteinases and Serum Concentrations of Proinsulin and C-Peptide Depending on the Compensation Stage of Type 2 Diabetes Mellitus.
Diabetes Mellitus
Diabetes Associated Markers After Bariatric Surgery: Fetuin-A, but Not Matrix Metalloproteinase-7, Is Reduced.
Diabetes Mellitus
Elevated Plasma Levels of MMP-12 Are Associated With Atherosclerotic Burden and Symptomatic Cardiovascular Disease in Subjects With Type 2 Diabetes.
Diabetes Mellitus
Matrix metalloproteinase -7, -8, -9 and -13 in gingival tissue of patients with type 1 diabetes and periodontitis.
Diabetes Mellitus
Matrix metalloproteinase-7 in periodontitis with type 2 diabetes mellitus.
Diabetes Mellitus
The impact of type 2 diabetes and atorvastatin treatment on serum levels of MMP-7 and MMP-8.
Diabetes Mellitus, Type 1
Matrix metalloproteinase -7, -8, -9 and -13 in gingival tissue of patients with type 1 diabetes and periodontitis.
Diabetes Mellitus, Type 1
Urinary excretion of RAS, BMP, and WNT pathway components in diabetic kidney disease.
Diabetes Mellitus, Type 2
Advanced glycation end products decrease mesangial cell MMP-7: a role in matrix accumulation in diabetic nephropathy?
Diabetes Mellitus, Type 2
Changes in Activity of Matrix Metalloproteinases and Serum Concentrations of Proinsulin and C-Peptide Depending on the Compensation Stage of Type 2 Diabetes Mellitus.
Diabetes Mellitus, Type 2
Diabetes Associated Markers After Bariatric Surgery: Fetuin-A, but Not Matrix Metalloproteinase-7, Is Reduced.
Diabetes Mellitus, Type 2
Elevated Plasma Levels of MMP-12 Are Associated With Atherosclerotic Burden and Symptomatic Cardiovascular Disease in Subjects With Type 2 Diabetes.
Diabetes Mellitus, Type 2
Matrix metalloproteinase-7 in periodontitis with type 2 diabetes mellitus.
Diabetes Mellitus, Type 2
The impact of type 2 diabetes and atorvastatin treatment on serum levels of MMP-7 and MMP-8.
Diabetes Mellitus, Type 2
Urine matrix metalloproteinase-7 and risk of kidney disease progression and mortality in type 2 diabetes.
Diabetic Retinopathy
Diabetes-induced peroxynitrite impairs the balance of pro-nerve growth factor and nerve growth factor, and causes neurovascular injury.
Digestive System Neoplasms
Current evidence on associations between the MMP-7 (-181A>G) polymorphism and digestive system cancer risk.
Distal Myopathies
Autosomal-dominant distal myopathy associated with a recurrent missense mutation in the gene encoding the nuclear matrix protein, matrin 3.
Distal Myopathies
Characterization of gene regulation and protein interaction networks for Matrin 3 encoding mutations linked to amyotrophic lateral sclerosis and myopathy.
Distal Myopathies
Heterogeneity of Matrin 3 in the developing and aging murine central nervous system.
Distal Myopathies
Matrin 3 in neuromuscular disease: physiology and pathophysiology.
Distal Myopathies
Mutant MATR3 mouse model to explain multisystem proteinopathy.
Distal Myopathies
Mutation analysis of MATR3 in Australian familial amyotrophic lateral sclerosis.
Distal Myopathies
Subcellular Localization of Matrin 3 Containing Mutations Associated with ALS and Distal Myopathy.
Distal Myopathies
Transgenic mice overexpressing the ALS-linked protein Matrin 3 develop a profound muscle phenotype.
Down Syndrome
Manifold decreased protein levels of matrin 3, reduced motor protein HMP and hlark in fetal Down's syndrome brain.
Duodenal Ulcer
Elevated Serum Matrix Metalloproteinase-3 and -7 in H. pylori-Related Gastric Cancer Can Be Biomarkers Correlating with a Poor Survival.
Dyspnea
Elevated MMP-7 levels in patients with systemic sclerosis: correlation with pulmonary involvement.
Dyspnea
Matrix metalloproteinase 7 in diagnosis and differentiation of pulmonary arterial hypertension.
Dyspnea
Serum Matrix Metalloproteinase-7, Respiratory Symptoms, and Mortality in Community-dwelling Adults: The Multi-Ethnic Study of Atherosclerosis.
Embolism
Association between expression of MMP-7 and MMP-9 and pelvic lymph node and para-aortic lymph node metastasis in early cervical cancer.
Encephalitis
Cleavage of neuronal synaptosomal-associated protein of 25 kDa by exogenous matrix metalloproteinase-7.
Encephalitis
Matrix metalloproteinase-7 modulates synaptic vesicle recycling and induces atrophy of neuronal synapses.
Encephalomyelitis
Matrix metalloproteinase-7 facilitates immune access to the CNS in experimental autoimmune encephalomyelitis.
Encephalomyelitis
Plasminogen activators and matrix metalloproteases, mediators of extracellular proteolysis in inflammatory demyelination of the central nervous system.
Encephalomyelitis, Autoimmune, Experimental
Matrix metalloproteinase-7 facilitates immune access to the CNS in experimental autoimmune encephalomyelitis.
Encephalomyelitis, Autoimmune, Experimental
Plasminogen activators and matrix metalloproteases, mediators of extracellular proteolysis in inflammatory demyelination of the central nervous system.
Endocarditis
[The study of activity of matrix metalloproteinases abd reactants of inflammation in patients with endocarditis.]
Endometrial Hyperplasia
Matrix Metalloproteinases and Their Tissue Inhibitors in Blood Serum of Patients with Endometrial Cancer: Clinical and Morphological Correlations.
Endometrial Hyperplasia
Significance of matrix metalloproteinase-7 [correction of matrix metalloproteinase-2], -11 and tissue inhibitor of metalloproteinase-1 expression in normal, hyperplastic and neoplastic endometrium.
Endometrial Neoplasms
Development of in situ zymography to localize active matrix metalloproteinase-7 (matrilysin-1).
Endometrial Neoplasms
Enhanced production and activation of matrix metalloproteinase-7 (matrilysin) in human endometrial carcinomas.
Endometrial Neoplasms
Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinase in uterine endometrial carcinoma and a correlation between expression of matrix metalloproteinase-7 and prognosis.
Endometrial Neoplasms
Matrix metalloproteinase-7 (MMP-7) polymorphism is a risk factor for endometrial cancer susceptibility.
Endometrial Neoplasms
Matrix Metalloproteinases and Their Tissue Inhibitors in Blood Serum of Patients with Endometrial Cancer: Clinical and Morphological Correlations.
Endometrial Neoplasms
No Association between Matrix Metalloproteinase (MMP)-1, MMP-3, and MMP-7 SNPs and Endometrial Cancer Risk.
Endometrial Neoplasms
Selected immunohistochemical prognostic factors in endometrial cancer.
Endometrial Neoplasms
Significance of matrix metalloproteinase-7 [correction of matrix metalloproteinase-2], -11 and tissue inhibitor of metalloproteinase-1 expression in normal, hyperplastic and neoplastic endometrium.
Endometrial Neoplasms
[Immunohistochemical markers expression in hysteroscopy and hysterectomy specimens from endometrial cancer patients: comparison]
Endometrial Neoplasms
[Matrix metalloproteinases and their tissue inhibitors in malignancies of the female genital tract]
Endometrial Neoplasms
[The utility of metalloproteinases (MMPs) and their inhibitors (TIMPs) in diagnostics of gynecological malignancies].
Endometriosis
Analysis of matrix metalloproteinase-7 expression in eutopic and ectopic endometrium samples from patients with different forms of endometriosis.
Endometriosis
Associations between various possible promoter polymorphisms of MMPs genes and endometriosis risk: a meta-analysis.
Endometriosis
Effect of Wnt/?-catenin signal pathway on of matrix metalloproteinase-7 and vascular endothelial growth factor gene expressions in endometriosis.
Endometriosis
EGFR-mediated matrix metalloproteinase-7 up-regulation promotes epithelial-mesenchymal transition via ERK1-AP1 axis during ovarian endometriosis progression.
Endometriosis
Endometriosis Leads to an Increased Trefoil Factor 3 Concentration in the Peritoneal Cavity but Does Not Alter Systemic Levels.
Endometriosis
Extracellular matrix metalloproteinase inducer (EMMPRIN) expression in the baboon endometrium: menstrual cycle and endometriosis.
Endometriosis
Polymorphisms in the promoter regions of the matrix metalloproteinases-7, -9 and the risk of endometriosis and adenomyosis in China.
Endometriosis
Steroid and cytokine regulation of matrix metalloproteinase expression in endometriosis and the establishment of experimental endometriosis in nude mice.
Esophageal Neoplasms
Clinicopathological significance of matrix metalloproteinase-7 protein expression in esophageal cancer: a meta-analysis.
Esophageal Neoplasms
Interrelation between expression of matrix metalloproteinase 7 and beta-catenin in esophageal cancer.
Esophageal Neoplasms
IPO5 promotes malignant progression of esophageal cancer through activating MMP7.
Esophageal Neoplasms
Malignant Potential of Gastrointestinal Cancers Assessed by Structural Equation Modeling.
Esophageal Neoplasms
Matrix metalloproteinase matrilysin (MMP-7) participates in the progression of human gastric and esophageal cancers.
Esophageal Neoplasms
MMP-10, MMP-7, TIMP-1 and TIMP-2 mRNA expression in esophageal cancer.
Esophageal Squamous Cell Carcinoma
A Panel of Tumor-associated Autoantibodies for the Detection of Early-stage Breast Cancer.
Esophageal Squamous Cell Carcinoma
Activin A enhances MMP-7 activity via the transcription factor AP-1 in an esophageal squamous cell carcinoma cell line.
Esophageal Squamous Cell Carcinoma
Association of matrilysin expression with recurrence and poor prognosis in human esophageal squamous cell carcinoma.
Esophageal Squamous Cell Carcinoma
Association of matrix metalloproteinase-7 (-181A>G) polymorphism with risk of esophageal squamous cell carcinoma in Kashmir Valley.
Esophageal Squamous Cell Carcinoma
Autoantibodies against MMP-7 as a novel diagnostic biomarker in esophageal squamous cell carcinoma.
Esophageal Squamous Cell Carcinoma
Combined detection of serum autoantibodies as diagnostic biomarkers in esophagogastric junction adenocarcinoma.
Esophageal Squamous Cell Carcinoma
Correlation among 16 biological factors [p53, p21(waf1), MIB-1 (Ki-67), p16(INK4A), cyclin D1, E-cadherin, Bcl-2, TNF-?, NF-?B, TGF-?, MMP-7, COX-2, EGFR, HER2/neu, ER, and HIF-1?] and clinical outcomes following curative chemoradiation therapy in 10 patients with esophageal squamous cell carcinoma.
Esophageal Squamous Cell Carcinoma
Difference in responsiveness of human esophageal squamous cell carcinoma lines to epidermal growth factor for MMP-7 expression.
Esophageal Squamous Cell Carcinoma
Differential expression of MMP and uPA systems and prognostic relevance of their expression in esophageal squamous cell carcinoma.
Esophageal Squamous Cell Carcinoma
Interrelation between expression of matrix metalloproteinase 7 and beta-catenin in esophageal cancer.
Esophageal Squamous Cell Carcinoma
The functional polymorphism in the matrix metalloproteinase-7 promoter increases susceptibility to esophageal squamous cell carcinoma, gastric cardiac adenocarcinoma and non-small cell lung carcinoma.
Extranodal Extension
The Matrix Metalloproteinase-7 Polymorphism Rs10895304 Is Associated with Increased Recurrence Risk in Patients with Clinically Localized Prostate Cancer.
Fatty Liver
Serum matrix metalloproteinase 7 (MMP7) is a biomarker of fibrosis in patients with non-alcoholic fatty liver disease.
Fibromatosis, Aggressive
Correlation between beta-catenin widespread nuclear expression and matrix metalloproteinase-7 overexpression in sporadic desmoid tumors.
Frontotemporal Dementia
Matrin 3 in neuromuscular disease: physiology and pathophysiology.
Frontotemporal Lobar Degeneration
Genetic analysis of matrin 3 gene in French amyotrophic lateral sclerosis patients and frontotemporal lobar degeneration with amyotrophic lateral sclerosis patients.
Gallbladder Neoplasms
Enhanced expression of trophinin promotes invasive and metastatic potential of human gallbladder cancer cells.
Gastritis
Elevated Serum Matrix Metalloproteinase-3 and -7 in H. pylori-Related Gastric Cancer Can Be Biomarkers Correlating with a Poor Survival.
Gastritis
Expression of Wnt3, ?-catenin and MMP-7 in gastric cancer and precancerous lesions and their correlations with Helicobacter pylori infection.
Gastritis
Helicobacter pylori upregulates matrilysin (MMP-7) in epithelial cells in vivo and in vitro in a Cag dependent manner.
Gastritis
Serum IL-10, MMP-7, MMP-9 Levels in Helicobacter pylori Infection and Correlation with Degree of Gastritis.
Gastrointestinal Neoplasms
Clinical impact of matrix metalloproteinase-7 mRNA expression in the invasive front and inner surface of tumor tissues in patients with colorectal cancer.
Gastrointestinal Neoplasms
Clinicopathologic and prognostic significance of matrilysin expression at the invasive front in human colorectal cancers.
Gastrointestinal Neoplasms
Contribution of matrilysin (MMP-7) to the metastatic pathway of human colorectal cancers.
Gastrointestinal Neoplasms
Insulin-like growth factor-I receptor blockade reduces the invasiveness of gastrointestinal cancers via blocking production of matrilysin.
Gastrointestinal Neoplasms
Matrix metalloproteinase matrilysin (MMP-7) participates in the progression of human gastric and esophageal cancers.
Gastrointestinal Neoplasms
Retinoic acids reduce matrilysin (matrix metalloproteinase 7) and inhibit tumor cell invasion in human colon cancer.
Gastrointestinal Neoplasms
[Prognostic significance of the molecular markers in human gastrointestinal cancer]
Gastrointestinal Stromal Tumors
The diagnostic importance of matrix metalloproteinase-7 and nestin in gastrointestinal stromal tumors.
Gingivitis
Immunohistochemical analysis of the gingiva with periodontitis of type I plasminogen deficiency compared to gingiva with gingivitis and periodontitis and healthy gingiva.
Gingivitis
Study of the participation of MMP-7, EMMPRIN and cyclophilin A in the pathogenesis of periodontal disease.
Glioblastoma
ADAM12 is selectively overexpressed in human glioblastomas and is associated with glioblastoma cell proliferation and shedding of heparin-binding epidermal growth factor.
Glioblastoma
Expression of MMP-2, MMP-7, MMP-9, MMP-10 and MMP-11 in human astrocytic and oligodendroglial gliomas.
Glioblastoma
Heterogeneous regional expression patterns of matrix metalloproteinases in human malignant gliomas.
Glioblastoma
MMP-7 (matrilysin) expression in human brain tumors.
Glioblastoma
[Increased expression of gelatinases A and B, matrilysin and TIMP-1 genes in human malignant gliomas ]
Glioma
Association between expression of HOTAIR and invasiveness of gliomas, and its predictive value.
Glioma
Expression of MMP-2, MMP-7, MMP-9, MMP-10 and MMP-11 in human astrocytic and oligodendroglial gliomas.
Glioma
Expressions of matrilysin and stromelysin in human glioma cells.
Glioma
Expressions of matrix metalloproteinase-7 and matrix metalloproteinase-14 associated with the activation of extracellular signal-regulated kinase1/2 in human brain gliomas of different pathological grades.
Glioma
Matrix metalloproteinases and tissue inhibitors of metalloproteinases in human gliomas.
Glioma
MMP-7 (matrilysin) expression in human brain tumors.
Glioma
MT1-MMP and MMP-7 in invasion and metastasis of human cancers.
Glioma
[Increased expression of gelatinases A and B, matrilysin and TIMP-1 genes in human malignant gliomas ]
Glomerulonephritis
Molecular characterization of a low-molecular-mass matrix metalloproteinase secreted by glomerular mesangial cells as PUMP-1.
Glomerulonephritis, IGA
Serum Matrix Metalloproteinase-7 Level is Associated with Fibrosis and Renal Survival in Patients with IgA Nephropathy.
Glomerulonephritis, IGA
Urinary Matrix Metalloproteinase 7 and Prediction of IgA Nephropathy Progression.
Glomerulosclerosis, Focal Segmental
Matrix metalloproteinase-7 as a surrogate marker predicts renal Wnt/?-catenin activity in CKD.
Guillain-Barre Syndrome
Matrix metalloproteinases MMP-9 and MMP-7 are expressed in experimental autoimmune neuritis and the Guillain-Barré syndrome.
Head and Neck Neoplasms
Matrix metalloproteinase-7 and -13 expression associate to cisplatin resistance in head and neck cancer cell lines.
Head and Neck Neoplasms
[Prediction of Post-operative Lymph Node Metastasis with a Molecular Biological Test in Head and Neck Cancer].
Heart Arrest
Serum matrix metalloproteinases in patients resuscitated from cardiac arrest. The association with therapeutic hypothermia.
Heart Failure
Matrix metalloproteinase 7 in diagnosis and differentiation of pulmonary arterial hypertension.
Heart Neoplasms
The functional polymorphism in the matrix metalloproteinase-7 promoter increases susceptibility to esophageal squamous cell carcinoma, gastric cardiac adenocarcinoma and non-small cell lung carcinoma.
Hepatitis C
Matrix metalloproteinase (MMP)-2, MMP-7, and tissue inhibitor of metalloproteinase-1 are closely related to the fibroproliferative process in the liver during chronic hepatitis C.
Hepatitis C, Chronic
Matrix metalloproteinase (MMP)-2, MMP-7, and tissue inhibitor of metalloproteinase-1 are closely related to the fibroproliferative process in the liver during chronic hepatitis C.
Hepatitis, Chronic
Matrix metalloproteinase (MMP)-2, MMP-7, and tissue inhibitor of metalloproteinase-1 are closely related to the fibroproliferative process in the liver during chronic hepatitis C.
Hidradenitis
Matrix metalloproteinase matrilysin is constitutively expressed in adult human exocrine epithelium.
HIV Infections
Effects of norepinephrine, HIV type 1 infection, and leukocyte interactions with endothelial cells on the expression of matrix metalloproteinases.
HIV Infections
Marked relationship between matrix metalloproteinase 7 and brain atrophy in HIV infection.
HIV Infections
Matrix metalloproteinase levels in early HIV infection and relation to in vivo brain status.
HIV Infections
MMP-7 promoter polymorphisms do not influence CD4+ recovery and changes in plasma viral load during antiretroviral therapy for HIV-1 infection.
Hyperlipidemias
Apolipoprotein A-IV is a novel substrate for matrix metalloproteinases.
Hypertension
Increased vascular and uteroplacental matrix metalloproteinase-1 and -7 levels and collagen type I deposition in hypertension in pregnancy: role of TNF-?.
Hypertension
Matrix metalloproteinase 7 in diagnosis and differentiation of pulmonary arterial hypertension.
Hypertension
Matrix metalloproteinase-7 and ADAM-12 (a disintegrin and metalloproteinase-12) define a signaling axis in agonist-induced hypertension and cardiac hypertrophy.
Hypertension
MMP-2 mediates angiotensin II-induced hypertension under the transcriptional control of MMP-7 and TACE.
Hypertension
The expression of MMP-7 in serum and aneurysm tissues of patients with abdominal aortic aneurysm associated with hypertension and the clinical efficacy of endovascular exclusion.
Hypertension, Pulmonary
Immunohistochemical study of endothelin-1 and matrix metalloproteinases in plexogenic pulmonary arteriopathy.
Hypertension, Pulmonary
Matrix metalloproteinase 7 in diagnosis and differentiation of pulmonary arterial hypertension.
Idiopathic Interstitial Pneumonias
Interstitial Score and Concentrations of IL-4R?, PAR-2, and MMP-7 in Bronchoalveolar Lavage Fluid Could Be Useful Markers for Distinguishing Idiopathic Interstitial Pneumonias.
Idiopathic Interstitial Pneumonias
Is metalloproteinase-7 specific for idiopathic pulmonary fibrosis?
Idiopathic Interstitial Pneumonias
MMP-7 and fcDNA serum levels in early NSCLC and idiopathic interstitial pneumonia: preliminary study.
Idiopathic Interstitial Pneumonias
Plasma Surfactant Protein-D, Matrix Metalloproteinase-7, and Osteopontin Index Distinguishes Idiopathic Pulmonary Fibrosis From Other Idiopathic Interstitial Pneumonias.
Idiopathic Pulmonary Fibrosis
Allele Specific Transactivation of Matrix Metalloproteinase 7 by FOXA2 and Correlation with Plasma Levels in Idiopathic Pulmonary Fibrosis.
Idiopathic Pulmonary Fibrosis
Blood biomarkers MMP-7 and SP-A: predictors of outcome in idiopathic pulmonary fibrosis.
Idiopathic Pulmonary Fibrosis
Comparative Study of Circulating MMP-7, CCL18, KL-6, SP-A, and SP-D as Disease Markers of Idiopathic Pulmonary Fibrosis.
Idiopathic Pulmonary Fibrosis
Current Concepts of Biliary Atresia and Matrix Metalloproteinase-7: A Review of Literature.
Idiopathic Pulmonary Fibrosis
Elevated matrilysin levels in bronchoalveolar lavage fluid do not distinguish idiopathic pulmonary fibrosis from other interstitial lung diseases.
Idiopathic Pulmonary Fibrosis
Is metalloproteinase-7 specific for idiopathic pulmonary fibrosis?
Idiopathic Pulmonary Fibrosis
Levels of circulating MMP-7 degraded elastin are elevated in pulmonary disorders.
Idiopathic Pulmonary Fibrosis
Matrix metalloproteinase-10: a novel biomarker for idiopathic pulmonary fibrosis.
Idiopathic Pulmonary Fibrosis
MMP-7 is a predictive biomarker of disease progression in patients with idiopathic pulmonary fibrosis.
Idiopathic Pulmonary Fibrosis
Plasma Surfactant Protein-D, Matrix Metalloproteinase-7, and Osteopontin Index Distinguishes Idiopathic Pulmonary Fibrosis From Other Idiopathic Interstitial Pneumonias.
Idiopathic Pulmonary Fibrosis
Production and activation of matrix metalloproteinase 7 (matrilysin 1) in the lungs of patients with idiopathic pulmonary fibrosis.
Idiopathic Pulmonary Fibrosis
Serial Measurements of Circulating KL-6, SP-D, MMP-7, CA19-9, CA-125, CCL18, and Periostin in Patients with Idiopathic Pulmonary Fibrosis Receiving Antifibrotic Therapy: An Exploratory Study.
Idiopathic Pulmonary Fibrosis
Serum Biomarkers in Differential Diagnosis of Idiopathic Pulmonary Fibrosis and Connective Tissue Disease-Associated Interstitial Lung Disease.
Idiopathic Pulmonary Fibrosis
Validation of the prognostic value of MMP-7 in idiopathic pulmonary fibrosis.
Idiopathic Pulmonary Fibrosis
[Change of matrix metalloproteinase-1 and matrix metalloproteinase-7 in serum and bronchoalveolar lavage fluid of patients with idiopathic pulmonary fibrosis and sarcoidosis].
Infections
A Cell Proliferation and Inflammatory Signature Is Induced by Lawsonia intracellularis Infection in Swine.
Infections
Bacterial exposure induces and activates matrilysin in mucosal epithelial cells.
Infections
cag Pathogenicity island-dependent upregulation of matrix metalloproteinase-7 in infected patients with Helicobacter pylori.
Infections
Elucidating the function and tolerance mechanism of gamma delta (? ?) T cells in a Helicobacter pylori infection model.
Infections
EMMPRIN (CD 147) is a central activator of extracellular matrix degradation by Chlamydia pneumoniae-infected monocytes. Implications for plaque rupture.
Infections
Expression of Wnt3, ?-catenin and MMP-7 in gastric cancer and precancerous lesions and their correlations with Helicobacter pylori infection.
Infections
Helicobacter pylori upregulates matrilysin (MMP-7) in epithelial cells in vivo and in vitro in a Cag dependent manner.
Infections
Heparanase-Regulated Syndecan-1 Shedding Facilitates Herpes Simplex Virus 1 Egress.
Infections
Human neural stem cell-derived neuron/astrocyte co-cultures respond to La Crosse virus infection with proinflammatory cytokines and chemokines.
Infections
Human T-cell leukemia virus type 1 Tax transactivates the matrix metalloproteinase 7 gene via JunD/AP-1 signaling.
Infections
Individual matrix metalloproteinases control distinct transcriptional responses in airway epithelial cells infected with Pseudomonas aeruginosa.
Infections
Juvenile, but Not Adult, Mice Display Increased Myeloid Recruitment and Extracellular Matrix Remodeling during Respiratory Syncytial Virus Infection.
Infections
Matrilysin (matrix metalloproteinase 7) in parturition, premature rupture of membranes, and intrauterine infection.
Infections
Matrix metalloproteinases and their tissue inhibitors in serum and cerebrospinal fluid of children with Japanese encephalitis virus infection.
Infections
Matrix metalloproteinases contribute to brain damage in experimental pneumococcal meningitis.
Infections
MMP-7 promoter polymorphisms do not influence CD4+ recovery and changes in plasma viral load during antiretroviral therapy for HIV-1 infection.
Infections
Newcastle disease virus mediated apoptosis and migration inhibition of human oral cancer cells: A probable role of ?-catenin and matrix metalloproteinase-7.
Infections
Nuclear matrix protein Matrin 3 is a regulator of ZAP-mediated retroviral restriction.
Infections
Regulation of matrilysin expression in airway epithelial cells by Pseudomonas aeruginosa flagellin.
Infections
Role of airway epithelial injury in murine orthotopic tracheal allograft rejection.
Infections
Role of matrix metalloproteinase-7 in the modulation of a Chlamydia trachomatis infection.
Infections
Serum IL-10, MMP-7, MMP-9 Levels in Helicobacter pylori Infection and Correlation with Degree of Gastritis.
Infections
The detection of Helicobacter pylori cag pathogenicity islands (PAIs) and expression of matrix metalloproteinase-7 (MMP-7) in gastric epithelial dysplasia and intramucosal cancer.
Infections
The role of matrix metalloproteinase-7 in redefining the gastric microenvironment in response to Helicobacter pylori.
Infections
[Expressions of MMP-7 and TIMP-1 in Chronic Stomach Disease Patients with Different Syndromes of Chinese Medicine].
Infertility, Male
Overexpression of the matrix metalloproteinase matrilysin results in premature mammary gland differentiation and male infertility.
Inflammatory Bowel Diseases
Enhanced expression of MMP-7 and MMP-13 in inflammatory bowel disease: a precancerous potential?
Inflammatory Bowel Diseases
Expressions of Matrix Metalloproteinases (MMP-2, MMP-7, and MMP-9) and Their Inhibitors (TIMP-1, TIMP-2) in Inflammatory Bowel Diseases.
Inflammatory Bowel Diseases
The Role of Matrix Metalloproteinases in Intestinal Epithelial Wound Healing During Normal and Inflammatory States.
Insulin Resistance
Do different bariatric surgical procedures influence plasma levels of matrix metalloproteinase-2, -7, and -9 among patients with type 2 diabetes mellitus?
Insulinoma
Molecular cloning of matrin 3. A 125-kilodalton protein of the nuclear matrix contains an extensive acidic domain.
Intervertebral Disc Degeneration
Human disc degeneration is associated with increased MMP 7 expression.
Intervertebral Disc Displacement
Experimental chemonucleolysis with recombinant human matrix metalloproteinase 7 in human herniated discs and dogs.
Intervertebral Disc Displacement
Experimental studies on the effects of recombinant human matrix metalloproteinases on herniated disc tissues--how to facilitate the natural resorption process of herniated discs.
Intervertebral Disc Displacement
Human disc degeneration is associated with increased MMP 7 expression.
Intervertebral Disc Displacement
Translational research of herniated discs: current status of diagnosis and treatment.
Intervertebral Disc Displacement
Up-regulated expression of matrilysin and neutrophil collagenase in human herniated discs.
Ischemic Stroke
Combined Effects of MMP-7, MMP-8 and MMP-26 on the Risk of Ischemic Stroke.
Ischemic Stroke
Discovery of New Risk Markers for Ischemic Stroke Using a Novel Targeted Proteomics Chip.
Kallmann Syndrome
Cigarette smoke modulates PC3 prostate cancer cell migration by altering adhesion molecules and the extracellular matrix.
Keratoacanthoma
Transformation-specific matrix metalloproteinases, MMP-7 and MMP-13, are present in epithelial cells of keratoacanthomas.
Kidney Diseases
The Many Faces of Matrix Metalloproteinase-7 in Kidney Diseases.
Kidney Diseases
Urine matrix metalloproteinase-7 and risk of kidney disease progression and mortality in type 2 diabetes.
Kidney Failure, Chronic
ACE I/D and MMP-7 A-181G variants and the risk of end stage renal disease.
Kidney Failure, Chronic
Urine matrix metalloproteinase-7 and risk of kidney disease progression and mortality in type 2 diabetes.
Kidney Neoplasms
Distance-dependent visual fluorescence immunoassay on CdTe quantum dot-impregnated paper through silver ion-exchange reaction.
Kidney Neoplasms
Prognostic Role of Matrix Metalloproteinases 2, 7, 8, 9 and Their Type 1 Tissue Inhibitor in Blood Serum of Patients with Kidney Cancer.
Kidney Neoplasms
Quantitative immunohistochemical analysis of matrilysin 1 (MMP-7) in various renal cell carcinoma subtypes.
Laminopathies
Laminopathies and lamin-associated signaling pathways.
Laryngeal Neoplasms
Matrix metalloproteinases (MMPs) and inhibitor of metalloproteinases (TIMP) mRNA and protein expression in laryngeal squamous cell carcinoma.
Laryngeal Neoplasms
[Relationship of matrilysin with invasion, metastasis, and prognosis in laryngeal cancer]
Laryngeal Neoplasms
[The expression of tumor related macrophages and matrix solution element in laryngeal squamous carcinoma tissue and the relationship with tumor microvascular density].
Laryngopharyngeal Reflux
Role of Matrix Metalloproteinases 7 in the Pathogenesis of Laryngopharyngeal Reflux: Decreased E-cadherin in Acid exposed Primary Human Pharyngeal Epithelial Cells.
Laryngopharyngeal Reflux
Usefulness of matrix metalloproteinase-7 in saliva as a diagnostic biomarker for laryngopharyngeal reflux disease.
Leg Ulcer
Expression of matrix metalloproteinase (MMP)-7 and MMP-13 and loss of MMP-19 and p16 are associated with malignant progression in chronic wounds.
Leiomyoma
Increased expression of stromelysin 3 mRNA in leiomyomas (uterine fibroids) compared with myometrium.
Leukemia
Automated Extraction of DNA and RNA from a Single Formalin-Fixed Paraffin-Embedded Tissue Section for Analysis of Both Single-Nucleotide Polymorphisms and mRNA Expression.
Leukemia
Contribution of Matrix Metalloproteinase-7 Genotypes to the Risk of Non-solid Tumor, Childhood Leukemia.
Leukemia
Genomic profiling of thousands of candidate polymorphisms predicts risk of relapse in 778 Danish and German childhood acute lymphoblastic leukemia patients.
Leukemia
Identification of novel genes regulated by chorionic gonadotropin in baboon endometrium during the window of implantation.
Leukemia
[Resistance of leukemia cells to Fas/FasL-mediated apoptosis and strategies replying to antiapoptosis of leukemia cells--review]
Leukemia, Myeloid, Acute
Expression and clinical significance of serum MMP-7 and PTEN levels in patients with acute myeloid leukemia.
Leukemia, Myeloid, Acute
The prognostic value of matrix metalloproteinase-7 and matrix metalloproteinase-15 in acute myeloid leukemia.
Leukemia, T-Cell
Human T-cell leukemia virus type 1 Tax transactivates the matrix metalloproteinase 7 gene via JunD/AP-1 signaling.
Lichen Planus, Oral
COX-2, MMP-7 expression in oral lichen planus and oral squamous cell carcinoma.
Listeriosis
Matrix metalloproteinase expression in sheep with listerial meningoencephalitis.
Liver Cirrhosis
A novel nonsynonymous variant of matrix metalloproteinase-7 confers risk of liver cirrhosis.
Liver Cirrhosis
Biomarkers for the diagnosis and post-Kasai portoenterostomy prognosis of biliary atresia: a systematic review and meta-analysis.
Liver Cirrhosis
Current Concepts of Biliary Atresia and Matrix Metalloproteinase-7: A Review of Literature.
Liver Cirrhosis
Evaluation of matrix metalloproteinases and their endogenous tissue inhibitors in biliary atresia-associated liver fibrosis.
Liver Cirrhosis
Increased MMP-7 expression in biliary epithelium and serum underpins native liver fibrosis after successful portoenterostomy in biliary atresia.
Liver Cirrhosis
Matrilysin (MMP-7) is a major matrix metalloproteinase upregulated in biliary atresia-associated liver fibrosis.
Liver Cirrhosis
Matrix Metalloproteinases-7 and Kidney Fibrosis.
Liver Cirrhosis
Predicting native liver injury and survival in biliary atresia.
Liver Cirrhosis
Quantification of Serum Matrix Metallopeptide 7 Levels May Assist in the Diagnosis and Predict the Outcome for Patients with Biliary Atresia.
Liver Cirrhosis
[Expressions of MDM2 and MMP-7 in normal liver, cirrhosis, hepatocellular carcinoma tissues]
Liver Diseases
Increased MMP-7 expression in biliary epithelium and serum underpins native liver fibrosis after successful portoenterostomy in biliary atresia.
Liver Diseases
Serum levels of TIMP-1 and MMP-7 as potential biomarkers in patients with metastatic colorectal cancer.
Liver Diseases
Serum matrix metalloproteinase 7 (MMP7) is a biomarker of fibrosis in patients with non-alcoholic fatty liver disease.
Liver Diseases
Serum Matrix Metalloproteinase 7 Is a Diagnostic Biomarker of Biliary Injury and Fibrosis in Pediatric Autoimmune Liver Disease.
Lung Diseases
Exploring the Role of Matrix Metalloproteinases as Biomarkers in Sporadic Lymphangioleiomyomatosis and Tuberous Sclerosis Complex. A Pilot Study.
Lung Diseases
Expression of MMP-7, MMP-9, TIMP-1 and TIMP-2 mRNA in lung tissue of patients with non-small cell lung cancer (NSCLC) and benign pulmonary disease.
Lung Diseases
Implications for matrix metalloproteinases as modulators of pediatric lung disease.
Lung Diseases
Levels of circulating MMP-7 degraded elastin are elevated in pulmonary disorders.
Lung Diseases
Matrix metalloproteinase-7 expression in fibrosing lung disease: restoring the balance.
Lung Diseases, Interstitial
Aberrant Wnt/beta-catenin pathway activation in idiopathic pulmonary fibrosis.
Lung Diseases, Interstitial
Cholesterol, lipoproteins and subclinical interstitial lung disease: the MESA study.
Lung Diseases, Interstitial
Elevated matrilysin levels in bronchoalveolar lavage fluid do not distinguish idiopathic pulmonary fibrosis from other interstitial lung diseases.
Lung Diseases, Interstitial
Extracellular matrix metalloproteinase inducer in interstitial pneumonias.
Lung Diseases, Interstitial
Matrix metalloproteinase 7 is a candidate biomarker in systemic sclerosis-associated interstitial lung disease.
Lung Diseases, Interstitial
Serum Biomarkers in Differential Diagnosis of Idiopathic Pulmonary Fibrosis and Connective Tissue Disease-Associated Interstitial Lung Disease.
Lung Diseases, Interstitial
Surfactant protein D is associated with 3-month mortality of anti-MDA5 antibody-interstitial lung disease.
Lung Injury
High attenuation areas on chest computed tomography in community-dwelling adults: the MESA study.
Lung Injury
Induction of pulmonary matrilysin expression by combustion and ambient air particles.
Lung Injury
Matrilysin (Matrix Metalloproteinase-7) regulates anti-inflammatory and antifibrotic pulmonary dendritic cells that express CD103 (alpha(E)beta(7)-integrin).
Lung Injury
Matrilysin (MMP-7) catalytic activity regulates ?-catenin localization and signaling activation in lung epithelial cells.
Lung Injury
MMP7 shedding of syndecan-1 facilitates re-epithelialization by affecting alpha(2)beta(1) integrin activation.
Lung Injury
The biological activity of FasL in human and mouse lungs is determined by the structure of its stalk region.
Lung Neoplasms
Beyond Conventional: The New Horizon of Anti-Angiogenic microRNAs in Non-Small Cell Lung Cancer Therapy.
Lung Neoplasms
CCL25 promotes the migration and invasion of non-small cell lung cancer cells by regulating VEGF and MMPs in a CCR9-dependent manner.
Lung Neoplasms
Clinical significance of immunohistochemical expression of insulin-like growth factor-1 receptor and matrix metalloproteinase-7 in resected non-small cell lung cancer.
Lung Neoplasms
Clinical significance of matrix metalloproteinase-7 and Ets-1 gene expression in patients with lung cancer.
Lung Neoplasms
Correlation Between MMP-7 and bFGF Expressions in Non-small Cell Lung Cancer Tissue and Clinicopathologic Features.
Lung Neoplasms
Detection of Matrilysin Activity Using Polypeptide Functionalized Reduced Graphene Oxide Field-Effect Transistor Sensor.
Lung Neoplasms
Effect of Osimertinib on the expression of serum mmp-7 and mmp-9 in patients with non-small cell lung cancer.
Lung Neoplasms
Elevated matrix metalloproteinase-7 expression promotes metastasis in human lung carcinoma.
Lung Neoplasms
Expression of gelatinase A, tissue inhibitor of metalloproteinases-2, matrilysin, and trypsin(ogen) in lung neoplasms: an immunohistochemical study.
Lung Neoplasms
Expression of matrix metalloproteinases 3, 10 and 11 (stromelysins 1, 2 and 3) and matrix metalloproteinase 7 (matrilysin) by cancer cells in non-small cell lung neoplasms. Clinicopathologic studies.
Lung Neoplasms
Expression of matrix metalloproteinases 7 and 9 in non-small cell lung cancer Relation to clinicopathological factors, beta-catenin and prognosis.
Lung Neoplasms
Expression of MMP-7, MMP-9, TIMP-1 and TIMP-2 mRNA in lung tissue of patients with non-small cell lung cancer (NSCLC) and benign pulmonary disease.
Lung Neoplasms
Expression of mRNA MMP-7 and mRNA TIMP-1 in non-small cell lung cancer.
Lung Neoplasms
Fibulin-3 promoter methylation alters the invasive behavior of non-small cell lung cancer cell lines via MMP-7 and MMP-2 regulation.
Lung Neoplasms
Fibulin-3 suppresses Wnt/?-catenin signaling and lung cancer invasion.
Lung Neoplasms
Fibulin-5 inhibits Wnt/?-catenin signaling in lung cancer.
Lung Neoplasms
Fibulin-5 suppresses lung cancer invasion by inhibiting matrix metalloproteinase-7 expression.
Lung Neoplasms
Levels of circulating MMP-7 degraded elastin are elevated in pulmonary disorders.
Lung Neoplasms
Matrilysin inhibits proliferation and modulates sensitivity of lung cancer cells to FasL-mediated apoptosis.
Lung Neoplasms
Matrilysin-1 mediates bronchiolization of alveoli, a potential premalignant change in lung cancer.
Lung Neoplasms
Matrix metalloproteinase-7 facilitates insulin-like growth factor bioavailability through its proteinase activity on insulin-like growth factor binding protein 3.
Lung Neoplasms
Overexpression of matrix metalloproteinase-7 (MMP-7) correlates with tumor proliferation, and a poor prognosis in non-small cell lung cancer.
Lung Neoplasms
Predictive value of MMP-7 expression for response to chemotherapy and survival in patients with non-small cell lung cancer.
Lung Neoplasms
Prognostic value of matrix metalloproteinase-7 expression in patients with non-small cell lung cancer.
Lung Neoplasms
Roles of osteopontin and matrix metalloproteinase-7 in occurrence, progression, and prognosis of nonsmall cell lung cancer.
Lung Neoplasms
The Contribution of MMP-7 Promoter Polymorphisms to Taiwan Lung Cancer Susceptibility.
Lung Neoplasms
[EFEMP1 Suppresses Growth and Invasion of Lung Cancer Cells ?by Downregulating Matrix Metalloproteinase-7 Expression].
Lung Neoplasms
[Expression of bone morphogenetic proteins, matrix metalloproteinases and inhibitors of matrix metalloproteinases in lung cancers and their prognostic significance]
Lung Neoplasms
[The expression level and clinical significance of MMP-7 protein?in peripheral blood in the patients with lung cancer].
Lupus Erythematosus, Systemic
Role of MMP-7 in the pathogenesis of systemic lupus erythematosus (SLE).
Lupus Nephritis
Association of Urinary Matrix Metalloproteinase 7 with Incident Renal Flare in Lupus Nephritis.
Lymphatic Metastasis
Association between expression of MMP-7 and MMP-9 and pelvic lymph node and para-aortic lymph node metastasis in early cervical cancer.
Lymphatic Metastasis
Association of matrilysin expression with progression and poor prognosis in human pancreatic adenocarcinoma.
Lymphatic Metastasis
Association of matrilysin mRNA expression with K-ras mutations and progression in pancreatic ductal adenocarcinomas.
Lymphatic Metastasis
CD44v6, MMP-7 and nuclear Cdx2 are significant biomarkers for prediction of lymph node metastasis in primary gastric cancer.
Lymphatic Metastasis
Clinical impact of matrix metalloproteinase-7 mRNA expression in the invasive front and inner surface of tumor tissues in patients with colorectal cancer.
Lymphatic Metastasis
Clinical significance of matrix metalloproteinase-7 and Ets-1 gene expression in patients with lung cancer.
Lymphatic Metastasis
Clinical Significance of MMP-7 and PTEN Expression in Colorectal Cancer.
Lymphatic Metastasis
Clinical significance of mucin phenotype, beta-catenin and matrix metalloproteinase 7 in early undifferentiated gastric carcinoma.
Lymphatic Metastasis
Clinicopathologic and prognostic significance of matrilysin expression at the invasive front in human colorectal cancers.
Lymphatic Metastasis
Correlation Between MMP-7 and bFGF Expressions in Non-small Cell Lung Cancer Tissue and Clinicopathologic Features.
Lymphatic Metastasis
Correlation of lymph node metastases and expression of matrix metalloproteinase-7 in patients with gastric cancer.
Lymphatic Metastasis
Correlation of polymorphism of IL-8 and MMP-7 with occurrence and lymph node metastasis of early stage cervical cancer.
Lymphatic Metastasis
Detection of regional lymph node metastases in colon cancer by using RT-PCR for matrix metalloproteinase 7, matrilysin.
Lymphatic Metastasis
Dickkopf-1 expression is associated with tumorigenity and lymphatic metastasis in human hilar cholangiocarcinoma.
Lymphatic Metastasis
Downregulation of matrix metalloprotease-9 and urokinase plasminogen activator by TX-1877 results in decreased tumor growth and metastasis on xenograft model of rectal cancer.
Lymphatic Metastasis
Expression and prognostic value of matrix metalloproteinase-7 in colorectal cancer.
Lymphatic Metastasis
Expression and significance of IGF-2, PCNA, MMP-7, and ?-actin in gastric carcinoma with Lauren classification.
Lymphatic Metastasis
Expression of matrix metalloproteinase-7 and tissue inhibitor of metalloproteinase-1 in human prostate.
Lymphatic Metastasis
Expression of Matrix Metalloproteinase-7 is an Unfavorable Prognostic Factor in Intrahepatic Cholangiocarcinoma.
Lymphatic Metastasis
Expression of matrix metalloproteinases in supraglottic carcinoma and its clinical implication for estimating lymph node metastases.
Lymphatic Metastasis
Expression of MMP-7 and MT1-MMP in oral squamous cell carcinoma as predictive indicator for tumor invasion and prognosis.
Lymphatic Metastasis
Expression of tissue levels of matrix metalloproteinases and their inhibitors in breast cancer.
Lymphatic Metastasis
Expression of tissue levels of matrix metalloproteinases and tissue inhibitors of metalloproteinases in gastric adenocarcinoma.
Lymphatic Metastasis
Expressions of Matrix Metalloproteinase-7 and -9 and their Prognostic Significances in Rectal Cancer.
Lymphatic Metastasis
Immunohistochemical molecular markers as predictors of curability of endoscopically resected submucosal colorectal cancer.
Lymphatic Metastasis
Immunohistochemical study of vascular endothelial growth factor (VEGF) and matrilysin (MMP-7) in T1 adenocarcinoma of the colon and rectum to predict lymph node metastases or distant metastases.
Lymphatic Metastasis
Malignant Potential of Gastrointestinal Cancers Assessed by Structural Equation Modeling.
Lymphatic Metastasis
Matrilsin expression is a useful marker of submucosal invasion and lymph node metastasis in early stage signet ring cell carcinoma of the stomach.
Lymphatic Metastasis
Matrix metalloproteinase-7 and matrix metalloproteinase-9 are associated with unfavourable prognosis in superficial oesophageal cancer.
Lymphatic Metastasis
MMP-10, MMP-7, TIMP-1 and TIMP-2 mRNA expression in esophageal cancer.
Lymphatic Metastasis
MMP-7 A-181G Polymorphism in Breast Cancer Patients from Western Iran.
Lymphatic Metastasis
MMP-7 is upregulated by COX-2 and promotes proliferation and invasion of lung adenocarcinoma cells.
Lymphatic Metastasis
Prognostic significance of matrix metalloproteinase-7 (MMP-7) expression at the invasive front in gastric carcinoma.
Lymphatic Metastasis
Prognostic significance of matrix metalloproteinase-7 in gastric cancer survival: a meta-analysis.
Lymphatic Metastasis
Relationship between E-cadherin, matrix metalloproteinase-7 gene expression and clinicopathological features in gastric carcinoma.
Lymphatic Metastasis
Role of MMP-7 in the formation of peritoneal dissemination in gastric cancer.
Lymphatic Metastasis
Roles of osteopontin and matrix metalloproteinase-7 in occurrence, progression, and prognosis of nonsmall cell lung cancer.
Lymphatic Metastasis
Serum endostatin levels correlate with enhanced extracellular matrix degradation and poor patients' prognosis in bladder cancer.
Lymphatic Metastasis
Suppression Of ?-catenin Nuclear Translocation By CGP57380 Decelerates Poor Progression And Potentiates Radiation-Induced Apoptosis in Nasopharyngeal Carcinoma.
Lymphatic Metastasis
The clinical value of Vav3 in peripheral blood for predicting lymphatic metastasis of gastric cancer.
Lymphatic Metastasis
[Correlation between expression of MMP-7 in gastric submucosal invasive carcinoma and lymph node micrometastasis]
Lymphatic Metastasis
[Expression and clinical significance of Ang-2 and MMP-7 in laryngeal carcinoma]
Lymphatic Metastasis
[Expression and clinical significance of matrilysin (MMP-7) in human rectal cancer]
Lymphatic Metastasis
[Expression of ETV5 and MMP-7 in Early Stage Cervical Squamous Cell Carcinoma and Its Role in Lymphatic Metastasis.]
Lymphatic Metastasis
[Prediction of Post-operative Lymph Node Metastasis with a Molecular Biological Test in Head and Neck Cancer].
Lymphatic Metastasis
[Prognostic significance of the molecular markers in human gastrointestinal cancer]
Lymphatic Metastasis
[Siliconchiptechnology-based MMP-7 analysis in urine : An option for preoperative identification of lymph node metastasis in bladder cancer.]
Lymphatic Metastasis
[The significance of beta-catenin and matrix metalloproteinase-7 expression in colorectal adenoma and carcinoma]
Lymphatic Metastasis
[The utility of metalloproteinases (MMPs) and their inhibitors (TIMPs) in diagnostics of gynecological malignancies].
Lymphoma
PCDH10 inhibits invasion of lymphoma cells by regulating ?-catenin.
Lymphoma
Significant increase in the expression of matrix metalloproteinase 7 in primary CNS lymphoma.
Lymphoma
Tungsten Oxide Nanoplates; the Novelty in Targeting Metalloproteinase-7 Gene in Both Cervix and Colon Cancer Cells.
Lymphoma
[mRNA and Protein Expression of AXIN,?-Catenin, MMP7 and MMP9 and Their Relationship in Lymphoma Cells].
Lymphoma, B-Cell
Expression of p16 in lymph node metastases of adjuvantly treated stage III colorectal cancer patients identifies poor prognostic subgroups: a retrospective analysis of biomarkers in matched primary tumor and lymph node metastases.
Lymphoma, B-Cell
Tungsten Oxide Nanoplates; the Novelty in Targeting Metalloproteinase-7 Gene in Both Cervix and Colon Cancer Cells.
Lymphoma, T-Cell
Mutated K-ras(Asp12) promotes tumourigenesis in Apc(Min) mice more in the large than the small intestines, with synergistic effects between K-ras and Wnt pathways.
Macular Degeneration
Expression of matrix metalloproteinase-7 in choroidal neovascular membranes in age-related macular degeneration.
Macular Degeneration
Role of matrix metalloproteinase-7 in angiogenesis associated with age-related macular degeneration.
matrilysin deficiency
Matrix metalloproteinase-7 and premalignant host responses in Helicobacter pylori-infected mice.
matrilysin deficiency
Matrix metalloproteinase-7 protects against acute kidney injury by priming renal tubules for survival and regeneration.
Medulloblastoma
Ciz1, Cip1 interacting zinc finger protein 1 binds the consensus DNA sequence ARYSR(0-2)YYAC.
Melanoma
Binding of alpha5 monoclonal antibody to cell surface alpha5beta1 integrin modulates MMP-2 and MMP-7 activity in B16F10 melanoma cells.
Melanoma
Expression of matrilysin (matrix metalloproteinase-7) in primary cutaneous and metastatic melanoma.
Melanoma
Melanocyte mediated paracrine induction of extracellular matrix degrading proteases in squamous cell carcinoma cells.
Meningoencephalitis
Matrix metalloproteinase expression in sheep with listerial meningoencephalitis.
Mesothelioma
Multiplex Soluble Biomarker Analysis from Pleural Effusion.
Mesothelioma, Malignant
MMP-7 is a highly specific negative marker for benign and malignant mesothelial cells in serous effusions.
Mesothelioma, Malignant
Multiplex Soluble Biomarker Analysis from Pleural Effusion.
Mouth Neoplasms
Association of Matrix Metalloproteinase-7 Genotypes to the Risk of Oral Cancer in Taiwan.
Mouth Neoplasms
High gene expression of matrix metalloproteinase-7 is associated with early stages of oral cancer.
Mouth Neoplasms
Newcastle disease virus mediated apoptosis and migration inhibition of human oral cancer cells: A probable role of ?-catenin and matrix metalloproteinase-7.
Mouth Neoplasms
Role of SIRT1 in regulation of epithelial-to-mesenchymal transition in oral squamous cell carcinoma metastasis.
Mucocutaneous Lymph Node Syndrome
Integrins ?4 and ?M, collagen1A1, and matrix metalloproteinase 7 are upregulated in acute Kawasaki disease vasculopathy.
Multiple Myeloma
A loss of host-derived MMP-7 promotes myeloma growth and osteolytic bone disease in vivo.
Multiple Sclerosis
Association of matrix metalloproteinase-7A-181G variants with the risk of multiple sclerosis.
Multiple Sclerosis
Enhanced expression of MMP-7 and MMP-9 in demyelinating multiple sclerosis lesions.
Multiple Sclerosis
Functional Promoter Polymorphisms of MMP-2 C-735T and MMP-9 C-1562T and Their Synergism with MMP-7 A-181G in Multiple Sclerosis.
Multiple Sclerosis
Matrix metalloproteinase activity stimulates N-cadherin shedding and the soluble N-cadherin ectodomain promotes classical microglial activation.
Multiple Sclerosis
Matrix metalloproteinase-7 and matrix metalloproteinase-9 in pediatric multiple sclerosis.
Multiple Sclerosis
Matrix metalloproteinase-7 facilitates immune access to the CNS in experimental autoimmune encephalomyelitis.
Multiple Sclerosis
Matrix metalloproteinase-7, matrix metalloproteinase-9, and disease activity in pediatric multiple sclerosis.
Multiple Sclerosis
The expression profile of matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) in lesions and normal appearing white matter of multiple sclerosis.
Muscle Cramp
Cationic antimicrobial peptides serve as activation signals for the Salmonella Typhimurium PhoPQ and PmrAB regulons in vitro and in vivo.
Muscular Atrophy
Transgenic mice overexpressing the ALS-linked protein Matrin 3 develop a profound muscle phenotype.
Muscular Diseases
Characterization of gene regulation and protein interaction networks for Matrin 3 encoding mutations linked to amyotrophic lateral sclerosis and myopathy.
Muscular Diseases
Knockdown of genes involved in axonal transport enhances the toxicity of human neuromuscular disease-linked MATR3 mutations in Drosophila.
Muscular Diseases
Obstetric risk in patients with myopathy due to MATR3 mutations.
Muscular Diseases
Subcellular Localization of Matrin 3 Containing Mutations Associated with ALS and Distal Myopathy.
Myocardial Infarction
Analysis of MMP-7 and TIMP-2 gene polymorphisms in coronary artery disease and myocardial infarction: A Turkish case-control study.
Myocardial Infarction
In vivo matrix metalloproteinase-7 substrates identified in the left ventricle post-myocardial infarction using proteomics.
Myocardial Infarction
Matrix metalloproteinase-7 affects connexin-43 levels, electrical conduction, and survival after myocardial infarction.
Myocardial Infarction
Proteomic Analysis of the Left Ventricle Post-myocardial Infarction to Identify In Vivo Candidate Matrix Metalloproteinase Substrates.
Myocardial Infarction
Role of matrix metalloproteinases in coronary artery disease.
Myocardial Infarction
Serum tissue-degrading proteinases and incident cardiovascular disease events.
Myoma
Analysis of matrix metalloproteinase-7 expression in eutopic and ectopic endometrium samples from patients with different forms of endometriosis.
Myositis
Matrix metalloproteinases in inflammatory myopathies: enhanced immunoreactivity near atrophic myofibers.
Nasal Polyps
Involvement of the extracellular matrix proteins periostin and tenascin C in nasal polyp remodeling by regulating the expression of MMPs.
Nasal Polyps
V?1? ??T Cells Are Correlated With Increasing Expression of Eosinophil Cationic Protein and Metalloproteinase-7 in Chronic Rhinosinusitis With Nasal Polyps Inducing the Formation of Edema.
Nasal Polyps
[The protein expression difference of transforming growth factor beta1, matrix metalloproteinases 1,7,9 and tissue inhibitors of matrix metalloproteinases-1 between chronic rhinosinusitis, nasal polyps and normal mucosa tissues]
Nasopharyngeal Carcinoma
Regulation of matrix metalloproteinase-1 by Epstein-Barr virus proteins.
Nasopharyngeal Carcinoma
The long noncoding RNA FOXCUT promotes proliferation and migration by targeting FOXC1 in nasopharyngeal carcinoma.
Neoplasm Metastasis
A new formula for predicting liver metastasis in patients with colorectal cancer: immunohistochemical analysis of a large series of 439 surgically resected cases.
Neoplasm Metastasis
Aberrant Activation Of Hedgehog Signalling Promotes Cell Migration And Invasion Via Matrix Metalloproteinase-7 In Ovarian Cancer Cells.
Neoplasm Metastasis
Activating transcription factor 4 promotes esophageal squamous cell carcinoma invasion and metastasis in mice and is associated with poor prognosis in human patients.
Neoplasm Metastasis
Alterations of metastasis-related genes identified using an oligonucleotide microarray of genistein-treated HCC1395 breast cancer cells.
Neoplasm Metastasis
Amperometric Biosensor of Matrix Metalloproteinase-7 Enhanced by Pd-Functionalized Carbon Nanocomposites.
Neoplasm Metastasis
Association between expression of MMP-7 and MMP-9 and pelvic lymph node and para-aortic lymph node metastasis in early cervical cancer.
Neoplasm Metastasis
Association of 12 serum biochemical markers of angiogenesis, tumour invasion and bone turnover with bone metastases from breast cancer: a crossectional and longitudinal evaluation.
Neoplasm Metastasis
Association of matrilysin expression with progression and poor prognosis in human pancreatic adenocarcinoma.
Neoplasm Metastasis
Association of matrilysin expression with recurrence and poor prognosis in human esophageal squamous cell carcinoma.
Neoplasm Metastasis
Association of matrilysin mRNA expression with K-ras mutations and progression in pancreatic ductal adenocarcinomas.
Neoplasm Metastasis
Association of matrix metalloproteinase-7 (-181A>G) polymorphism with risk of esophageal squamous cell carcinoma in Kashmir Valley.
Neoplasm Metastasis
beta-catenin regulates the expression of the matrix metalloproteinase-7 in human colorectal cancer.
Neoplasm Metastasis
Beta-catenin up-regulates the expression of cyclinD1, c-myc and MMP-7 in human pancreatic cancer: relationships with carcinogenesis and metastasis.
Neoplasm Metastasis
Bio-informatics analysis of renal carcinoma gene matrix metalloproteinase-7.
Neoplasm Metastasis
By activating matrix metalloproteinase-7, shear stress promotes chondrosarcoma cell motility, invasion and lung colonization.
Neoplasm Metastasis
c-Myc transactivates GP73 and promotes metastasis of hepatocellular carcinoma cells through GP73-mediated MMP-7 trafficking in a mildly hypoxic microenvironment.
Neoplasm Metastasis
Cancer invasion regulates vascular complexity in a three-dimensional biomimetic model.
Neoplasm Metastasis
Catecholamine up-regulates MMP-7 expression by activating AP-1 and STAT3 in gastric cancer.
Neoplasm Metastasis
CAV1 promotes HCC cell progression and metastasis through Wnt/?-catenin pathway.
Neoplasm Metastasis
CD44v6, MMP-7 and nuclear Cdx2 are significant biomarkers for prediction of lymph node metastasis in primary gastric cancer.
Neoplasm Metastasis
Cholesterol sulfate alters substrate preference of matrix metalloproteinase-7 and promotes degradations of pericellular laminin-332 and fibronectin.
Neoplasm Metastasis
Cleavage of the Perlecan-Semaphorin 3A-Plexin A1-Neuropilin-1 (PSPN) Complex by Matrix Metalloproteinase 7/Matrilysin Triggers Prostate Cancer Cell Dyscohesion and Migration.
Neoplasm Metastasis
Clinical impact of matrix metalloproteinase-7 mRNA expression in the invasive front and inner surface of tumor tissues in patients with colorectal cancer.
Neoplasm Metastasis
Clinical relevance of the expression of mRNA of MMP-7, MMP-9, TIMP-1, TIMP-2 and CEA tissue samples from colorectal liver metastases.
Neoplasm Metastasis
Clinical significance of immunohistochemical expression of insulin-like growth factor-1 receptor and matrix metalloproteinase-7 in resected non-small cell lung cancer.
Neoplasm Metastasis
Clinical significance of matrix metalloproteinase-7 and Ets-1 gene expression in patients with lung cancer.
Neoplasm Metastasis
Clinical Significance of MMP-7 and PTEN Expression in Colorectal Cancer.
Neoplasm Metastasis
Clinical significance of mucin phenotype, beta-catenin and matrix metalloproteinase 7 in early undifferentiated gastric carcinoma.
Neoplasm Metastasis
Clinicopathologic and prognostic significance of matrilysin expression at the invasive front in human colorectal cancers.
Neoplasm Metastasis
Clinicopathologic and prognostic significance of MMP-7 (matrilysin) expression in human rectal cancer.
Neoplasm Metastasis
Clinicopathological significance of matrix metalloproteinase-7 protein expression in esophageal cancer: a meta-analysis.
Neoplasm Metastasis
Clinicopathological significance of the gene expression of matrix metalloproteinase-7, insulin-like growth factor-1, insulin-like growth factor-2 and insulin-like growth factor-1 receptor in patients with colorectal cancer: insulin-like growth factor-1 receptor gene expression is a useful predictor of liver metastasis from colorectal cancer.
Neoplasm Metastasis
Coexpression of matrix metalloproteinase-7 (MMP-7) and epidermal growth factor (EGF) receptor in colorectal cancer: an EGF receptor tyrosine kinase inhibitor is effective against MMP-7-expressing cancer cells.
Neoplasm Metastasis
Colorectal carcinoma susceptibility and metastases are associated with matrix metalloproteinase-7 promoter polymorphisms.
Neoplasm Metastasis
Common MMP-7 polymorphisms and breast cancer susceptibility: a multistage study of association and functionality.
Neoplasm Metastasis
Concomitantly elevated serum matrix metalloproteinases 3 and 9 can predict survival of synchronous squamous cell carcinoma of the upper aero-digestive tract.
Neoplasm Metastasis
Contribution of matrilysin (MMP-7) to the metastatic pathway of human colorectal cancers.
Neoplasm Metastasis
Contribution of sialidase NEU1 to suppression of metastasis of human colon cancer cells through desialylation of integrin beta4.
Neoplasm Metastasis
Correlation Between MMP-7 and bFGF Expressions in Non-small Cell Lung Cancer Tissue and Clinicopathologic Features.
Neoplasm Metastasis
Correlation of lymph node metastases and expression of matrix metalloproteinase-7 in patients with gastric cancer.
Neoplasm Metastasis
Correlation of polymorphism of IL-8 and MMP-7 with occurrence and lymph node metastasis of early stage cervical cancer.
Neoplasm Metastasis
Detection of regional lymph node metastases in colon cancer by using RT-PCR for matrix metalloproteinase 7, matrilysin.
Neoplasm Metastasis
Development of in situ zymography to localize active matrix metalloproteinase-7 (matrilysin-1).
Neoplasm Metastasis
Diallyl trisulfide increases the effectiveness of TRAIL and inhibits prostate cancer growth in an orthotopic model: molecular mechanisms.
Neoplasm Metastasis
DOC-2/DAB2 interactive protein regulates proliferation and mobility of nasopharyngeal carcinoma cells by targeting PI3K/Akt pathway.
Neoplasm Metastasis
Down-regulation of matrix metalloproteinase-7 inhibits metastasis of human anaplastic thyroid cancer cell line.
Neoplasm Metastasis
Downregulation of matrix metalloprotease-9 and urokinase plasminogen activator by TX-1877 results in decreased tumor growth and metastasis on xenograft model of rectal cancer.
Neoplasm Metastasis
Effect of Wnt/?-catenin signal pathway on of matrix metalloproteinase-7 and vascular endothelial growth factor gene expressions in endometriosis.
Neoplasm Metastasis
EGCG inhibits growth, invasion, angiogenesis and metastasis of pancreatic cancer.
Neoplasm Metastasis
Elevated matrix metalloproteinase 7 expression promotes the proliferation, motility and metastasis of tongue squamous cell carcinoma.
Neoplasm Metastasis
Elevated matrix metalloproteinase-7 expression promotes metastasis in human lung carcinoma.
Neoplasm Metastasis
Elevated serum matrix metalloproteinase 7 levels predict poor prognosis after radical prostatectomy.
Neoplasm Metastasis
Enhanced production and activation of matrix metalloproteinase-7 (matrilysin) in human endometrial carcinomas.
Neoplasm Metastasis
Evaluation of the correlation of KAI1/CD82, CD44, MMP7 and ?-catenin in the prediction of prognosis and metastasis in colorectal carcinoma.
Neoplasm Metastasis
Expression and activity levels of matrix metalloproteinase-7 and in situ localization of caseinolytic activity in colorectal cancer.
Neoplasm Metastasis
Expression and localization of matrix-degrading metalloproteinases during colorectal tumorigenesis.
Neoplasm Metastasis
Expression and prognostic value of matrix metalloproteinase-7 in colorectal cancer.
Neoplasm Metastasis
Expression and significance of IGF-2, PCNA, MMP-7, and ?-actin in gastric carcinoma with Lauren classification.
Neoplasm Metastasis
Expression and tissue localization of matrix metalloproteinase 7 (matrilysin) in human gastric carcinomas. Implications for vessel invasion and metastasis.
Neoplasm Metastasis
Expression of gelatinases A and B, stromelysin-3 and matrilysin genes in breast carcinomas: clinico-pathological correlations.
Neoplasm Metastasis
Expression of heparanase gene, CD44v6, MMP-7 and nm23 protein and their relationship with the invasion and metastasis of gastric carcinomas.
Neoplasm Metastasis
Expression of insulin-like growth factor-2, c-MET, matrix metalloproteinase-7 and MUC-1 in primary lesions and lymph node metastatic lesions of gastric cancer.
Neoplasm Metastasis
Expression of matrilysin (matrix metalloproteinase-7) in primary cutaneous and metastatic melanoma.
Neoplasm Metastasis
Expression of matrilysin in vascular endothelial cells adjacent to matrilysin-producing tumors.
Neoplasm Metastasis
Expression of matrix metalloproteinase 7, laminin and type IV collagen-associated liver metastasis in human colorectal cancer: immunohistochemical approach.
Neoplasm Metastasis
Expression of matrix metalloproteinase matrilysin (MMP-7) was induced by activated Ki-ras via AP-1 activation in SW1417 colon cancer cells.
Neoplasm Metastasis
Expression of matrix metalloproteinase-7 and tissue inhibitor of metalloproteinase-1 in human prostate.
Neoplasm Metastasis
Expression of matrix metalloproteinase-7 involving in growth, invasion, metastasis and angiogenesis of gastric cancer.
Neoplasm Metastasis
Expression of Matrix Metalloproteinase-7 is an Unfavorable Prognostic Factor in Intrahepatic Cholangiocarcinoma.
Neoplasm Metastasis
Expression of matrix metalloproteinase-7 on cancer cells and tissue endothelial cells in renal cell carcinoma: prognostic implications and clinical significance for invasion and metastasis.
Neoplasm Metastasis
Expression of matrix metalloproteinases 7 and 2 in human renal cell carcinoma.
Neoplasm Metastasis
Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinase in uterine endometrial carcinoma and a correlation between expression of matrix metalloproteinase-7 and prognosis.
Neoplasm Metastasis
Expression of matrix metalloproteinases in human transitional cell carcinoma of the urinary bladder.
Neoplasm Metastasis
Expression of matrix metalloproteinases in supraglottic carcinoma and its clinical implication for estimating lymph node metastases.
Neoplasm Metastasis
Expression of MMP-7 and MT1-MMP in oral squamous cell carcinoma as predictive indicator for tumor invasion and prognosis.
Neoplasm Metastasis
Expression of MMP-7 and MT1-MMP in peritoneal dissemination of gastric cancer.
Neoplasm Metastasis
Expression of p16 in lymph node metastases of adjuvantly treated stage III colorectal cancer patients identifies poor prognostic subgroups: a retrospective analysis of biomarkers in matched primary tumor and lymph node metastases.
Neoplasm Metastasis
Expression of tissue levels of matrix metalloproteinases and their inhibitors in breast cancer.
Neoplasm Metastasis
Expression of tissue levels of matrix metalloproteinases and tissue inhibitors of metalloproteinases in gastric adenocarcinoma.
Neoplasm Metastasis
Expressions of Matrix Metalloproteinase-7 and -9 and their Prognostic Significances in Rectal Cancer.
Neoplasm Metastasis
Expressions of TIMP-1, COX-2 and MMP-7 in Colon Polyp and Colon Cancer.
Neoplasm Metastasis
Fibulin-3 suppresses Wnt/?-catenin signaling and lung cancer invasion.
Neoplasm Metastasis
Fibulin-5 suppresses lung cancer invasion by inhibiting matrix metalloproteinase-7 expression.
Neoplasm Metastasis
First evidence that the anti-malarial drug Artesunate inhibits invasion and in vivo metastasis in lung cancer by targeting essential extracellular proteases.
Neoplasm Metastasis
High-mobility group box?1: a novel inducer of the epithelial-mesenchymal transition in colorectal carcinoma.
Neoplasm Metastasis
Immunohistochemical expression of MMP-7 protein and its serum level in colorectal cancer.
Neoplasm Metastasis
Immunohistochemical molecular markers as predictors of curability of endoscopically resected submucosal colorectal cancer.
Neoplasm Metastasis
Immunohistochemical study of vascular endothelial growth factor (VEGF) and matrilysin (MMP-7) in T1 adenocarcinoma of the colon and rectum to predict lymph node metastases or distant metastases.
Neoplasm Metastasis
In silico trials to design potent inhibitors against matrilysin (MMP-7).
Neoplasm Metastasis
In vitro method for diagnosing and monitoring renal cell carcinoma using matrix metalloprotease-7 as humoral biomarker.
Neoplasm Metastasis
Inhibition of peritoneal dissemination in human gastric cancer by MMP-7-specific antisense oligonucleotide.
Neoplasm Metastasis
Inhibitory effect of matrilysin antisense oligonucleotides on human colon cancer cell invasion in vitro.
Neoplasm Metastasis
Inhibitory effects of green tea catechins on the activity of human matrix metalloproteinase 7 (matrilysin).
Neoplasm Metastasis
Intrahepatic micrometastases around liver metastases from gastric cancer.
Neoplasm Metastasis
In vivo and in vitro inhibition of human gastric cancer progress by upregulating Kank1 gene.
Neoplasm Metastasis
Malignant Potential of Gastrointestinal Cancers Assessed by Structural Equation Modeling.
Neoplasm Metastasis
Matrilsin expression is a useful marker of submucosal invasion and lymph node metastasis in early stage signet ring cell carcinoma of the stomach.
Neoplasm Metastasis
Matrilysin (matrix metalloprotease-7) cleaves membrane-bound annexin II and enhances binding of tissue-type plasminogen activator to cancer cell surfaces.
Neoplasm Metastasis
Matrilysin (matrix metalloproteinase-7) expression in ulcerative colitis-related tumorigenesis.
Neoplasm Metastasis
Matrilysin (MMP-7) as a significant determinant of malignant potential of early invasive colorectal carcinomas.
Neoplasm Metastasis
Matrilysin (MMP-7) induces homotypic adhesion of human colon cancer cells and enhances their metastatic potential in nude mouse model.
Neoplasm Metastasis
Matrilysin (MMP-7) promotes invasion of ovarian cancer cells by activation of progelatinase.
Neoplasm Metastasis
Matrilysin as a target for chemotherapy for colon cancer: use of antisense oligonucleotides as antimetastatic agents.
Neoplasm Metastasis
Matrilysin over-expression in MCF-7 cells enhances cellular invasiveness and pro-gelatinase activation.
Neoplasm Metastasis
Matrilysin stimulates DNA synthesis of cultured vascular endothelial cells and induces angiogenesis in vivo.
Neoplasm Metastasis
Matrilysin-specific antisense oligonucleotide inhibits liver metastasis of human colon cancer cells in a nude mouse model.
Neoplasm Metastasis
Matrilysin/MMP-7 Cleavage of Perlecan/HSPG2 Complexed with Semaphorin 3A Supports FAK-Mediated Stromal Invasion by Prostate Cancer Cells.
Neoplasm Metastasis
Matrix metalloproteinase matrilysin (MMP-7) participates in the progression of human gastric and esophageal cancers.
Neoplasm Metastasis
Matrix metalloproteinase-2 and -7 expression in colorectal cancer.
Neoplasm Metastasis
Matrix metalloproteinase-7 and matrix metalloproteinase-25 in oral tongue squamous cell carcinoma.
Neoplasm Metastasis
Matrix metalloproteinase-7 and matrix metalloproteinase-9 are associated with unfavourable prognosis in superficial oesophageal cancer.
Neoplasm Metastasis
Matrix metalloproteinase-7 as a marker of metastasis and predictor of poor survival in bladder cancer.
Neoplasm Metastasis
Matrix metalloproteinase-7 degrades all insulin-like growth factor binding proteins and facilitates insulin-like growth factor bioavailability.
Neoplasm Metastasis
Matrix metalloproteinase-7 expression in colorectal cancer liver metastases: evidence for involvement of MMP-7 activation in human cancer metastases.
Neoplasm Metastasis
Matrix metalloproteinase-7 expression in gastric carcinoma.
Neoplasm Metastasis
Matrix metalloproteinase-7 facilitates insulin-like growth factor bioavailability through its proteinase activity on insulin-like growth factor binding protein 3.
Neoplasm Metastasis
Matrix metalloproteinase-7 induces homotypic tumor cell aggregation via proteolytic cleavage of the membrane-bound Kunitz-type inhibitor HAI-1.
Neoplasm Metastasis
Matrix metalloproteinase-7 may serve as a novel biomarker for cervical cancer.
Neoplasm Metastasis
Matrix metalloproteinase-7 mRNA and protein expression in gastric carcinoma: a meta-analysis.
Neoplasm Metastasis
Matrix metalloproteinase-9 from bone marrow-derived cells contributes to survival but not growth of tumor cells in the lung microenvironment.
Neoplasm Metastasis
Matrix metalloproteinases contribute distinct roles in neuroendocrine prostate carcinogenesis, metastasis, and angiogenesis progression.
Neoplasm Metastasis
Matrix metalloproteinases may contribute compensationally to tumor invasion in T1 colorectal carcinomas.
Neoplasm Metastasis
Mesothelin binding to CA125/MUC16 promotes pancreatic cancer cell motility and invasion via MMP-7 activation.
Neoplasm Metastasis
Messenger RNA expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human hepatocellular carcinoma.
Neoplasm Metastasis
MMP-10, MMP-7, TIMP-1 and TIMP-2 mRNA expression in esophageal cancer.
Neoplasm Metastasis
MMP-7 A-181G Polymorphism in Breast Cancer Patients from Western Iran.
Neoplasm Metastasis
MMP-7 is upregulated by COX-2 and promotes proliferation and invasion of lung adenocarcinoma cells.
Neoplasm Metastasis
Modulation of matrilysin levels in colon carcinoma cell lines affects tumorigenicity in vivo.
Neoplasm Metastasis
Modulation of matrix metalloproteinase-7 (matrilysin) secretion in coculture of human colon carcinoma cells with fibroblasts from orthotopic and ectopic organs.
Neoplasm Metastasis
MT1-MMP and MMP-7 in invasion and metastasis of human cancers.
Neoplasm Metastasis
Multistep carcinogenesis of perihilar cholangiocarcinoma arising in the intrahepatic large bile ducts.
Neoplasm Metastasis
Mutated K-ras(Asp12) promotes tumourigenesis in Apc(Min) mice more in the large than the small intestines, with synergistic effects between K-ras and Wnt pathways.
Neoplasm Metastasis
Nobiletin, a citrus flavonoid, down-regulates matrix metalloproteinase-7 (matrilysin) expression in HT-29 human colorectal cancer cells.
Neoplasm Metastasis
Osteoclast-derived matrix metalloproteinase-7, but not matrix metalloproteinase-9, contributes to tumor-induced osteolysis.
Neoplasm Metastasis
Overexpression of a disintegrin and metalloproteinase 21 is associated with motility, metastasis, and poor prognosis in hepatocellular carcinoma.
Neoplasm Metastasis
Overexpression of matrix metalloproteinase-7 mRNA in human colon carcinomas.
Neoplasm Metastasis
Overexpression of Reg4, alone or combined with MMP-7 overexpression, is predictive of poor prognosis in colorectal cancer.
Neoplasm Metastasis
Pericellular activation of proMMP-7 (promatrilysin-1) through interaction with CD151.
Neoplasm Metastasis
Peritoneal expression of Matrilysin helps identify early post-operative recurrence of colorectal cancer.
Neoplasm Metastasis
Plasma matrix metalloproteinase-7 as a metastatic marker and survival predictor in patients with renal cell carcinomas.
Neoplasm Metastasis
Plasma MMP-2 and MMP-7 levels are elevated first month after surgery and may promote growth of residual metastases.
Neoplasm Metastasis
Polymorphisms of matrix metalloproteinase-7 and -9 are associated with oral tongue squamous cell carcinoma.
Neoplasm Metastasis
Prediction of distant metastasis by using reverse transcriptase-polymerase chain reaction for epithelial and variant CD44 mRNA in the peripheral blood of patients with colorectal cancer.
Neoplasm Metastasis
Prognostic significance of matrix metalloproteinase-7 (MMP-7) expression at the invasive front in gastric carcinoma.
Neoplasm Metastasis
Prognostic significance of matrix metalloproteinase-7 in epithelial ovarian cancer and its relation to beta-catenin expression.
Neoplasm Metastasis
Prognostic significance of matrix metalloproteinase-7 in gastric cancer survival: a meta-analysis.
Neoplasm Metastasis
Prognostic significance of MMP-7 expression in colorectal cancer: A meta-analysis.
Neoplasm Metastasis
Regulation of osteopontin and related proteins in rat CC531 colorectal cancer cells.
Neoplasm Metastasis
Relation of enhanced secretion of active matrix metalloproteinases with tumor spread in human hepatocellular carcinoma.
Neoplasm Metastasis
Relationship between E-cadherin, matrix metalloproteinase-7 gene expression and clinicopathological features in gastric carcinoma.
Neoplasm Metastasis
Retinoic acids reduce matrilysin (matrix metalloproteinase 7) and inhibit tumor cell invasion in human colon cancer.
Neoplasm Metastasis
Role of matrix metalloproteinases and their inhibitors in tumor invasion and metastasis.
Neoplasm Metastasis
Role of MMP-7 in the formation of peritoneal dissemination in gastric cancer.
Neoplasm Metastasis
Role of PTEN and MMP-7 expression in growth, invasion, metastasis and angiogenesis of gastric carcinoma.
Neoplasm Metastasis
Roles of matrix metalloproteinase-7 (MMP-7) in cancer.
Neoplasm Metastasis
Roles of osteopontin and matrix metalloproteinase-7 in occurrence, progression, and prognosis of nonsmall cell lung cancer.
Neoplasm Metastasis
Serum endostatin levels correlate with enhanced extracellular matrix degradation and poor patients' prognosis in bladder cancer.
Neoplasm Metastasis
Serum levels of TIMP-1 and MMP-7 as potential biomarkers in patients with metastatic colorectal cancer.
Neoplasm Metastasis
Serum matrilysin levels predict outcome in curatively resected colorectal cancer patients.
Neoplasm Metastasis
Sex determining region Y-box 12 (SOX12) promotes gastric cancer metastasis by upregulating MMP7 and IGF1.
Neoplasm Metastasis
SIPA1 promotes invasion and migration in human oral squamous cell carcinoma by ITGB1 and MMP7.
Neoplasm Metastasis
Study of matrix metalloproteinases and their inhibitors in breast cancer.
Neoplasm Metastasis
Suppression Of ?-catenin Nuclear Translocation By CGP57380 Decelerates Poor Progression And Potentiates Radiation-Induced Apoptosis in Nasopharyngeal Carcinoma.
Neoplasm Metastasis
Suppression of matrilysin inhibits colon cancer cell invasion in vitro.
Neoplasm Metastasis
The Contribution of MMP-7 Genotypes to Colorectal Cancer Susceptibility in Taiwan.
Neoplasm Metastasis
The Contribution of MMP-7 Promoter Polymorphisms to Taiwan Lung Cancer Susceptibility.
Neoplasm Metastasis
The matrix metalloproteinase 7 (MMP7) links Hsp90 chaperone with acquired drug resistance and tumor metastasis.
Neoplasm Metastasis
The matrix metalloproteinase-7 and pro-enzyme of metalloproteinase-1 as a potential marker for patients with rectal cancer without distant metastasis.
Neoplasm Metastasis
The Role of Matrix Metalloproteinases in the Epithelial-Mesenchymal Transition of Hepatocellular Carcinoma.
Neoplasm Metastasis
Tissue factor/activated factor VIIa induces matrix metalloproteinase-7 expression through activation of c-Fos via ERK1/2 and p38 MAPK signaling pathways in human colon cancer cell.
Neoplasm Metastasis
TNM staging for GIT cancers is correlated with the level of MMPs and TGF-?1.
Neoplasm Metastasis
Trefoil Factor 1 Suppresses Epithelial-mesenchymal Transition through Inhibition of TGF-beta Signaling in Gastric Cancer Cells.
Neoplasm Metastasis
Tumour matrilysin expression predicts metastatic potential of stage I (pT1) colon and rectal cancers.
Neoplasm Metastasis
Upregulation and differential expression of matrilysin (MMP-7) and metalloelastase (MMP-12) and their inhibitors TIMP-1 and TIMP-3 in Barrett's oesophageal adenocarcinoma.
Neoplasm Metastasis
Urinary matrix metalloproteinase-7 level is associated with the presence of metastasis in bladder cancer.
Neoplasm Metastasis
Validation of the diagnostic and prognostic relevance of serum MMP-7 levels in renal cell cancer by using a novel automated fluorescent immunoassay method.
Neoplasm Metastasis
[beta-Catenin induces invasive growth by activating matrix metalloproteinases in colorectal carcinoma]
Neoplasm Metastasis
[Correlation between expression of MMP-7 in gastric submucosal invasive carcinoma and lymph node micrometastasis]
Neoplasm Metastasis
[Expression and clinical significance of Ang-2 and MMP-7 in laryngeal carcinoma]
Neoplasm Metastasis
[Expression and clinical significance of matrilysin (MMP-7) in human rectal cancer]
Neoplasm Metastasis
[Expression of ETV5 and MMP-7 in Early Stage Cervical Squamous Cell Carcinoma and Its Role in Lymphatic Metastasis.]
Neoplasm Metastasis
[Expression of matrix metalloproteinases and tissue inhibitor of metalloproteinases in colorectal neoplasm]
Neoplasm Metastasis
[Expressions of FOXC1 and MMP-7 in molecular subtypes of breast cancer and their association with clinicopathological characteristics].
Neoplasm Metastasis
[Genetic diagnosis of colorectal cancer]
Neoplasm Metastasis
[Localization and expression of matrix metalloproteinase-7 in human prostate]
Neoplasm Metastasis
[Prediction of Post-operative Lymph Node Metastasis with a Molecular Biological Test in Head and Neck Cancer].
Neoplasm Metastasis
[Prognostic significance of the molecular markers in human gastrointestinal cancer]
Neoplasm Metastasis
[Relationship of matrilysin with invasion, metastasis, and prognosis in laryngeal cancer]
Neoplasm Metastasis
[Siliconchiptechnology-based MMP-7 analysis in urine : An option for preoperative identification of lymph node metastasis in bladder cancer.]
Neoplasm Metastasis
[The expression of matrix metalloproteinases and tissue inhibitor of metalloproteinases in transplanted tumor of salivary adenoid cystic carcinoma cell lines]
Neoplasm Metastasis
[The significance of beta-catenin and matrix metalloproteinase-7 expression in colorectal adenoma and carcinoma]
Neoplasm Metastasis
[The utility of metalloproteinases (MMPs) and their inhibitors (TIMPs) in diagnostics of gynecological malignancies].
Neoplasm Micrometastasis
Intrahepatic micrometastases around liver metastases from gastric cancer.
Neoplasm Micrometastasis
Prediction of peritoneal micrometastasis by peritoneal lavaged cytology and reverse transcriptase-polymerase chain reaction for matrix metalloproteinase-7 mRNA.
Neoplasm Micrometastasis
[Correlation between expression of MMP-7 in gastric submucosal invasive carcinoma and lymph node micrometastasis]
Neoplasm, Residual
Prognostic significance of matrix metalloproteinase-7 in epithelial ovarian cancer and its relation to beta-catenin expression.
Neoplasms
14-3-3 Proteins Modulate the ETS Transcription Factor ETV1 in Prostate Cancer.
Neoplasms
?-Catenin-independent noncanonical Wnt pathway might be induced in gastric cancers.
Neoplasms
A loss of host-derived MMP-7 promotes myeloma growth and osteolytic bone disease in vivo.
Neoplasms
A new formula for predicting liver metastasis in patients with colorectal cancer: immunohistochemical analysis of a large series of 439 surgically resected cases.
Neoplasms
A novel orthotopic mouse model of head and neck cancer and lymph node metastasis.
Neoplasms
A rat monoclonal antibody that recognizes pro- and active MMP-7 indicates polarized expression in vivo.
Neoplasms
A subset of high-grade pulmonary neuroendocrine carcinomas shows up-regulation of matrix metalloproteinase-7 associated with nuclear beta-catenin immunoreactivity, independent of EGFR and HER-2 gene amplification or expression.
Neoplasms
A/G polymorphism of matrix metalloproteinase 7 gene promoter region and cancer risk: A meta-analysis.
Neoplasms
A/G Polymorphism of the MMP-7 Gene Promoter Region in Colorectal Cancer.
Neoplasms
Aberrant Activation Of Hedgehog Signalling Promotes Cell Migration And Invasion Via Matrix Metalloproteinase-7 In Ovarian Cancer Cells.
Neoplasms
Activation of adventitial fibroblasts in the early stage of the aortic transplant vasculopathy in rat.
Neoplasms
Active matrix metalloproteinase-7 is associated with invasion in buccal squamous cell carcinoma.
Neoplasms
ADAM12 is selectively overexpressed in human glioblastomas and is associated with glioblastoma cell proliferation and shedding of heparin-binding epidermal growth factor.
Neoplasms
Amperometric Biosensor of Matrix Metalloproteinase-7 Enhanced by Pd-Functionalized Carbon Nanocomposites.
Neoplasms
Andrographolide as a Therapeutic Agent Against Breast and Ovarian Cancers.
Neoplasms
Application of MMP-7 and MMP-10 in assisting the diagnosis of malignant pleural effusion.
Neoplasms
Assessing matrix metalloproteinase expression and activity in hepatocellular carcinomas.
Neoplasms
Association between expression of MMP-7 and MMP-9 and pelvic lymph node and para-aortic lymph node metastasis in early cervical cancer.
Neoplasms
Association between the functional polymorphism in the matrix metalloproteinase-7 promoter and susceptibility to adult astrocytoma.
Neoplasms
Association of E1AF mRNA expression with tumor progression and matrilysin in human rectal cancer.
Neoplasms
Association of ets-related transcriptional factor E1AF expression with tumour progression and overexpression of MMP-1 and matrilysin in human colorectal cancer.
Neoplasms
Association of matrilysin expression with progression and poor prognosis in human pancreatic adenocarcinoma.
Neoplasms
Association of matrilysin expression with recurrence and poor prognosis in human esophageal squamous cell carcinoma.
Neoplasms
Association of matrilysin mRNA expression with K-ras mutations and progression in pancreatic ductal adenocarcinomas.
Neoplasms
Association of matrix metalloproteinase-7 (-181A>G) polymorphism with risk of esophageal squamous cell carcinoma in Kashmir Valley.
Neoplasms
Association of Matrix Metalloproteinase-7 Genotypes with the Risk of Bladder Cancer.
Neoplasms
Association of matrix metalloproteinases 1, 7, and 9 gene polymorphisms with genetic susceptibility to colorectal carcinoma in a Han Chinese population.
Neoplasms
Association of trypsin expression with tumour progression and matrilysin expression in human colorectal cancer.
Neoplasms
beta-catenin regulates the expression of the matrix metalloproteinase-7 in human colorectal cancer.
Neoplasms
Beta-catenin up-regulates the expression of cyclinD1, c-myc and MMP-7 in human pancreatic cancer: relationships with carcinogenesis and metastasis.
Neoplasms
Binding of active matrilysin to cell surface cholesterol sulfate is essential for its membrane-associated proteolytic action and induction of homotypic cell adhesion.
Neoplasms
Bio-informatics analysis of renal carcinoma gene matrix metalloproteinase-7.
Neoplasms
Biochemical changes during growth and regression of pregnancy-dependent mammary tumors of GR/A mice.
Neoplasms
Biochemical characterization and zinc binding group (ZBGs) inhibition studies on the catalytic domain of MMP7 (cdMMP7).
Neoplasms
Biological and molecular characterization of a new human ampullary cancer cell line.
Neoplasms
Breast Heterogeneity: Obstacles to Developing Universal Biomarkers of Breast Cancer Initiation and Progression.
Neoplasms
Butein blocks tumor necrosis factor alpha-induced interleukin 8 and matrix metalloproteinase 7 production by inhibiting p38 kinase and osteopontin mediated signaling events in HT-29 cells.
Neoplasms
Cancer cell death induced by the intracellular self-assembly of an enzyme-responsive supramolecular gelator.
Neoplasms
Cancer chemopreventive effects of lycopene: suppression of MMP-7 expression and cell invasion in human colon cancer cells.
Neoplasms
Cancer invasion regulates vascular complexity in a three-dimensional biomimetic model.
Neoplasms
Carcinoma of the parotid gland: developing prognostic indices.
Neoplasms
CCL25 promotes the migration and invasion of non-small cell lung cancer cells by regulating VEGF and MMPs in a CCR9-dependent manner.
Neoplasms
CD44 anchors the assembly of matrilysin/MMP-7 with heparin-binding epidermal growth factor precursor and ErbB4 and regulates female reproductive organ remodeling.
Neoplasms
Cellular sources of MMP-7, MMP-13 and MMP-28 in ulcerative colitis.
Neoplasms
Characterization of matrix metalloproteinase-26, a novel metalloproteinase widely expressed in cancer cells of epithelial origin.
Neoplasms
Charge-Triggered Membrane Insertion of Matrix Metalloproteinase-7, Supporter of Innate Immunity and Tumors.
Neoplasms
Cholesterol sulfate alters substrate preference of matrix metalloproteinase-7 and promotes degradations of pericellular laminin-332 and fibronectin.
Neoplasms
Chronic exposure to exogenous matrilysin induces chemoresistance and enhances Bcl-2 expression in A549 lung adenocarcinoma cells.
Neoplasms
Chronic stress promotes gastric cancer progression and metastasis: an essential role for ADRB2.
Neoplasms
Circulating Anti-Matrix Metalloproteinase-7 Antibodies May Be a Potential Biomarker for Oral Squamous Cell Carcinoma.
Neoplasms
Circulating Plasma Biomarkers of Survival in Antifibrotic-Treated Patients With Idiopathic Pulmonary Fibrosis.
Neoplasms
Circulating proteins as predictors of cardiovascular mortality in end-stage renal disease.
Neoplasms
Clarification of the active gelatinolytic sites in human ovarian neoplasms using in situ zymography.
Neoplasms
Cleavage of CD95 by matrix metalloproteinase-7 induces apoptosis resistance in tumour cells.
Neoplasms
Cleavage of E-Cadherin by Matrix Metalloproteinase-7 Promotes Cellular Proliferation in Nontransformed Cell Lines via Activation of RhoA.
Neoplasms
Cleavage of the Perlecan-Semaphorin 3A-Plexin A1-Neuropilin-1 (PSPN) Complex by Matrix Metalloproteinase 7/Matrilysin Triggers Prostate Cancer Cell Dyscohesion and Migration.
Neoplasms
CLEC3A, MMP7, and LCN2 as novel markers for predicting recurrence in resected G1 and G2 pancreatic neuroendocrine tumors.
Neoplasms
Clinical impact of matrix metalloproteinase-7 mRNA expression in the invasive front and inner surface of tumor tissues in patients with colorectal cancer.
Neoplasms
Clinical significance of immunohistochemical expression of insulin-like growth factor-1 receptor and matrix metalloproteinase-7 in resected non-small cell lung cancer.
Neoplasms
Clinical significance of matrix metalloproteinase-7 and Ets-1 gene expression in patients with lung cancer.
Neoplasms
Clinical significance of matrix metalloproteinase-7 expression in esophageal carcinoma.
Neoplasms
Clinical Significance of Matrix Metalloproteinases in Blood Plasma of Patients with Gastric Cancer.
Neoplasms
Clinical Significance of MMP-7 and PTEN Expression in Colorectal Cancer.
Neoplasms
Clinical significance of serum MMP-2 and MMP-7 in patients with ovarian cancer.
Neoplasms
Clinical utility of circulating matrix metalloproteinase-7 (MMP-7), CC chemokine ligand 18 (CCL18) and CC chemokine ligand 11 (CCL11) as markers for diagnosis of epithelial ovarian cancer.
Neoplasms
Clinicopathologic and prognostic significance of matrilysin expression at the invasive front in human colorectal cancers.
Neoplasms
Clinicopathologic and prognostic significance of matrix metalloproteinases in rectal cancer.
Neoplasms
Clinicopathologic and prognostic significance of MMP-7 (matrilysin) expression in human rectal cancer.
Neoplasms
Clinicopathological assessment and quantitative estimation of the matrix metalloproteinases MMP-2 and MMP-7 and the inhibitors TIMP-1 and TIMP-2 in colorectal carcinoma tissue samples.
Neoplasms
Clinicopathological significance of matrix metalloproteinase-7 protein expression in esophageal cancer: a meta-analysis.
Neoplasms
Clinicopathological significance of the gene expression of matrix metalloproteinase-7, insulin-like growth factor-1, insulin-like growth factor-2 and insulin-like growth factor-1 receptor in patients with colorectal cancer: insulin-like growth factor-1 receptor gene expression is a useful predictor of liver metastasis from colorectal cancer.
Neoplasms
Cobalt chloride-induced hypoxia modulates the invasive potential and matrix metalloproteinases of primary and metastatic breast cancer cells.
Neoplasms
Coexpression of matrilysin and laminin-5 gamma2 chain may contribute to tumor cell migration in colorectal carcinomas.
Neoplasms
Coexpression of matrix metalloproteinase-7 (MMP-7) and epidermal growth factor (EGF) receptor in colorectal cancer: an EGF receptor tyrosine kinase inhibitor is effective against MMP-7-expressing cancer cells.
Neoplasms
Coexpression of Matrix Metalloproteinase-7 and Tissue Inhibitor of Metalloproteinase-1 as a Prognostic Biomarker in Gastric Cancer.
Neoplasms
Common MMP-7 polymorphisms and breast cancer susceptibility: a multistage study of association and functionality.
Neoplasms
Comparative enzyme immunoassay of matrix metalloproteinases-2, -7, -9 and their tissue inhibitor-2 in tumors and plasma of patients with gastric cancer.
Neoplasms
Comprehensive analysis of matrix metalloproteinase and tissue inhibitor expression in pancreatic cancer: increased expression of matrix metalloproteinase-7 predicts poor survival.
Neoplasms
Comprehensive Omics Analysis of a Novel Small-Molecule Inhibitor of Chemoresistant Oncogenic Signatures in Colorectal Cancer Cell with Antitumor Effects.
Neoplasms
Concomitant consumption of lycopene and fish oil inhibits tumor growth and progression in a mouse xenograft model of colon cancer.
Neoplasms
Considering the critical interface between tumor cells and stromal cells in the search for targets for anticancer therapy.
Neoplasms
Construction of a sensitive protease sensor with DNA-peptide conjugates for single-molecule detection of multiple matrix metalloproteinases.
Neoplasms
Contribution of matrilysin (MMP-7) to the metastatic pathway of human colorectal cancers.
Neoplasms
Contribution of Matrix Metalloproteinase-7 Genotypes to the Risk of Non-solid Tumor, Childhood Leukemia.
Neoplasms
Contribution of sialidase NEU1 to suppression of metastasis of human colon cancer cells through desialylation of integrin beta4.
Neoplasms
Correlation among 16 biological factors [p53, p21(waf1), MIB-1 (Ki-67), p16(INK4A), cyclin D1, E-cadherin, Bcl-2, TNF-?, NF-?B, TGF-?, MMP-7, COX-2, EGFR, HER2/neu, ER, and HIF-1?] and clinical outcomes following curative chemoradiation therapy in 10 patients with esophageal squamous cell carcinoma.
Neoplasms
Correlation between beta-catenin widespread nuclear expression and matrix metalloproteinase-7 overexpression in sporadic desmoid tumors.
Neoplasms
Correlation between the immunohistochemical expressions of MMP-1, MMP-7 and VEGF and prognostic factors in colorectal adenocarcinoma.
Neoplasms
Correlation of lymph node metastases and expression of matrix metalloproteinase-7 in patients with gastric cancer.
Neoplasms
Correlation of polymorphism of IL-8 and MMP-7 with occurrence and lymph node metastasis of early stage cervical cancer.
Neoplasms
Correlations of Moesin expression with the pathological stage, nerve infiltration, tumor location and pain severity in patients with pancreatic cancer.
Neoplasms
Current evidence on associations between the MMP-7 (-181A>G) polymorphism and digestive system cancer risk.
Neoplasms
CYR61 downregulation correlates with tumor progression by promoting MMP-7 expression in human gastric carcinoma.
Neoplasms
Cytoplasmic Kaiso is associated with poor prognosis in non-small cell lung cancer.
Neoplasms
Decreased synthesis of matrix metalloproteinase-7 and adhesion to the extracellular matrix proteins of human colon cancer cells treated with troglitazone.
Neoplasms
Degradation of entactin by matrix metalloproteinases. Susceptibility to matrilysin and identification of cleavage sites.
Neoplasms
Degradation of fibronectin fibrils by matrilysin and characterization of the degradation products.
Neoplasms
Depletion of cell surface CD44 in nonmelanoma skin tumours is associated with increased expression of matrix metalloproteinase 7.
Neoplasms
Design, Synthesis and Biological Evaluation of 3,9-diazatetraasteranes as Novel Matrilysin Inhibitors.
Neoplasms
Designing 129Xe NMR biosensors for matrix metalloproteinase detection.
Neoplasms
Detection of Matrilysin Activity Using Polypeptide Functionalized Reduced Graphene Oxide Field-Effect Transistor Sensor.
Neoplasms
Determination of matrilysin activity in gastrointestinal neoplasia.
Neoplasms
Development of a Non-Hydroxamate Dual Matrix Metalloproteinase (MMP)-7/-13 Inhibitor.
Neoplasms
Dickkopf-1 expression is associated with tumorigenity and lymphatic metastasis in human hilar cholangiocarcinoma.
Neoplasms
Differential expression of c-jun and c-fos mRNAs in squamous cell carcinoma of the head and neck: associations with uPA, gelatinase B, and matrilysin mRNAs.
Neoplasms
Differential expression of matrilysin and cyclooxygenase-2 in intestinal and colorectal neoplasms.
Neoplasms
Differential expression of matrilysin-1 (MMP-7), 92 kD gelatinase (MMP-9), and metalloelastase (MMP-12) in oral verrucous and squamous cell cancer.
Neoplasms
Differential Protein Expression Profiles in Glaucomatous Trabecular Meshwork: An Evaluation Study on a Small Primary Open Angle Glaucoma Population.
Neoplasms
Differential regulation of MMP-9 and TIMP-2 expression in malignant melanoma developed in metallothionein/RET transgenic mice.
Neoplasms
Differing effects of endogenous and synthetic inhibitors of metalloproteinases on intestinal tumorigenesis.
Neoplasms
Discovery of New Risk Markers for Ischemic Stroke Using a Novel Targeted Proteomics Chip.
Neoplasms
Docosahexaenoic acid induces proteasome-dependent degradation of beta-catenin, down-regulation of survivin and apoptosis in human colorectal cancer cells not expressing COX-2.
Neoplasms
Down-regulation of matrix metalloproteinase-7 inhibits metastasis of human anaplastic thyroid cancer cell line.
Neoplasms
Downregulation of matrix metalloprotease-9 and urokinase plasminogen activator by TX-1877 results in decreased tumor growth and metastasis on xenograft model of rectal cancer.
Neoplasms
Downregulation of SFRP5 expression and its inverse correlation with those of MMP-7 and MT1-MMP in gastric cancer.
Neoplasms
Dynamic molecular changes associated with epithelial-mesenchymal transition and subsequent mesenchymal-epithelial transition in the early phase of metastatic tumor formation.
Neoplasms
E-cadherin, beta-catenin adhesion complex and relation to matrilysin expression in pT3 rectosigmoid cancers.
Neoplasms
E1A-F is overexpressed early in human colorectal neoplasia and associated with cyclooxygenase-2 and matrix metalloproteinase-7.
Neoplasms
Effect of hGC-MSCs from human gastric cancer tissue on cell proliferation, invasion and epithelial-mesenchymal transition in tumor tissue of gastric cancer tumor-bearing mice.
Neoplasms
Effect of preoperative radiotherapy on matrilysin gene expression in rectal cancer.
Neoplasms
Effect of Repeated Freezing and Thawing on Biomarker Stability in Plasma and Serum Samples.
Neoplasms
Effect of sulindac sulfide on metallohydrolases in the human colon cancer cell line HT-29.
Neoplasms
Effects of angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor blockers on lymphangiogenesis of gastric cancer in a nude mouse model.
Neoplasms
Effects of chlorella on activities of protein tyrosine phosphatases, matrix metalloproteinases, caspases, cytokine release, B and T cell proliferations, and phorbol ester receptor binding.
Neoplasms
Effects of silencing S100A8 and S100A9 with small interfering RNA on the migration of CNE1 nasopharyngeal carcinoma cells.
Neoplasms
EGCG inhibits growth, invasion, angiogenesis and metastasis of pancreatic cancer.
Neoplasms
Electrochemical detection of matrix metalloproteinase-7 using an immunoassay on a methylene blue/2D MoS2/graphene oxide electrode.
Neoplasms
Elevated matrix metalloproteinase 7 expression promotes the proliferation, motility and metastasis of tongue squamous cell carcinoma.
Neoplasms
Elevated matrix metalloproteinase-7 expression promotes metastasis in human lung carcinoma.
Neoplasms
Elevated Plasma Levels of MMP-12 Are Associated With Atherosclerotic Burden and Symptomatic Cardiovascular Disease in Subjects With Type 2 Diabetes.
Neoplasms
Elevated serum matrix metalloproteinase 7 levels predict poor prognosis after radical prostatectomy.
Neoplasms
Enamel matrix derivative induces the expression of tissue inhibitor of matrix metalloproteinase-3 in human gingival fibroblasts via extracellular signal-regulated kinase.
Neoplasms
Encapsulation of individual living cells with enzyme responsive polymer nanoshell.
Neoplasms
Endometrial tumor invasiveness is related to metalloproteinase 2 and tissue inhibitor of metalloproteinase 2 expressions.
Neoplasms
Endometriosis Leads to an Increased Trefoil Factor 3 Concentration in the Peritoneal Cavity but Does Not Alter Systemic Levels.
Neoplasms
Endothelium specific matrilysin (MMP-7) expression in human cancers.
Neoplasms
Enhanced expression of MMP-7 and MMP-13 in inflammatory bowel disease: a precancerous potential?
Neoplasms
Enhanced secretion and activation of matrilysin during malignant conversion of human colorectal epithelium and its relationship with invasive potential of colon cancer cells.
Neoplasms
Enteric bacterial protein AvrA promotes colonic tumorigenesis and activates colonic beta-catenin signaling pathway.
Neoplasms
Enzyme-Triggered Morphological Transition of Peptide Nanostructures for Tumor-Targeted Drug Delivery and Enhanced Cancer Therapy.
Neoplasms
Ethanolic Extract of Traditional Chinese Medicine (TCM) Gamboge Inhibits Colon Cancer
Neoplasms
ETS variant 1 regulates matrix metalloproteinase-7 transcription in LNCaP prostate cancer cells.
Neoplasms
Examining the role of Paneth cells in the small intestine by lineage ablation in transgenic mice.
Neoplasms
Expression and localization of matrix-degrading metalloproteinases during colorectal tumorigenesis.
Neoplasms
Expression and localization of the matrix metalloproteinase pump-1 (MMP-7) in human gastric and colon carcinomas.
Neoplasms
Expression and significance of IGF-2, PCNA, MMP-7, and ?-actin in gastric carcinoma with Lauren classification.
Neoplasms
Expression of ets-related transcriptional factor E1AF is associated with tumor progression and over-expression of matrilysin in human gastric cancer.
Neoplasms
Expression of gelatinase A, tissue inhibitor of metalloproteinases-2, matrilysin, and trypsin(ogen) in lung neoplasms: an immunohistochemical study.
Neoplasms
Expression of insulin-like growth factor-2, c-MET, matrix metalloproteinase-7 and MUC-1 in primary lesions and lymph node metastatic lesions of gastric cancer.
Neoplasms
Expression of matrilysin (matrix metalloproteinase-7) in primary cutaneous and metastatic melanoma.
Neoplasms
Expression of matrilysin in vascular endothelial cells adjacent to matrilysin-producing tumors.
Neoplasms
Expression of matrilysin mRNA in colorectal adenomas and its induction by truncated fibronectin.
Neoplasms
Expression of matrix metalloproteinase (MMP)-7 and MMP-13 and loss of MMP-19 and p16 are associated with malignant progression in chronic wounds.
Neoplasms
Expression of matrix metalloproteinase 7 (matrilysin) in human osteoarthritic cartilage.
Neoplasms
Expression of matrix metalloproteinase matrilysin (MMP-7) was induced by activated Ki-ras via AP-1 activation in SW1417 colon cancer cells.
Neoplasms
Expression of matrix metalloproteinase-7 correlates with the invasion of T1 colorectal carcinoma.
Neoplasms
Expression of matrix metalloproteinase-7 involving in growth, invasion, metastasis and angiogenesis of gastric cancer.
Neoplasms
Expression of Matrix Metalloproteinase-7 is an Unfavorable Prognostic Factor in Intrahepatic Cholangiocarcinoma.
Neoplasms
Expression of matrix metalloproteinase-7 on cancer cells and tissue endothelial cells in renal cell carcinoma: prognostic implications and clinical significance for invasion and metastasis.
Neoplasms
Expression of matrix metalloproteinases (MMPs) in primary human breast cancer and breast cancer cell lines: New findings and review of the literature.
Neoplasms
Expression of matrix metalloproteinases 2 and 7 in tumor cells correlates with the World Health Organization classification subtype and clinical stage of thymic epithelial tumors.
Neoplasms
Expression of matrix metalloproteinases 2, 7 and 9 in patients with colorectal cancer.
Neoplasms
Expression of matrix metalloproteinases 3, 10 and 11 (stromelysins 1, 2 and 3) and matrix metalloproteinase 7 (matrilysin) by cancer cells in non-small cell lung neoplasms. Clinicopathologic studies.
Neoplasms
Expression of matrix metalloproteinases 7 and 2 in human renal cell carcinoma.
Neoplasms
Expression of matrix metalloproteinases 7 and 9 in non-small cell lung cancer Relation to clinicopathological factors, beta-catenin and prognosis.
Neoplasms
Expression of matrix metalloproteinases and their inhibitors correlates with invasion and metastasis in squamous cell carcinoma of the head and neck.
Neoplasms
Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinase in uterine endometrial carcinoma and a correlation between expression of matrix metalloproteinase-7 and prognosis.
Neoplasms
Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human pancreatic adenocarcinomas: clinicopathologic and prognostic significance of matrilysin expression.
Neoplasms
Expression of matrix metalloproteinases in benign and malignant follicular thyroid lesions.
Neoplasms
Expression of matrix metalloproteinases in human transitional cell carcinoma of the urinary bladder.
Neoplasms
Expression of matrix metalloproteinases in supraglottic carcinoma and its clinical implication for estimating lymph node metastases.
Neoplasms
Expression of metalloproteinase genes in human prostate cancer.
Neoplasms
Expression of MMP-2, MMP-7, MMP-9, MMP-10 and MMP-11 in human astrocytic and oligodendroglial gliomas.
Neoplasms
Expression of MMP-7 and MT1-MMP in oral squamous cell carcinoma as predictive indicator for tumor invasion and prognosis.
Neoplasms
Expression of MMP-7 and MT1-MMP in peritoneal dissemination of gastric cancer.
Neoplasms
Expression of MMP-7(PUMP-1) mRNA in human colorectal cancers.
Neoplasms
Expression of MMP-7, MMP-9, TIMP-1 and TIMP-2 mRNA in lung tissue of patients with non-small cell lung cancer (NSCLC) and benign pulmonary disease.
Neoplasms
Expression of most matrix metalloproteinase family members in breast cancer represents a tumor-induced host response.
Neoplasms
Expression of nuclear beta-catenin and c-myc is correlated with tumor size but not with proliferative activity of colorectal adenomas.
Neoplasms
Expression of p16 in lymph node metastases of adjuvantly treated stage III colorectal cancer patients identifies poor prognostic subgroups: a retrospective analysis of biomarkers in matched primary tumor and lymph node metastases.
Neoplasms
Expression of the metalloproteinase matrilysin in DU-145 cells increases their invasive potential in severe combined immunodeficient mice.
Neoplasms
Expression of tissue levels of matrix metalloproteinases and their inhibitors in breast cancer.
Neoplasms
Expression of tissue levels of matrix metalloproteinases and tissue inhibitors of metalloproteinases in gastric adenocarcinoma.
Neoplasms
Expression of urokinase-type plasminogen activator, stromelysin 1, stromelysin 3, and matrilysin genes in lung carcinomas.
Neoplasms
Expression of Wnt target genes in solid pseudopapillary tumor of the pancreas: a pilot study.
Neoplasms
Expression of Wnt3, ?-catenin and MMP-7 in gastric cancer and precancerous lesions and their correlations with Helicobacter pylori infection.
Neoplasms
Expressions of Matrix Metalloproteinase-7 and -9 and their Prognostic Significances in Rectal Cancer.
Neoplasms
Expressions of Matrix Metalloproteinases 2, 7, and 9 in Carcinogenesis of Pancreatic Ductal Adenocarcinoma.
Neoplasms
Expressions of TIMP-1, COX-2 and MMP-7 in Colon Polyp and Colon Cancer.
Neoplasms
FGF-1/-3/FGFR4 signaling in cancer-associated fibroblasts promotes tumor progression in colon cancer through Erk and MMP-7.
Neoplasms
Fibulin-3 suppresses Wnt/?-catenin signaling and lung cancer invasion.
Neoplasms
Fibulin-5 inhibits Wnt/?-catenin signaling in lung cancer.
Neoplasms
Fibulin-5 suppresses lung cancer invasion by inhibiting matrix metalloproteinase-7 expression.
Neoplasms
Functional expression of the chemokine receptor XCR1 on oral epithelial cells.
Neoplasms
Genetic Alterations in Gastric Cancer Associated with Helicobacter pylori Infection.
Neoplasms
Genetic polymorphisms in matrix metalloproteinases -1 and -7 and susceptibility to gastric cancer: an association study and meta-analysis.
Neoplasms
Ginkgo biloba L. leaf extract offers multiple mechanisms in bridling N-methylnitrosourea - mediated experimental colorectal cancer.
Neoplasms
HER2-dependent MMP-7 expression is mediated by activated STAT3.
Neoplasms
Heterogeneous regional expression patterns of matrix metalloproteinases in human malignant gliomas.
Neoplasms
High levels of serum VEGF and TIMP-1 are correlated with colon cancer liver metastasis and intrahepatic recurrence after liver resection.
Neoplasms
High-mobility group box?1: a novel inducer of the epithelial-mesenchymal transition in colorectal carcinoma.
Neoplasms
HRCT and histopathological evaluation of fibrosis and tissue destruction in IPF associated with pulmonary emphysema.
Neoplasms
Human leukocyte elastase counteracts matrix metalloproteinase-7 induced apoptosis resistance of tumor cells.
Neoplasms
Identification of early-stage colorectal cancer patients at risk of relapse post-resection by immunobead reverse transcription-PCR analysis of peritoneal lavage fluid for malignant cells.
Neoplasms
Identification of gene expression profiles correlated to tumor progression in a preclinical model of colon carcinogenesis.
Neoplasms
IL-18 immunoadjuvanted xenogeneic canine MMP-7 DNA vaccine overcomes immune tolerance and supresses the growth of murine mammary tumor.
Neoplasms
Immunohistochemical Comparison of Malignancy Between Radial Invasion and Mucosal Extension in Hilar Cholangiocarcinoma.
Neoplasms
Immunohistochemical expression of matrix metalloproteinases in squamous cell carcinoma of the tongue and lower lip.
Neoplasms
Immunohistochemical expression of MMP-7 protein and its serum level in colorectal cancer.
Neoplasms
Immunohistochemical molecular markers as predictors of curability of endoscopically resected submucosal colorectal cancer.
Neoplasms
Immunohistochemical study of vascular endothelial growth factor (VEGF) and matrilysin (MMP-7) in T1 adenocarcinoma of the colon and rectum to predict lymph node metastases or distant metastases.
Neoplasms
In silico trials to design potent inhibitors against matrilysin (MMP-7).
Neoplasms
In vitro method for diagnosing and monitoring renal cell carcinoma using matrix metalloprotease-7 as humoral biomarker.
Neoplasms
Increased expression of matrix metalloproteinase 7 and 9 and membrane type 1-matrix metalloproteinase in esophageal squamous cell carcinomas.
Neoplasms
Increased expression of matrix metalloproteinase-7 in invasive early gastric cancer.
Neoplasms
Increased metabolites of 5-lipoxygenase from hypoxic ovarian cancer cells promote tumor-associated macrophage infiltration.
Neoplasms
Increased production of matrix metalloproteinase-7 (MMP-7) by asbestos exposure enhances tissue migration of human regulatory T-like cells.
Neoplasms
Independent histological risk factors for lymph node metastasis of superficial esophageal squamous cell carcinoma; implication of claudin-5 immunohistochemistry for expanding the indications of endoscopic resection.
Neoplasms
Induction of matrix metalloprotease-7 is common in mucinous ovarian tumors including early stage disease.
Neoplasms
Induction of tumour cell apoptosis by matrix metalloproteinase inhibitors: new tricks from a (not so) old drug.
Neoplasms
Inflammation-related factors predicting prognosis of gastric cancer.
Neoplasms
Influence of "Flexible" versus "Rigid" Nanoparticles on the Stability of Matrix Metalloproteinase-7.
Neoplasms
Inhibition of peritoneal dissemination in human gastric cancer by MMP-7-specific antisense oligonucleotide.
Neoplasms
Inhibitory effect of matrilysin antisense oligonucleotides on human colon cancer cell invasion in vitro.
Neoplasms
Inhibitory effect of soluble EP2 receptor on ovarian tumor growth in nude mice and utility of TMPRSS4 as a combinatorial molecular target.
Neoplasms
Inhibitory effects of andrographolide on migration and invasion in human non-small cell lung cancer A549 cells via down-regulation of PI3K/Akt signaling pathway.
Neoplasms
Inhibitory effects of green tea catechins on the activity of human matrix metalloproteinase 7 (matrilysin).
Neoplasms
Insulin-like growth factor binding protein-5 is a target of matrix metalloproteinase-7: implications for epithelial-mesenchymal signaling.
Neoplasms
Insulin-like growth factor-I receptor blockade reduces the invasiveness of gastrointestinal cancers via blocking production of matrilysin.
Neoplasms
Integrin- and cadherin-mediated induction of the matrix metalloprotease matrilysin in cocultures of malignant oral squamous cell carcinoma cells and dermal fibroblasts.
Neoplasms
Interaction between Tumor-Associated Dendritic Cells and Colon Cancer Cells Contributes to Tumor Progression via CXCL1.
Neoplasms
Interleukin-12 deficiency is permissive for angiogenesis in UV radiation-induced skin tumors.
Neoplasms
Interleukin-1beta secreted from monocytic cells induces the expression of matrilysin in the prostatic cell line LNCaP.
Neoplasms
Interplay of insulin-like growth factor-II, insulin-like growth factor-I, insulin-like growth factor-I receptor, COX-2, and matrix metalloproteinase-7, play key roles in the early stage of colorectal carcinogenesis.
Neoplasms
Interrelation between expression of matrix metalloproteinase 7 and beta-catenin in esophageal cancer.
Neoplasms
Intestinal tumorigenesis is suppressed in mice lacking the metalloproteinase matrilysin.
Neoplasms
Intraductal papillary mucinous neoplasms of the pancreas: an analysis of protein expression and clinical features.
Neoplasms
Intrahepatic micrometastases around liver metastases from gastric cancer.
Neoplasms
Inverse relationship between matrilysin expression and proliferative activity of cells in advanced gastric carcinoma.
Neoplasms
Investigations for a multi-marker RT-PCR to improve sensitivity of disseminated tumor cell detection.
Neoplasms
Involvement of matrix metalloproteinase-7 in invasion-metastasis through induction of cell dissociation in pancreatic cancer.
Neoplasms
Involvement of specific matrix metalloproteinases during tumor necrosis factor/IFNgamma-based cancer therapy in mice.
Neoplasms
In vivo and in vitro inhibition of human gastric cancer progress by upregulating Kank1 gene.
Neoplasms
IPO5 promotes malignant progression of esophageal cancer through activating MMP7.
Neoplasms
Knockdown of MMP-7 inhibits cell proliferation and enhances sensitivity to 5-fluorouracil and X-ray irradiation in colon cancer cells.
Neoplasms
Magnolol suppresses the proliferation and invasion of cholangiocarcinoma cells via inhibiting the NF-?B signaling pathway.
Neoplasms
Mangiferin exerts antitumor activity in breast cancer cells by regulating matrix metalloproteinases, epithelial to mesenchymal transition, and ?-catenin signaling pathway.
Neoplasms
Mangiferin: a natural miracle bioactive compound against lifestyle related disorders.
Neoplasms
Mapping of the metalloproteinase gene matrilysin (MMP7) to human chromosome 11q21-->q22.
Neoplasms
Matrilsin expression is a useful marker of submucosal invasion and lymph node metastasis in early stage signet ring cell carcinoma of the stomach.
Neoplasms
Matrilysin (matrix metalloprotease-7) cleaves membrane-bound annexin II and enhances binding of tissue-type plasminogen activator to cancer cell surfaces.
Neoplasms
Matrilysin (matrix metalloproteinase-7) expression in ulcerative colitis-related tumorigenesis.
Neoplasms
Matrilysin (matrix metalloproteinase-7) selects for apoptosis-resistant mammary cells in vivo.
Neoplasms
Matrilysin (matrix metalloproteinase-7): a new promising drug target in cancer and inflammation?
Neoplasms
Matrilysin (MMP-7) as a significant determinant of malignant potential of early invasive colorectal carcinomas.
Neoplasms
Matrilysin (MMP-7) cleaves C-type lectin domain family 3 member A (CLEC3A) on tumor cell surface and modulates its cell adhesion activity.
Neoplasms
Matrilysin (MMP-7) degrades VE-cadherin and accelerates accumulation of beta-catenin in the nucleus of human umbilical vein endothelial cells.
Neoplasms
Matrilysin (MMP-7) induces homotypic adhesion of human colon cancer cells and enhances their metastatic potential in nude mouse model.
Neoplasms
Matrilysin (MMP-7) is a novel broadly expressed tumor antigen recognized by antigen-specific T cells.
Neoplasms
Matrilysin (MMP-7) promotes invasion of ovarian cancer cells by activation of progelatinase.
Neoplasms
Matrilysin (PUMP) correlates with dermal invasion during appendageal development and cutaneous neoplasia.
Neoplasms
Matrilysin expression in human prostate carcinoma.
Neoplasms
Matrilysin gene expression in sporadic and familial colorectal adenomas.
Neoplasms
Matrilysin in early stage intestinal tumorigenesis.
Neoplasms
Matrilysin inhibits proliferation and modulates sensitivity of lung cancer cells to FasL-mediated apoptosis.
Neoplasms
Matrilysin is associated with progression of colorectal tumor.
Neoplasms
Matrilysin over-expression in MCF-7 cells enhances cellular invasiveness and pro-gelatinase activation.
Neoplasms
Matrilysin stimulates DNA synthesis of cultured vascular endothelial cells and induces angiogenesis in vivo.
Neoplasms
Matrilysin [MMP-7] expression selects for cells with reduced sensitivity to apoptosis.
Neoplasms
Matrilysin-1 mediates bronchiolization of alveoli, a potential premalignant change in lung cancer.
Neoplasms
Matrilysin-specific antisense oligonucleotide inhibits liver metastasis of human colon cancer cells in a nude mouse model.
Neoplasms
Matrilysin/matrix metalloproteinase-7(MMP7) cleavage of perlecan/HSPG2 creates a molecular switch to alter prostate cancer cell behavior.
Neoplasms
Matrilysin: a rapidly expanding role in the etiopathogenesis of systemic malignancies.
Neoplasms
Matrix Metalloprotease-7 Mediates Nucleolar Assembly and Intra-nucleolar Cleaving p53 in Gefitinib-Resistant Cancer Stem Cells.
Neoplasms
Matrix metalloproteinase (MMP)-7 in Barrett's esophagus and esophageal adenocarcinoma: expression, metabolism, and functional significance.
Neoplasms
Matrix metalloproteinase (MMP)-7 in salivary gland cancer.
Neoplasms
Matrix metalloproteinase 7 and perlecan in oral epithelial dysplasia and carcinoma in situ: an aid for histopathologic recognition of their cell proliferation centers.
Neoplasms
Matrix metalloproteinase 7 expression in ampullary carcinoma.
Neoplasms
Matrix metalloproteinase 7 is required for tumor formation, but dispensable for invasion and fibrosis in SMAD4-deficient intestinal adenocarcinomas.
Neoplasms
Matrix metalloproteinase matrilysin (MMP-7) participates in the progression of human gastric and esophageal cancers.
Neoplasms
Matrix metalloproteinase matrilysin is constitutively expressed in adult human exocrine epithelium.
Neoplasms
Matrix Metalloproteinase Responsive, Proximity-activated Polymeric Nanoparticles for siRNA Delivery.
Neoplasms
Matrix metalloproteinase-2 and -7 expression in colorectal cancer.
Neoplasms
Matrix metalloproteinase-7 (MMP-7) polymorphism is a risk factor for endometrial cancer susceptibility.
Neoplasms
Matrix metalloproteinase-7 activates heparin-binding epidermal growth factor-like growth factor in cutaneous squamous cell carcinoma.
Neoplasms
Matrix metalloproteinase-7 and matrix metalloproteinase-25 in oral tongue squamous cell carcinoma.
Neoplasms
Matrix metalloproteinase-7 and matrix metalloproteinase-9 are associated with unfavourable prognosis in superficial oesophageal cancer.
Neoplasms
Matrix metalloproteinase-7 degrades all insulin-like growth factor binding proteins and facilitates insulin-like growth factor bioavailability.
Neoplasms
Matrix metalloproteinase-7 expression and biologic aggressiveness of cholangiocellular carcinoma.
Neoplasms
Matrix metalloproteinase-7 expression in colorectal cancer liver metastases: evidence for involvement of MMP-7 activation in human cancer metastases.
Neoplasms
Matrix metalloproteinase-7 expression in gastric carcinoma.
Neoplasms
Matrix metalloproteinase-7 facilitates insulin-like growth factor bioavailability through its proteinase activity on insulin-like growth factor binding protein 3.
Neoplasms
Matrix metalloproteinase-7 increases resistance to Fas-mediated apoptosis and is a poor prognostic factor of patients with colorectal carcinoma.
Neoplasms
Matrix metalloproteinase-7 induces homotypic tumor cell aggregation via proteolytic cleavage of the membrane-bound Kunitz-type inhibitor HAI-1.
Neoplasms
Matrix metalloproteinase-7 is expressed by pancreatic cancer precursors and regulates acinar-to-ductal metaplasia in exocrine pancreas.
Neoplasms
Matrix metalloproteinase-7 mRNA and protein expression in gastric carcinoma: a meta-analysis.
Neoplasms
Matrix metalloproteinase-7-mediated cleavage of Fas ligand protects tumor cells from chemotherapeutic drug cytotoxicity.
Neoplasms
Matrix metalloproteinase-9 contributes to intestinal tumourigenesis in the adenomatous polyposis coli multiple intestinal neoplasia mouse.
Neoplasms
Matrix metalloproteinase-9 from bone marrow-derived cells contributes to survival but not growth of tumor cells in the lung microenvironment.
Neoplasms
Matrix metalloproteinase-9 interplays with the IGFBP2-IGFII complex to promote cell growth and motility in astrocytomas.
Neoplasms
Matrix metalloproteinase7 -181A/G polymorphism is associated with increased cancer risk among high-quality studies: Evidence from a meta-analysis.
Neoplasms
Matrix metalloproteinases (MMPs) in targeted drug delivery: Synthesis of a Potent and Highly Selective Inhibitor against Matrix metalloproteinases-7.
Neoplasms
Matrix metalloproteinases 2, 7, and 9 in tumors and sera of patients with breast cancer.
Neoplasms
Matrix metalloproteinases 7 and 9 and their types 1 and 4 tissue inhibitors in tumors and plasma of patients with colorectal cancer.
Neoplasms
Matrix Metalloproteinases and Their Tissue Inhibitors in Blood Serum of Patients with Endometrial Cancer: Clinical and Morphological Correlations.
Neoplasms
Matrix metalloproteinases and tissue inhibitors of metalloproteinases in human gliomas.
Neoplasms
Matrix metalloproteinases contribute distinct roles in neuroendocrine prostate carcinogenesis, metastasis, and angiogenesis progression.
Neoplasms
Matrix metalloproteinases contribute to brain damage in experimental pneumococcal meningitis.
Neoplasms
Matrix metalloproteinases in blood vessel development in human fetal skin and in cutaneous tumors.
Neoplasms
Matrix metalloproteinases involvement in pathologic conditions.
Neoplasms
Matrix metalloproteinases may contribute compensationally to tumor invasion in T1 colorectal carcinomas.
Neoplasms
Matrix metalloproteinases-7, -8, -9 and TIMP-1 in the follow-up of diisocyanate-induced asthma.
Neoplasms
Matrix-degrading metalloproteinases in tumor progression.
Neoplasms
Matrix-metalloproteinases in Hodgkin lymphoma.
Neoplasms
Measurement of indicator genes using global complementary DNA (cDNA) amplification, by polyadenylic acid reverse transcriptase polymerase chain reaction (poly A RT-PCR): A feasibility study using paired samples from tissue and ductal juice in patients undergoing pancreatoduodenectomy.
Neoplasms
Mechanisms of the Epithelial-Mesenchymal Transition and Tumor Microenvironment in Helicobacter pylori-Induced Gastric Cancer.
Neoplasms
Medulloblastoma displays distinct regional matrix metalloprotease expression.
Neoplasms
Mesothelin enhances invasion of ovarian cancer by inducing MMP-7 through MAPK/ERK and JNK pathways.
Neoplasms
Messenger RNA expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human hepatocellular carcinoma.
Neoplasms
Metalloelastase (MMP-12) expression by tumour cells in squamous cell carcinoma of the vulva correlates with invasiveness, while that by macrophages predicts better outcome.
Neoplasms
Metalloproteinase-1, metalloproteinase-7, and p53 immunoexpression and their correlation with clinicopathological prognostic factors in colorectal adenocarcinoma.
Neoplasms
Methotrexate gamma-hydroxamate derivatives as potential dual target antitumor drugs.
Neoplasms
Microarray Analysis of Gene Expression at the Tumor Front of Colon Cancer.
Neoplasms
Microenvironmental markers are correlated with lymph node metastasis in invasive submucosal colorectal cancer.
Neoplasms
Mixed lineage kinase-3/JNK1 axis promotes migration of human gastric cancer cells following gastrin stimulation.
Neoplasms
MMP and TIMP gene expression in head and neck squamous cell carcinomas and adjacent tissues.
Neoplasms
MMP-10, MMP-7, TIMP-1 and TIMP-2 mRNA expression in esophageal cancer.
Neoplasms
MMP-7 (-181A>G) promoter polymorphisms and risk for cervical cancer.
Neoplasms
MMP-7 (matrilysin) accelerated growth of human umbilical vein endothelial cells.
Neoplasms
MMP-7 (matrilysin) expression in human brain tumors.
Neoplasms
MMP-7 and SGCE as distinctive molecular factors in sporadic colorectal cancers from the mutator phenotype pathway.
Neoplasms
MMP-7 as a prognostic marker in colorectal cancer.
Neoplasms
MMP-7 derived peptides with MHC class-I binding motifs from canine mammary tumor tissue elicit strong antigen-specific T-cell responses in BALB/c mice.
Neoplasms
MMP-7 expression may influence the rate of distant recurrences and disease-specific survival in HPV-positive oropharyngeal squamous cell carcinoma.
Neoplasms
MMP-7 is upregulated by COX-2 and promotes proliferation and invasion of lung adenocarcinoma cells.
Neoplasms
MMP-7 overexpression is an independent prognostic marker in gastric cancer.
Neoplasms
MMP-7 Serum and Tissue Levels Are Associated with Poor Survival in Platinum-Treated Bladder Cancer Patients.
Neoplasms
MMP7 Modulation by Short- and Long-term Radiotherapy in Patients with Rectal Cancer.
Neoplasms
Modulation of matrilysin levels in colon carcinoma cell lines affects tumorigenicity in vivo.
Neoplasms
Modulation of matrix metalloproteinase-7 (matrilysin) secretion in coculture of human colon carcinoma cells with fibroblasts from orthotopic and ectopic organs.
Neoplasms
Molecular characterization of a low-molecular-mass matrix metalloproteinase secreted by glomerular mesangial cells as PUMP-1.
Neoplasms
Molecular genetic alterations in endometrioid carcinomas of the ovary: similar frequency of beta-catenin abnormalities but lower rate of microsatellite instability and PTEN alterations than in uterine endometrioid carcinomas.
Neoplasms
MT1-MMP and MMP-7 in invasion and metastasis of human cancers.
Neoplasms
Multiple Plasma Biomarkers for Risk Stratification in Patients With Heart Failure and Preserved Ejection Fraction.
Neoplasms
N-cadherin haploinsufficiency increases survival in a mouse model of pancreatic cancer.
Neoplasms
Nanoassembled Peptide Biosensors for Rapid Detection of Matrilysin Cancer Biomarker.
Neoplasms
Nobiletin, a citrus flavonoid, down-regulates matrix metalloproteinase-7 (matrilysin) expression in HT-29 human colorectal cancer cells.
Neoplasms
Nuclear beta-catenin expression is closely related to ulcerative growth of colorectal carcinoma.
Neoplasms
Oncogenic beta-catenin and MMP-7 (matrilysin) cosegregate in late-stage clinical colon cancer.
Neoplasms
Optimization of Erlotinib Plus Sulindac Dosing Regimens for Intestinal Cancer Prevention in an Apc-Mutant Model of Familial Adenomatous Polyposis (FAP).
Neoplasms
Osteoclast-derived matrix metalloproteinase-7, but not matrix metalloproteinase-9, contributes to tumor-induced osteolysis.
Neoplasms
Overexpression of matrix metalloproteinase-7 (MMP-7) correlates with tumor proliferation, and a poor prognosis in non-small cell lung cancer.
Neoplasms
Overexpression of matrix metalloproteinase-7 and -9 in NSCLC tumor and stromal cells: Correlation with a favorable clinical outcome.
Neoplasms
Overexpression of matrix metalloproteinase-7 mRNA in human colon carcinomas.
Neoplasms
Overexpression of MMP-13 gene in colorectal cancer with liver metastasis.
Neoplasms
Overexpression of poly(ADP-ribose) polymerase-1 (PARP-1) in the early stage of colorectal carcinogenesis.
Neoplasms
Oxidative stress mediates air pollution particle-induced acute lung injury and molecular pathology.
Neoplasms
Paracrine factor and cell-cell contact-mediated induction of protease and c-ets gene expression in malignant keratinocyte/dermal fibroblast cocultures.
Neoplasms
Pericellular activation of proMMP-7 (promatrilysin-1) through interaction with CD151.
Neoplasms
Phosphatase of regenerating liver-3 promotes migration and invasion by upregulating matrix metalloproteinases-7 in human colorectal cancer cells.
Neoplasms
Photodynamic molecular beacon as an activatable photosensitizer based on protease-controlled singlet oxygen quenching and activation.
Neoplasms
Plasma levels of MMP-7 and TIMP-1 in laboratory diagnostics and differentiation of selected histological types of epithelial ovarian cancers.
Neoplasms
Plasma MMP-2 and MMP-7 levels are elevated first month after surgery and may promote growth of residual metastases.
Neoplasms
Polyamine-dependent expression of the matrix metalloproteinase matrilysin in a human colon cancer-derived cell line.
Neoplasms
Polymorphisms in MMP-1, MMP-2, MMP-7, MMP-13 and MT2A do not contribute to breast, lung and colon cancer risk in polish population.
Neoplasms
Polymorphisms of matrix metalloproteinase-7 and -9 are associated with oral tongue squamous cell carcinoma.
Neoplasms
Polyozellin blocks tumor necrosis factor ?-induced interleukin 8 and matrix metalloproteinase 7 production in the human intestinal epithelial cell line HT-29.
Neoplasms
Polyphenol Extract from Evening Primrose (Oenothera paradoxa) Inhibits Invasion Properties of Human Malignant Pleural Mesothelioma Cells.
Neoplasms
Prediction of distant metastasis by using reverse transcriptase-polymerase chain reaction for epithelial and variant CD44 mRNA in the peripheral blood of patients with colorectal cancer.
Neoplasms
Prediction of peritoneal micrometastasis by peritoneal lavaged cytology and reverse transcriptase-polymerase chain reaction for matrix metalloproteinase-7 mRNA.
Neoplasms
Predictive value of MMP-7 expression for response to chemotherapy and survival in patients with non-small cell lung cancer.
Neoplasms
Preoperative levels of matrix metalloproteinase-7 and -9 and tissue inhibitor of matrix metalloproteinase-1 relation to pathologic parameters in bladder carcinoma patients.
Neoplasms
Production of metalloproteinase-7 (matrilysin) by human myeloma cells and its potential involvement in metalloproteinase-2 activation.
Neoplasms
Production of recombinant human matrix metalloproteinase 7 (Matrilysin) with potential role in tumor invasion by refolding from Escherichia coli inclusion bodies and development of sandwich ELISA of MMP-7.
Neoplasms
Prognostic impact of ER? and MMP7 expression on overall survival in colon cancer.
Neoplasms
Prognostic Role of Matrix Metalloproteinases 2, 7, 8, 9 and Their Type 1 Tissue Inhibitor in Blood Serum of Patients with Kidney Cancer.
Neoplasms
Prognostic role of tumor-associated proteases in colorectal cancer.
Neoplasms
Prognostic significance of matrix metalloproteinase 7 immunohistochemical expression in colorectal cancer: a meta-analysis.
Neoplasms
Prognostic significance of matrix metalloproteinase-7 (MMP-7) expression at the invasive front in gastric carcinoma.
Neoplasms
Prognostic significance of matrix metalloproteinase-7 in epithelial ovarian cancer and its relation to beta-catenin expression.
Neoplasms
Prognostic significance of MMP-7 expression in colorectal cancer: A meta-analysis.
Neoplasms
Prognostic significance of the TNM system criteria, levels of serum insulin-like growth factors and their transport proteins, VEGF and MMP-7 in colorectal cancer.
Neoplasms
Prognostic value of matrix metalloproteinases in oral squamous cell carcinoma.
Neoplasms
Protease-activated receptor-1 antagonist F 16618 reduces arterial restenosis by down-regulation of tumor necrosis factor ? and matrix metalloproteinase 7 expression, migration, and proliferation of vascular smooth muscle cells.
Neoplasms
Proteomic profiling for detection of early-stage heart failure in the community.
Neoplasms
Pump-1 cDNA codes for a protein with characteristics similar to those of classical collagenase family members.
Neoplasms
Quantitative estimation of matrix metalloproteinases 2 and 7 (MMP-2, MMP-7) and tissue inhibitors of matrix metalloproteinases 1 and 2 (TIMP-1, TIMP-2) in colorectal carcinoma tissue samples.
Neoplasms
Quantitative immunohistochemical analysis of matrilysin 1 (MMP-7) in various renal cell carcinoma subtypes.
Neoplasms
Rapid detection of matrix metalloproteinase-7 and carcinoembryonic antigen mRNA expression in intraoperative pleural lavage samples using the reverse transcriptase loop-mediated isothermal amplification method.
Neoplasms
Regulation of matrix metalloproteinases: an overview.
Neoplasms
Regulation of osteopontin and related proteins in rat CC531 colorectal cancer cells.
Neoplasms
Relation of enhanced secretion of active matrix metalloproteinases with tumor spread in human hepatocellular carcinoma.
Neoplasms
Relation of matrilysin messenger RNA expression with invasive activity in human gastric cancer.
Neoplasms
Relationship between E-cadherin, matrix metalloproteinase-7 gene expression and clinicopathological features in gastric carcinoma.
Neoplasms
Relationship between matrix metalloproteinase-7 and pit pattern in early stage colorectal cancer.
Neoplasms
Relationship between morphological features and kinetic patterns of enhancement of the dynamic breast magnetic resonance imaging and tumor expression of metalloproteases and their inhibitors in invasive breast cancer.
Neoplasms
Relationship between the expression of VEGF signal components and matrix metalloproteinases in ovarian tumors.
Neoplasms
Release of membrane-associated mucins from ocular surface epithelia.
Neoplasms
Retinoic acids reduce matrilysin (matrix metalloproteinase 7) and inhibit tumor cell invasion in human colon cancer.
Neoplasms
Role of matrix metalloproteinase-7 (matrilysin) in human cancer invasion, apoptosis, growth, and angiogenesis.
Neoplasms
Role of matrix metalloproteinases and their inhibitors in tumor invasion and metastasis.
Neoplasms
Role of MMP-7 in the formation of peritoneal dissemination in gastric cancer.
Neoplasms
Role of PTEN and MMP-7 expression in growth, invasion, metastasis and angiogenesis of gastric carcinoma.
Neoplasms
Role of the Metalloproteinase-7 (181A>G) Polymorphism in Gastric Cancer Susceptibility: A Case Control Study in Kashmir Valley.
Neoplasms
Roles of matrix metalloproteinase-7 (MMP-7) in cancer.
Neoplasms
SCC-S2 Facilitates Tumor Proliferation and Invasion via Activating Wnt Signaling and Depressing Hippo Signaling in Colorectal Cancer Cells and Predicts Poor Prognosis of Patients.
Neoplasms
Selected Matrix Metalloproteinases (MMP-2, MMP-7) and Their Inhibitor (TIMP-2) in Adult and Pediatric Cancer.
Neoplasms
Selective cleavage of human IgG by the matrix metalloproteinases, matrilysin and stromelysin.
Neoplasms
Sequential dynamics of inflammatory cytokine, angiogenesis inducing factor and matrix degrading enzymes during spontaneous resorption of the herniated disc.
Neoplasms
Serial Measurements of Circulating KL-6, SP-D, MMP-7, CA19-9, CA-125, CCL18, and Periostin in Patients with Idiopathic Pulmonary Fibrosis Receiving Antifibrotic Therapy: An Exploratory Study.
Neoplasms
Serous and mucinous ovarian tumors express different profiles of MMP-2, -7, -9, MT1-MMP, and TIMP-1 and -2.
Neoplasms
Serum levels of TIMP-1 and MMP-7 as potential biomarkers in patients with metastatic colorectal cancer.
Neoplasms
Serum markers of intrahepatic cholangiocarcinoma.
Neoplasms
Serum matrix metalloproteinase 7 levels identifies poor prognosis advanced colorectal cancer patients.
Neoplasms
Serum Matrix Metalloproteinase-7 is an independent prognostic biomarker in advanced bladder cancer.
Neoplasms
Shed Syndecan-1 is involved in chemotherapy resistance via the EGFR pathway in colorectal cancer.
Neoplasms
Silencing of estrogen receptor ? promotes the invasion and migration of osteosarcoma cells through activating Wnt signaling pathway.
Neoplasms
Sodium-Glucose Co-Transporter 2 Inhibitors and Insights from Biomarker Measurement in Heart Failure Patients.
Neoplasms
Stimulation of MMP-7 (matrilysin) by Helicobacter pylori in human gastric epithelial cells: role in epithelial cell migration.
Neoplasms
Structure and expression of the human gene for the matrix metalloproteinase matrilysin.
Neoplasms
Study of matrix metalloproteinases and their inhibitors in breast cancer.
Neoplasms
Suppression of matrilysin inhibits colon cancer cell invasion in vitro.
Neoplasms
Synergistic cooperation between the AP-1 and LEF-1 transcription factors in activation of the matrilysin promoter by the src oncogene: implications in cellular invasion.
Neoplasms
Systematic analysis of proteins from different signaling pathways in the tumor center and the invasive front of colorectal cancer.
Neoplasms
Systemic Th17-like cytokine pattern in gangrenous appendicitis but not in phlegmonous appendicitis.
Neoplasms
Targeting matrilysin and its impact on tumor growth in vivo: the potential implications in breast cancer therapy.
Neoplasms
The behavior of MMP-2, MMP-7, MMP-9 and their inhibitors TIMP-1, TIMP-2 in adenoma-colorectal cancer sequence.
Neoplasms
The clinical value of Vav3 in peripheral blood for predicting lymphatic metastasis of gastric cancer.
Neoplasms
The combinational therapy of trastuzumab and cetuximab inhibits tumor growth in a patient-derived tumor xenograft model of gastric cancer.
Neoplasms
The Contribution of MMP-7 Genotypes to Colorectal Cancer Susceptibility in Taiwan.
Neoplasms
The Contribution of MMP-7 Promoter Polymorphisms to Taiwan Lung Cancer Susceptibility.
Neoplasms
The detection of Helicobacter pylori cag pathogenicity islands (PAIs) and expression of matrix metalloproteinase-7 (MMP-7) in gastric epithelial dysplasia and intramucosal cancer.
Neoplasms
The diagnostic importance of matrix metalloproteinase-7 and nestin in gastrointestinal stromal tumors.
Neoplasms
The expression of matrix metalloproteinase matrilysin indicates the degree of inflammation in ulcerative colitis.
Neoplasms
The expression of mmp-7 messenger-RNA in primary and metastatic human colorectal adenocarcinoma.
Neoplasms
The expression profile of matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) in lesions and normal appearing white matter of multiple sclerosis.
Neoplasms
The functional polymorphism in the matrix metalloproteinase-7 promoter increases susceptibility to esophageal squamous cell carcinoma, gastric cardiac adenocarcinoma and non-small cell lung carcinoma.
Neoplasms
The influence of matrix metalloproteinase-7 on early mammary tumorigenesis in the multiple intestinal neoplasia mouse.
Neoplasms
The intrinsic mitochondrial membrane potential of colonic carcinoma cells is linked to the probability of tumor progression.
Neoplasms
The matrix metalloprotease pump-1 (MMP-7, Matrilysin): A candidate marker/target for ovarian cancer detection and treatment.
Neoplasms
The matrix metalloproteinase 7 (MMP7) links Hsp90 chaperone with acquired drug resistance and tumor metastasis.
Neoplasms
The matrix metalloproteinase inhibitor RS-130830 attenuates brain injury in experimental pneumococcal meningitis.
Neoplasms
The matrix metalloproteinase matrilysin influences early-stage mammary tumorigenesis.
Neoplasms
The matrix metalloproteinase-7 and pro-enzyme of metalloproteinase-1 as a potential marker for patients with rectal cancer without distant metastasis.
Neoplasms
The metalloproteinase matrilysin is a target of beta-catenin transactivation in intestinal tumors.
Neoplasms
The multifunctional role of the immunohistochemical expression of MMP-7 in invasive breast cancer.
Neoplasms
The PEA3 subfamily of Ets transcription factors synergizes with beta-catenin-LEF-1 to activate matrilysin transcription in intestinal tumors.
Neoplasms
The VEGF angiogenic switch of fibroblasts is regulated by MMP-7 from cancer cells.
Neoplasms
Therapy of Advanced Squamous Cell Carcinoma of the Skin.
Neoplasms
Tissue factor/activated factor VIIa induces matrix metalloproteinase-7 expression through activation of c-Fos via ERK1/2 and p38 MAPK signaling pathways in human colon cancer cell.
Neoplasms
TNM staging for GIT cancers is correlated with the level of MMPs and TGF-?1.
Neoplasms
Transformation-specific matrix metalloproteinases (MMP)-7 and MMP-13 are expressed by tumour cells in epidermolysis bullosa-associated squamous cell carcinomas.
Neoplasms
Transformation-specific matrix metalloproteinases, MMP-7 and MMP-13, are present in epithelial cells of keratoacanthomas.
Neoplasms
Transforming growth factor-beta1 modulates tumor-stromal cell interactions of prostate cancer through insulin-like growth factor-I.
Neoplasms
Trefoil Factor 1 Suppresses Epithelial-mesenchymal Transition through Inhibition of TGF-beta Signaling in Gastric Cancer Cells.
Neoplasms
Tricolor imaging of MMPs to investigate the promoting roles of inflammation on invasion and migration of tumor cells.
Neoplasms
Tumor associated proteases -- prognostic markers of colorectal cancer.
Neoplasms
Tumor suppressive function of Matrin 3 in the basal-like breast cancer.
Neoplasms
Tumour matrilysin expression predicts metastatic potential of stage I (pT1) colon and rectal cancers.
Neoplasms
Tuneable peptide cross-linked nanogels for enzyme-triggered protein delivery.
Neoplasms
Tuning Liposome Membrane Permeability by Competitive Peptide Dimerization and Partitioning-Folding Interactions Regulated by Proteolytic Activity.
Neoplasms
Type IV collagen ?1-chain noncollagenous domain blocks MMP-2 activation both in-vitro and in-vivo.
Neoplasms
Update meta-analysis on MMP-7 -181A>G polymorphism and cancer risk: evidence from 25 studies.
Neoplasms
Upregulation and differential expression of matrilysin (MMP-7) and metalloelastase (MMP-12) and their inhibitors TIMP-1 and TIMP-3 in Barrett's oesophageal adenocarcinoma.
Neoplasms
Vaccine Against Gastrin, Polyclonal Antibody Stimulator, Decreases Pancreatic Cancer Metastases.
Neoplasms
Validation of the diagnostic and prognostic relevance of serum MMP-7 levels in renal cell cancer by using a novel automated fluorescent immunoassay method.
Neoplasms
[beta-Catenin induces invasive growth by activating matrix metalloproteinases in colorectal carcinoma]
Neoplasms
[Clinical prospects of tumor-associated proteases and their tissue inhibitors investigation in oncologic patient].
Neoplasms
[Correlation between expression of MMP-7 in gastric submucosal invasive carcinoma and lymph node micrometastasis]
Neoplasms
[Diversity of invasiveness and matrix metalloproteinases expression profile of human gastric carcinoma xenografted in different tissue environments]
Neoplasms
[Effects of angiotensin converting enzyme inhibitors and angiotensin II receptor blockers on angiogenesis of gastric cancer in a nude mouse model]
Neoplasms
[Expression and clinical significance of matrilysin (MMP-7) in human rectal cancer]
Neoplasms
[Expression of ETV5 and MMP-7 in Early Stage Cervical Squamous Cell Carcinoma and Its Role in Lymphatic Metastasis.]
Neoplasms
[Expression of matrix metalloproteinases and tissue inhibitor of metalloproteinases in colorectal neoplasm]
Neoplasms
[Genetic diagnosis of colorectal cancer]
Neoplasms
[Increased expression of gelatinases A and B, matrilysin and TIMP-1 genes in human malignant gliomas ]
Neoplasms
[Inflammatory-destructive biomarkers of atherosclerotic plaques instability. Study of arterial wall and blood].
Neoplasms
[Localization and expression of matrix metalloproteinase-7 in human prostate]
Neoplasms
[Matrilysin-1 and cancer pathology]
Neoplasms
[Matrix metalloproteinases and their tissue inhibitors in malignancies of the female genital tract]
Neoplasms
[Prognostic significance of the molecular markers in human gastrointestinal cancer]
Neoplasms
[Relationship of matrilysin with invasion, metastasis, and prognosis in laryngeal cancer]
Neoplasms
[The expression of matrix metalloproteinases and tissue inhibitor of metalloproteinases in transplanted tumor of salivary adenoid cystic carcinoma cell lines]
Neoplasms
[The expression of tumor related macrophages and matrix solution element in laryngeal squamous carcinoma tissue and the relationship with tumor microvascular density].
Neoplasms
[The significance of beta-catenin and matrix metalloproteinase-7 expression in colorectal adenoma and carcinoma]
Neoplasms
[VALUE OF METALPROTEINASES OF BLOOD IN PATHOGENESIS OF EPITELIAL SKIN TUMORS AND THE POSSIBILITY OF THEIR SURGICAL CORRECTION].
Neoplasms, Squamous Cell
Differential expression of matrilysin-1 (MMP-7), 92 kD gelatinase (MMP-9), and metalloelastase (MMP-12) in oral verrucous and squamous cell cancer.
Neoplastic Cells, Circulating
Cleavage of the Perlecan-Semaphorin 3A-Plexin A1-Neuropilin-1 (PSPN) Complex by Matrix Metalloproteinase 7/Matrilysin Triggers Prostate Cancer Cell Dyscohesion and Migration.
Nephritis, Hereditary
Dysregulation of renal MMP-3 and MMP-7 in canine X-linked Alport syndrome.
Neuritis
Matrix metalloproteinases MMP-9 and MMP-7 are expressed in experimental autoimmune neuritis and the Guillain-Barré syndrome.
Neuritis, Autoimmune, Experimental
Matrix metalloproteinases MMP-9 and MMP-7 are expressed in experimental autoimmune neuritis and the Guillain-Barré syndrome.
Neuroblastoma
Amyloid-? with isomerized Asp7 cytotoxicity is coupled to protein phosphorylation.
Neuroendocrine Tumors
A subset of high-grade pulmonary neuroendocrine carcinomas shows up-regulation of matrix metalloproteinase-7 associated with nuclear beta-catenin immunoreactivity, independent of EGFR and HER-2 gene amplification or expression.
Neuromuscular Diseases
Matrin 3 in neuromuscular disease: physiology and pathophysiology.
Newcastle Disease
Newcastle disease virus mediated apoptosis and migration inhibition of human oral cancer cells: A probable role of ?-catenin and matrix metalloproteinase-7.
Non-alcoholic Fatty Liver Disease
Serum biomarkers of fibrosis and extracellular matrix remodeling in patients with nonalcoholic fatty liver disease: association with liver histology.
Non-alcoholic Fatty Liver Disease
Serum matrix metalloproteinase 7 (MMP7) is a biomarker of fibrosis in patients with non-alcoholic fatty liver disease.
Obesity
Influence of significant weight loss on serum matrix metalloproteinase (MMP)-7 levels.
Obesity
Matrix metalloproteinases are differentially expressed in adipose tissue during obesity and modulate adipocyte differentiation.
Obesity
Role of MMP-1 (-519A/G, -1607 1G/2G), MMP-3 (Lys45Glu), MMP-7 (-181A/G), and MMP-12 (-82A/G) Variants and Plasma MMP Levels on Obesity-Related Phenotypes and Microvascular Reactivity in a Tunisian Population.
Obstetric Labor, Premature
Matrilysin (matrix metalloproteinase 7) in parturition, premature rupture of membranes, and intrauterine infection.
Oligodendroglioma
Correlations of polymorphisms in matrix metalloproteinase-1, -2, and -7 promoters to susceptibility to malignant gliomas.
Oligodendroglioma
Expression of MMP-2, MMP-7, MMP-9, MMP-10 and MMP-11 in human astrocytic and oligodendroglial gliomas.
Opisthorchiasis
Plasma hydroxyproline, MMP-7 and collagen I as novel predictive risk markers of hepatobiliary disease-associated cholangiocarcinoma.
Osteoarthritis
A Mixture Containing Fermented Achyranthes japonica Nakai Ameliorates Osteoarthritis in Knee Joints of Monoiodoacetate-Injected Rats.
Osteoarthritis
Expression and correlation of matrix metalloproteinase-7 and interleukin-15 in human osteoarthritis.
Osteoarthritis
Expression of ADAM15 in rheumatoid synovium: up-regulation by vascular endothelial growth factor and possible implications for angiogenesis.
Osteoarthritis
Expression of matrix metalloproteinase 7 (matrilysin) in human osteoarthritic cartilage.
Osteoarthritis
Immunolocalisation studies on six matrix metalloproteinases and their inhibitors, TIMP-1 and TIMP-2, in synovia from patients with osteo- and rheumatoid arthritis.
Osteoarthritis, Knee
[Influence of Bushen Huoxue decoction on beta-catenin, MMP-7 of synoviocytes in rats with knee osteoarthritis].
Osteolysis
MMP-7 promotes prostate cancer-induced osteolysis via the solubilization of RANKL.
Osteolysis
Osteoclast-derived matrix metalloproteinase-7, but not matrix metalloproteinase-9, contributes to tumor-induced osteolysis.
Osteoporosis
Estrogen-deficient osteoporosis enhances the recruitment and activity of osteoclasts by breast cancer cells.
Osteoporosis
Inhibition of osteoclast differentiation and matrix metalloproteinase production by CD4+CD25+ T cells in mice.
Osteosarcoma
Effects of SOST Gene Silencing on Proliferation, Apoptosis, Invasion, and Migration of Human Osteosarcoma Cells Through the Wnt/?-Catenin Signaling Pathway.
Osteosarcoma
Irisin reverses the IL-6 induced epithelial-mesenchymal transition in osteosarcoma cell migration and invasion through the STAT3/Snail signaling pathway.
Osteosarcoma
Osteosarcoma oncogene expression detected by in situ hybridization.
Ovarian Diseases
Clinical significance of serum MMP-2 and MMP-7 in patients with ovarian cancer.
Ovarian Neoplasms
Aberrant Activation Of Hedgehog Signalling Promotes Cell Migration And Invasion Via Matrix Metalloproteinase-7 In Ovarian Cancer Cells.
Ovarian Neoplasms
Andrographolide as a Therapeutic Agent Against Breast and Ovarian Cancers.
Ovarian Neoplasms
Clinical significance of serum MMP-2 and MMP-7 in patients with ovarian cancer.
Ovarian Neoplasms
Inhibition of matrilysin expression by antisense or RNA interference decreases lysophosphatidic acid-induced epithelial ovarian cancer invasion.
Ovarian Neoplasms
Leptin Induces Matrix Metalloproteinase 7 Expression To Promote Ovarian Cancer Cell Invasion By Activating ERK And JNK Pathways.
Ovarian Neoplasms
Matrilysin (MMP-7) promotes invasion of ovarian cancer cells by activation of progelatinase.
Ovarian Neoplasms
Matrix metalloproteinase-9 expression correlates with prognosis and involved in ovarian cancer cell invasion.
Ovarian Neoplasms
Mesothelin enhances invasion of ovarian cancer by inducing MMP-7 through MAPK/ERK and JNK pathways.
Ovarian Neoplasms
Plasma endothelial protein C receptor influences innate immune response in ovarian cancer by decreasing the population of natural killer and TH17 helper cells.
Ovarian Neoplasms
Polymorphisms in the promoter regions of the matrix metalloproteinases-1, -3, -7, and -9 and the risk of epithelial ovarian cancer in China.
Ovarian Neoplasms
Potential role of HE4 in multimodal screening for epithelial ovarian cancer.
Ovarian Neoplasms
Serial Patterns of Ovarian Cancer Biomarkers in a Prediagnosis Longitudinal Dataset.
Ovarian Neoplasms
The matrix metalloprotease pump-1 (MMP-7, Matrilysin): A candidate marker/target for ovarian cancer detection and treatment.
Ovarian Neoplasms
Validation of a Biomarker Panel and Longitudinal Biomarker Performance for Early Detection of Ovarian Cancer.
Ovarian Neoplasms
[The utility of metalloproteinases (MMPs) and their inhibitors (TIMPs) in diagnostics of gynecological malignancies].
Paget Disease, Extramammary
Matrilysin-1 (MMP-7) and MMP-19 are expressed by Paget's cells in extramammary Paget's disease.
Pancreatic Neoplasms
Association of matrilysin mRNA expression with K-ras mutations and progression in pancreatic ductal adenocarcinomas.
Pancreatic Neoplasms
Beta-catenin up-regulates the expression of cyclinD1, c-myc and MMP-7 in human pancreatic cancer: relationships with carcinogenesis and metastasis.
Pancreatic Neoplasms
Comprehensive analysis of matrix metalloproteinase and tissue inhibitor expression in pancreatic cancer: increased expression of matrix metalloproteinase-7 predicts poor survival.
Pancreatic Neoplasms
Evaluation of matrix metalloproteinase 7 in plasma and pancreatic juice as a biomarker for pancreatic cancer.
Pancreatic Neoplasms
Identification of genes showing differential expression in antisense K-ras-transduced pancreatic cancer cells with suppressed tumorigenicity.
Pancreatic Neoplasms
Involvement of matrix metalloproteinase-7 in invasion-metastasis through induction of cell dissociation in pancreatic cancer.
Pancreatic Neoplasms
Involvement of MMP-7 in invasion of pancreatic cancer cells through activation of the EGFR mediated MEK-ERK signal transduction pathway.
Pancreatic Neoplasms
Matrix metalloproteinase 7 expression in ampullary carcinoma.
Pancreatic Neoplasms
Matrix metalloproteinase-7 is expressed by pancreatic cancer precursors and regulates acinar-to-ductal metaplasia in exocrine pancreas.
Pancreatic Neoplasms
Mesothelin binding to CA125/MUC16 promotes pancreatic cancer cell motility and invasion via MMP-7 activation.
Pancreatic Neoplasms
Nuclear Localizing Peptide-Conjugated, Redox-Sensitive Polymersomes for Delivering Curcumin and Doxorubicin to Pancreatic Cancer Microtumors.
Pancreatic Neoplasms
Prognostic impact of a compartment-specific angiogenic marker profile in patients with pancreatic cancer.
Pancreatic Neoplasms
REG4 contributes to the invasiveness of pancreatic cancer by upregulating MMP-7 and MMP-9.
Pancreatic Neoplasms
STAT3 knockdown reduces pancreatic cancer cell invasiveness and matrix metalloproteinase-7 expression in nude mice.
Pancreatic Neoplasms
The potential molecular mechanism of overexpression of uPA, IL-8, MMP-7 and MMP-9 induced by TRAIL in pancreatic cancer cell.
Pancreatic Neoplasms
Triterpenes from Poria cocos suppress growth and invasiveness of pancreatic cancer cells through the downregulation of MMP-7.
Pancreatic Neoplasms
[Erratum] Triterpenes from Poria cocos suppress growth and invasiveness of pancreatic cancer cells through the downregulation of MMP-7.
Pancreatitis
Association of Matrix Metalloproteinases -7, -8 and -9 and TIMP -1 with Disease Severity in Acute Pancreatitis. A Cohort Study.
Pancreatitis
Role of IL-6 in the resolution of pancreatitis in obese mice.
Pancreatitis, Chronic
Association of matrix metalloproteinase-7 (-181A/G) promoter polymorphism in chronic pancreatitis.
Pancreatitis, Chronic
Evaluation of matrix metalloproteinase 7 in plasma and pancreatic juice as a biomarker for pancreatic cancer.
Papilloma
MMP-7 expression may influence the rate of distant recurrences and disease-specific survival in HPV-positive oropharyngeal squamous cell carcinoma.
Paralysis
Transgenic mice overexpressing the ALS-linked protein Matrin 3 develop a profound muscle phenotype.
Paresis
Transgenic mice overexpressing the ALS-linked protein Matrin 3 develop a profound muscle phenotype.
Peptic Ulcer
cag Pathogenicity island-dependent upregulation of matrix metalloproteinase-7 in infected patients with Helicobacter pylori.
Peptic Ulcer
Enhanced expression of matrilysin, collagenase, and stromelysin-1 in gastrointestinal ulcers.
Peri-Implantitis
Levels and molecular forms of MMP-7 (matrilysin-1) and MMP-8 (collagenase-2) in diseased human peri-implant sulcular fluid.
Periapical Periodontitis
MMP-7 and TIMP-1, New Targets in Predicting Poor Wound Healing in Apical Periodontitis.
Periodontal Diseases
Gingival crevicular fluid matrix metalloproteinase (MMP)-7, extracellular MMP inducer, and tissue inhibitor of MMP-1 levels in periodontal disease.
Periodontal Diseases
Study of the participation of MMP-7, EMMPRIN and cyclophilin A in the pathogenesis of periodontal disease.
Periodontal Diseases
[The relationship between chronic periodontitis and the instability of carotid atherosclerotic plaque by serum level of MMP-9, MCP-1 and MMP-7].
Periodontal Pocket
Matrilysin (matrix metalloproteinase-7) expression in human junctional epithelium.
Periodontitis
Immunohistochemical analysis of the gingiva with periodontitis of type I plasminogen deficiency compared to gingiva with gingivitis and periodontitis and healthy gingiva.
Periodontitis
Matrix metalloproteinase-7 in periodontitis with type 2 diabetes mellitus.
Periodontitis
Mucin 4 and matrix metalloproteinase 7 as novel salivary biomarkers for periodontitis.
Periodontitis
Study of the participation of MMP-7, EMMPRIN and cyclophilin A in the pathogenesis of periodontal disease.
Periodontitis
[The relationship between chronic periodontitis and the instability of carotid atherosclerotic plaque by serum level of MMP-9, MCP-1 and MMP-7].
Pleural Effusion
Application of MMP-7 and MMP-10 in assisting the diagnosis of malignant pleural effusion.
Pleural Effusion
Multiplex Soluble Biomarker Analysis from Pleural Effusion.
Pleural Effusion, Malignant
Application of MMP-7 and MMP-10 in assisting the diagnosis of malignant pleural effusion.
Pneumoconiosis
Associations of MMP-7 and OPN gene polymorphisms with risk of coal workers' pneumoconiosis in a Chinese population: a case-control study.
Pneumoconiosis
Serum concentrations of Krebs von den Lungen-6, surfactant protein D, and matrix metalloproteinase-2 as diagnostic biomarkers in patients with asbestosis and silicosis: a case-control study.
Pneumonia
Is metalloproteinase-7 specific for idiopathic pulmonary fibrosis?
Pneumonia
Oxidative stress mediates air pollution particle-induced acute lung injury and molecular pathology.
Pneumonia
Role of matrix metalloproteinase-7 in the modulation of a Chlamydia trachomatis infection.
Pneumonia, Bacterial
Comparative Study of Circulating MMP-7, CCL18, KL-6, SP-A, and SP-D as Disease Markers of Idiopathic Pulmonary Fibrosis.
Polyarteritis Nodosa
Role of matrix metalloproteinases, proinflammatory cytokines, and oxidative stress-derived molecules in hepatitis C virus-associated mixed cryoglobulinemia vasculitis neuropathy.
Polycystic Kidney Diseases
Matrilysin (MMP-7) expression in renal tubular damage: association with Wnt4.
Polymyositis
Expression of matrix metalloproteinases in the muscle of patients with inflammatory myopathies.
Polymyositis
Matrix metalloproteinases in inflammatory myopathies: enhanced immunoreactivity near atrophic myofibers.
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
Matrix metalloproteinase upregulation in chronic inflammatory demyelinating polyneuropathy and nonsystemic vasculitic neuropathy.
Pre-Eclampsia
Collagenase-I, stromelysin-I, and matrilysin are expressed within the placenta during multiple stages of human pregnancy.
Pre-Eclampsia
Increased vascular and uteroplacental matrix metalloproteinase-1 and -7 levels and collagen type I deposition in hypertension in pregnancy: role of TNF-?.
Pre-Eclampsia
Matrix metalloproteinase multiplex screening identifies increased MMP-2 urine concentrations in women predicted to develop preeclampsia.
Pre-Eclampsia
Matrix metalloproteinase-2 C-735T and its interaction with matrix metalloproteinase-7 A-181G polymorphism are associated with the risk of preeclampsia: influence on total antioxidant capacity and blood pressure.
Pre-Eclampsia
Matrix metalloproteinase-7 A-181G and its interaction with matrix metalloproteinase-9 C-1562T polymorphism in preeclamptic patients: association with malondialdehyde level and severe preeclampsia.
Pre-Eclampsia
The prediction of early preeclampsia: Results from a longitudinal proteomics study.
Pre-Eclampsia
The prediction of late-onset preeclampsia: Results from a longitudinal proteomics study.
Pregnancy, Ectopic
Progesterone exposure prevents matrix metalloproteinase-3 (MMP-3) stimulation by interleukin-1alpha in human endometrial stromal cells.
Prostatic Neoplasms
A loss of host-derived MMP-7 promotes myeloma growth and osteolytic bone disease in vivo.
Prostatic Neoplasms
Aberrant expression of fibroblast growth factor receptor-1 in prostate epithelial cells allows induction of promatrilysin expression by fibroblast growth factors.
Prostatic Neoplasms
Association of zinc level and polymorphism in MMP-7 gene with prostate cancer in Polish population.
Prostatic Neoplasms
Considering the critical interface between tumor cells and stromal cells in the search for targets for anticancer therapy.
Prostatic Neoplasms
E1AF expression is associated with extra-prostatic growth and matrix metalloproteinase-7 expression in prostate cancer.
Prostatic Neoplasms
EGF induces the expression of matrilysin in the human prostate adenocarcinoma cell line, LNCaP.
Prostatic Neoplasms
Elevated serum matrix metalloproteinase 7 levels predict poor prognosis after radical prostatectomy.
Prostatic Neoplasms
ETS variant 1 regulates matrix metalloproteinase-7 transcription in LNCaP prostate cancer cells.
Prostatic Neoplasms
Expression and functional role of CCR9 in prostate cancer cell migration and invasion.
Prostatic Neoplasms
Expression of the metalloproteinase matrilysin in DU-145 cells increases their invasive potential in severe combined immunodeficient mice.
Prostatic Neoplasms
Fibroblast growth factor-1 induced promatrilysin expression through the activation of extracellular-regulated kinases and STAT3.
Prostatic Neoplasms
IL-7/IL-7 receptor axis stimulates prostate cancer cell invasion and migration via AKT/NF-?B pathway.
Prostatic Neoplasms
Matrilysin expression in the involuting rat ventral prostate.
Prostatic Neoplasms
Matrilysin mediates extracellular cleavage of E-cadherin from prostate cancer cells: a key mechanism in hepatocyte growth factor/scatter factor-induced cell-cell dissociation and in vitro invasion.
Prostatic Neoplasms
Matrix metalloproteinase 7, soluble Fas and Fas ligand serum levels for predicting docetaxel resistance and survival in castration-resistant prostate cancer.
Prostatic Neoplasms
Molecular basis for the involvement of thymidine phosphorylase in cancer invasion.
Prostatic Neoplasms
Overexpression of SOX18 promotes prostate cancer progression via the regulation of TCF1, c-Myc, cyclin D1 and MMP-7.
Prostatic Neoplasms
Pharmacological inhibition of FGF receptor signaling inhibits LNCaP prostate tumor growth, promatrilysin, and PSA expression.
Prostatic Neoplasms
Production of recombinant human matrix metalloproteinase 7 (Matrilysin) with potential role in tumor invasion by refolding from Escherichia coli inclusion bodies and development of sandwich ELISA of MMP-7.
Prostatic Neoplasms
Promatrilysin expression is induced by fibroblast growth factors in the prostatic carcinoma cell line LNCaP but not in normal primary prostate epithelial cells.
Prostatic Neoplasms
The Matrix Metalloproteinase-7 Polymorphism Rs10895304 Is Associated with Increased Recurrence Risk in Patients with Clinically Localized Prostate Cancer.
Prostatic Neoplasms
The prognostic value of serum MMP-7 levels in prostate cancer patients who received docetaxel, abiraterone, or enzalutamide therapy.
Prostatic Neoplasms
Up-regulation of TRPM-2, MMP-7 and ID-1 during sex hormone-induced prostate carcinogenesis in the Noble rat.
Prostatic Neoplasms
[Localization and expression of matrix metalloproteinase-7 in human prostate]
Prostatic Neoplasms
[Protein kinase D3 is involved in negative regulation of MMP-7 in prostate cancer cells.]
Prostatitis
Matrix metalloproteinases in the pathogenesis of estradiol-induced nonbacterial prostatitis in the lateral prostate lobe of the Wistar rat.
Proteinuria
The Many Faces of Matrix Metalloproteinase-7 in Kidney Diseases.
Proteinuria
Tubular injury triggers podocyte dysfunction by ?-catenin-driven release of MMP-7.
Psoriasis
Matrix metalloproteinase-7 could be a predictor for acute inflammation in psoriatic patients.
Psoriasis
Metalloelastase (MMP-12) and 92-kDa gelatinase (MMP-9) as well as their inhibitors, TIMP-1 and -3, are expressed in psoriatic lesions.
Pterygium
Active matrilysin (MMP-7) in human pterygia: potential role in angiogenesis.
Pulmonary Arterial Hypertension
Matrix metalloproteinase 7 in diagnosis and differentiation of pulmonary arterial hypertension.
Pulmonary Disease, Chronic Obstructive
Is MMP-7 Gene Polymorphism a Possible Risk Factor for Chronic Obstructive Pulmonary Disease in Turkish Patients.
Pulmonary Disease, Chronic Obstructive
MMP-3 (-1171 5A/6A; Lys45Glu) variants affect serum levels of matrix metalloproteinase (MMP)-3 and correlate with severity of COPD: A study of MMP-3, MMP-7 and MMP-12 in a Tunisian population.
Pulmonary Disease, Chronic Obstructive
Plasma sE-cadherin and the plasma sE-cadherin/sVE-cadherin ratio are potential biomarkers for chronic obstructive pulmonary disease.
Pulmonary Disease, Chronic Obstructive
Sputum biomarkers in IPF: Evidence for raised gene expression and protein level of IGFBP-2, IL-8 and MMP-7.
Pulmonary Edema
Osteopontin Exacerbates Pulmonary Damage in Influenza-Induced Lung Injury.
Pulmonary Fibrosis
Antifibrotic effects of a novel pirfenidone derivative in vitro and in vivo.
Pulmonary Fibrosis
Associations of MMP-7 and OPN gene polymorphisms with risk of coal workers' pneumoconiosis in a Chinese population: a case-control study.
Pulmonary Fibrosis
Current Concepts of Biliary Atresia and Matrix Metalloproteinase-7: A Review of Literature.
Pulmonary Fibrosis
Gene expression analysis reveals matrilysin as a key regulator of pulmonary fibrosis in mice and humans.
Pulmonary Fibrosis
Matrilysin (matrix metalloproteinase-7) mediates E-cadherin ectodomain shedding in injured lung epithelium.
Pulmonary Fibrosis
Matrix Metalloproteinases-7 and Kidney Fibrosis.
Pulmonary Fibrosis
Overexpression of matrix metalloproteinase-7 in pulmonary fibrosis.
Pulmonary Fibrosis
Time course of matrix metalloproteases and tissue inhibitors in bleomycin-induced pulmonary fibrosis.
Q Fever
Involvement of matrix metalloproteinases in chronic Q fever.
Rectal Neoplasms
Association of E1AF mRNA expression with tumor progression and matrilysin in human rectal cancer.
Rectal Neoplasms
Clinicopathologic and prognostic significance of MMP-7 (matrilysin) expression in human rectal cancer.
Rectal Neoplasms
Effect of preoperative radiotherapy on matrilysin gene expression in rectal cancer.
Rectal Neoplasms
Expressions of Matrix Metalloproteinase-7 and -9 and their Prognostic Significances in Rectal Cancer.
Rectal Neoplasms
The matrix metalloproteinase-7 and pro-enzyme of metalloproteinase-1 as a potential marker for patients with rectal cancer without distant metastasis.
Rectal Neoplasms
Tumour matrilysin expression predicts metastatic potential of stage I (pT1) colon and rectal cancers.
Rectal Neoplasms
[Expression and clinical significance of matrilysin (MMP-7) in human rectal cancer]
Renal Insufficiency, Chronic
Matrix metalloproteinase-7 as a surrogate marker predicts renal Wnt/?-catenin activity in CKD.
Renal Insufficiency, Chronic
MMP-7 as a potential marker of cardiovascular complications in patients with chronic kidney disease (CKD).
Renal Insufficiency, Chronic
The Many Faces of Matrix Metalloproteinase-7 in Kidney Diseases.
Reperfusion Injury
Matrix metalloproteinase-7 protects against acute kidney injury by priming renal tubules for survival and regeneration.
Reproductive Tract Infections
Role of matrix metalloproteinase-7 in the modulation of a Chlamydia trachomatis infection.
Respiratory Insufficiency
Implications for matrix metalloproteinases as modulators of pediatric lung disease.
Retinoblastoma
[Analysis of angiogenesis associated factors of retinoblastoma cell line and tumor tissues]
Rheumatoid Nodule
MMP expression in rheumatoid inflammation: the rs11568818 polymorphism is associated with MMP-7 expression at an extra-articular site.
Salivary Gland Neoplasms
Matrix metalloproteinase (MMP)-7 in salivary gland cancer.
Sarcoidosis
Elevated matrilysin levels in bronchoalveolar lavage fluid do not distinguish idiopathic pulmonary fibrosis from other interstitial lung diseases.
Sarcoidosis
Matrix metalloproteinases and their tissue inhibitors in the lesions of cardiac and pulmonary sarcoidosis: an immunohistochemical study.
Sarcoidosis
Plasma matrix metalloproteinase 7, CC-chemokine ligand 18, and periostin as markers for pulmonary sarcoidosis.
Sarcoidosis
Serum metalloproteinases 1 and 7 in the diagnosis of idiopathic pulmonary fibrosis and other interstitial pneumonias.
Sarcoidosis
[Change of matrix metalloproteinase-1 and matrix metalloproteinase-7 in serum and bronchoalveolar lavage fluid of patients with idiopathic pulmonary fibrosis and sarcoidosis].
Sarcoidosis, Pulmonary
Plasma matrix metalloproteinase 7, CC-chemokine ligand 18, and periostin as markers for pulmonary sarcoidosis.
Sarcoma
Effusion cytodiagnosis of carcinosarcoma derived from the female genital tract: immunohistochemical features of MMP-7 and Ki-67 and immunofluorescence double staining analyses of eight cases.
Sarcoma
Osteosarcoma oncogene expression detected by in situ hybridization.
Scleroderma, Localized
Immunohistochemical Similarities between Lichen Sclerosus et Atrophicus and Morphea: A Case Study.
Scleroderma, Systemic
Elevated MMP-7 levels in patients with systemic sclerosis: correlation with pulmonary involvement.
Seizures
Matrix metalloproteinase-7 regulates cleavage of pro-nerve growth factor and is neuroprotective following kainic acid-induced seizures.
Silicosis
Effects of tetrandrine combined with acetylcysteine on exercise tolerance, pulmonary function and serum TNF-?1 and MMP-7 in silicosis patients.
Silicosis
Serum concentrations of Krebs von den Lungen-6, surfactant protein D, and matrix metalloproteinase-2 as diagnostic biomarkers in patients with asbestosis and silicosis: a case-control study.
Sinusitis
Matrix metalloproteinases MMP-7, MMP-9 and their tissue inhibitor TIMP-1: expression in chronic sinusitis vs nasal polyposis.
Skin Diseases
Matrix metalloproteinase-7 could be a predictor for acute inflammation in psoriatic patients.
Skin Neoplasms
Autoantibodies against p53, MMP-7, and Hsp70 as Potential Biomarkers for Detection of Nonmelanoma Skin Cancers.
Skin Neoplasms
[VALUE OF METALPROTEINASES OF BLOOD IN PATHOGENESIS OF EPITELIAL SKIN TUMORS AND THE POSSIBILITY OF THEIR SURGICAL CORRECTION].
Squamous Cell Carcinoma of Head and Neck
A novel orthotopic mouse model of head and neck cancer and lymph node metastasis.
Squamous Cell Carcinoma of Head and Neck
Active matrix metalloproteinase-7 is associated with invasion in buccal squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
Circulating Anti-Matrix Metalloproteinase-7 Antibodies May Be a Potential Biomarker for Oral Squamous Cell Carcinoma.
Squamous Cell Carcinoma of Head and Neck
COX-2, MMP-7 expression in oral lichen planus and oral squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
Differential expression of c-jun and c-fos mRNAs in squamous cell carcinoma of the head and neck: associations with uPA, gelatinase B, and matrilysin mRNAs.
Squamous Cell Carcinoma of Head and Neck
Expression of MMP-7 and MT1-MMP in oral squamous cell carcinoma as predictive indicator for tumor invasion and prognosis.
Squamous Cell Carcinoma of Head and Neck
High gene expression of matrix metalloproteinase-7 is associated with early stages of oral cancer.
Squamous Cell Carcinoma of Head and Neck
Integrin- and cadherin-mediated induction of the matrix metalloprotease matrilysin in cocultures of malignant oral squamous cell carcinoma cells and dermal fibroblasts.
Squamous Cell Carcinoma of Head and Neck
Matrix metalloproteinase-7 and matrix metalloproteinase-25 in oral tongue squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
Matrix metalloproteinases (MMPs) and inhibitor of metalloproteinases (TIMP) mRNA and protein expression in laryngeal squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
MMP and TIMP gene expression in head and neck squamous cell carcinomas and adjacent tissues.
Squamous Cell Carcinoma of Head and Neck
MMP-7 expression may influence the rate of distant recurrences and disease-specific survival in HPV-positive oropharyngeal squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
MT1-MMP and MMP-7 in invasion and metastasis of human cancers.
Squamous Cell Carcinoma of Head and Neck
Polymorphisms of matrix metalloproteinase-7 and -9 are associated with oral tongue squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
Prognostic value of matrix metalloproteinases in oral squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
Regulation of programmed-death ligand in the human head and neck squamous cell carcinoma microenvironment is mediated through matrix metalloproteinase-mediated proteolytic cleavage.
Squamous Cell Carcinoma of Head and Neck
The role of matrix metalloproteinases in squamous cell carcinomas of the head and neck.
Stomach Diseases
[Expressions of MMP-7 and TIMP-1 in Chronic Stomach Disease Patients with Different Syndromes of Chinese Medicine].
Stomach Neoplasms
?-Catenin-independent noncanonical Wnt pathway might be induced in gastric cancers.
Stomach Neoplasms
Apoptosis-promoting and migration-suppressing effect of alantolactone on gastric cancer cell lines BGC-823 and SGC-7901 via regulating p38MAPK and NF-?B pathways.
Stomach Neoplasms
Association of extracellular cleavage of E-cadherin mediated by MMP-7 with HGF-induced in vitro invasion in human stomach cancer cells.
Stomach Neoplasms
ASSOCIATION OF MMP-7 -181A>G POLYMORPHISM WITH COLORECTAL CANCER AND GASTRIC CANCER SUSCEPTIBILITY: A SYSTEMATIC REVIEW AND META-ANALYSIS.
Stomach Neoplasms
Catecholamine up-regulates MMP-7 expression by activating AP-1 and STAT3 in gastric cancer.
Stomach Neoplasms
CD44v6, MMP-7 and nuclear Cdx2 are significant biomarkers for prediction of lymph node metastasis in primary gastric cancer.
Stomach Neoplasms
Clinical Significance of Matrix Metalloproteinases in Blood Plasma of Patients with Gastric Cancer.
Stomach Neoplasms
Coexpression of Matrix Metalloproteinase-7 and Tissue Inhibitor of Metalloproteinase-1 as a Prognostic Biomarker in Gastric Cancer.
Stomach Neoplasms
Comparative enzyme immunoassay of matrix metalloproteinases-2, -7, -9 and their tissue inhibitor-2 in tumors and plasma of patients with gastric cancer.
Stomach Neoplasms
Correlation of lymph node metastases and expression of matrix metalloproteinase-7 in patients with gastric cancer.
Stomach Neoplasms
Downregulation of SFRP5 expression and its inverse correlation with those of MMP-7 and MT1-MMP in gastric cancer.
Stomach Neoplasms
Effect of hGC-MSCs from human gastric cancer tissue on cell proliferation, invasion and epithelial-mesenchymal transition in tumor tissue of gastric cancer tumor-bearing mice.
Stomach Neoplasms
Elevated Serum Matrix Metalloproteinase-3 and -7 in H. pylori-Related Gastric Cancer Can Be Biomarkers Correlating with a Poor Survival.
Stomach Neoplasms
Expression and significance of IGF-2, PCNA, MMP-7, and ?-actin in gastric carcinoma with Lauren classification.
Stomach Neoplasms
Expression of ets-related transcriptional factor E1AF is associated with tumor progression and over-expression of matrilysin in human gastric cancer.
Stomach Neoplasms
Expression of insulin-like growth factor-2, c-MET, matrix metalloproteinase-7 and MUC-1 in primary lesions and lymph node metastatic lesions of gastric cancer.
Stomach Neoplasms
Expression of matrix metalloproteinase-7 involving in growth, invasion, metastasis and angiogenesis of gastric cancer.
Stomach Neoplasms
Expression of MMP-7 and MT1-MMP in peritoneal dissemination of gastric cancer.
Stomach Neoplasms
Expression of reversion-inducing-cysteine-rich protein with Kazal motifs (RECK) as a prognostic indicator in gastric cancer.
Stomach Neoplasms
Expression of tissue levels of matrix metalloproteinases and tissue inhibitors of metalloproteinases in gastric adenocarcinoma.
Stomach Neoplasms
Expression of Wnt3, ?-catenin and MMP-7 in gastric cancer and precancerous lesions and their correlations with Helicobacter pylori infection.
Stomach Neoplasms
Helicobacter pylori potentiates epithelial:mesenchymal transition in gastric cancer: links to soluble HB-EGF, gastrin and matrix metalloproteinase-7.
Stomach Neoplasms
Helicobacter pylori strain-selective induction of matrix metalloproteinase-7 in vitro and within gastric mucosa.
Stomach Neoplasms
Helicobacter pylori upregulates matrilysin (MMP-7) in epithelial cells in vivo and in vitro in a Cag dependent manner.
Stomach Neoplasms
Increased expression of matrix metalloproteinase-7 in invasive early gastric cancer.
Stomach Neoplasms
Inhibition of peritoneal dissemination in human gastric cancer by MMP-7-specific antisense oligonucleotide.
Stomach Neoplasms
In vivo and in vitro inhibition of human gastric cancer progress by upregulating Kank1 gene.
Stomach Neoplasms
Isocitrate dehydrogenase 2 inhibits gastric cancer cell invasion via matrix metalloproteinase 7.
Stomach Neoplasms
Matrix metalloproteinase gene expressions might be oxidative stress targets in gastric cancer cell lines.
Stomach Neoplasms
Matrix metalloproteinase matrilysin (MMP-7) participates in the progression of human gastric and esophageal cancers.
Stomach Neoplasms
Matrix metalloproteinase-2 is a consistent prognostic factor in gastric cancer.
Stomach Neoplasms
Meta-analysis of Associations Between four Polymorphisms in the Matrix Metalloproteinases Gene and Gastric Cancer Risk.
Stomach Neoplasms
MMP-7 overexpression is an independent prognostic marker in gastric cancer.
Stomach Neoplasms
Overexpression of matrix metalloproteinase-7 mRNA in human colon carcinomas.
Stomach Neoplasms
p120 and Kaiso regulate Helicobacter pylori-induced expression of matrix metalloproteinase-7.
Stomach Neoplasms
Polymorphisms of matrix metalloproteinase-7 and chymase are associated with susceptibility to and progression of gastric cancer in Japan.
Stomach Neoplasms
Prediction of peritoneal recurrence by the mRNA level of CEA and MMP-7 in peritoneal lavage of gastric cancer patients.
Stomach Neoplasms
Prognostic significance of matrix metalloproteinase-7 in gastric cancer survival: a meta-analysis.
Stomach Neoplasms
PTEN Gene Induces Cell Invasion and Migration via Regulating AKT/GSK-3?/?-Catenin Signaling Pathway in Human Gastric Cancer.
Stomach Neoplasms
Relation of matrilysin messenger RNA expression with invasive activity in human gastric cancer.
Stomach Neoplasms
Role of MMP-7 in the formation of peritoneal dissemination in gastric cancer.
Stomach Neoplasms
Role of the Metalloproteinase-7 (181A>G) Polymorphism in Gastric Cancer Susceptibility: A Case Control Study in Kashmir Valley.
Stomach Neoplasms
Secreted Protein Acidic and Rich in Cysteine (SPARC) Suppresses Angiogenesis by Down-Regulating the Expression of VEGF and MMP-7 in Gastric Cancer.
Stomach Neoplasms
Stimulation of MMP-7 (matrilysin) by Helicobacter pylori in human gastric epithelial cells: role in epithelial cell migration.
Stomach Neoplasms
The clinical value of Vav3 in peripheral blood for predicting lymphatic metastasis of gastric cancer.
Stomach Neoplasms
The detection of Helicobacter pylori cag pathogenicity islands (PAIs) and expression of matrix metalloproteinase-7 (MMP-7) in gastric epithelial dysplasia and intramucosal cancer.
Stomach Neoplasms
The influence of transforming growth factor-?, cyclooxygenase-2, matrix metalloproteinase (MMP)-7, MMP-9 and CXCR4 proteins involved in epithelial-mesenchymal transition on overall survival of patients with gastric cancer.
Stomach Neoplasms
[Effects of FRZB on growth and metastasis of gastric cancer cell line SGC-7901]
Stomach Ulcer
Genetic variants in matrix metalloproteinase genes are associated with development of gastric ulcer in H. Pylori infection.
Stroke
Matrix metalloproteinase and cytokine profiles in monocytes over the course of stroke.
Stroke
Optical Interference-Free Surface-Enhanced Raman Scattering CO-Nanotags for Logical Multiplex Detection of Vascular Disease-Related Biomarkers.
Stroke
Serum tissue-degrading proteinases and incident cardiovascular disease events.
Subarachnoid Hemorrhage
High Serum Level of Matrix Metalloproteinase-7 Is Associated With Increased Risk of Spontaneous Subarachnoid Hemorrhage.
Thrombosis
Expression changes and roles of matrix metalloproteinases in a rat model of traumatic deep vein thrombosis.
Thymoma
Expression of matrix metalloproteinases 2 and 7 in tumor cells correlates with the World Health Organization classification subtype and clinical stage of thymic epithelial tumors.
Thymoma
Matrin 3 co-immunoprecipitates with the heat shock proteins glucose-regulated protein 78 (GRP78), GRP75 and glutathione S-transferase ? isoform 2 (GST?2) in thymoma cells.
Thyroid Cancer, Papillary
Inverse relationships between the expression of MMP-7 and MMP-11 and predictors of poor prognosis of papillary thyroid carcinoma.
Thyroid Carcinoma, Anaplastic
Down-regulation of matrix metalloproteinase-7 inhibits metastasis of human anaplastic thyroid cancer cell line.
Thyroid Neoplasms
Down-regulation of matrix metalloproteinase-7 inhibits metastasis of human anaplastic thyroid cancer cell line.
Tonsillitis
The role of matrix metalloproteinases in recurrent tonsillitis.
Trichiasis
Conjunctival gene expression profiling using pathway focused arrays reveals increased matrix metalloproteinase-7 (matrilysin) transcription in trachomatous trichiasis.
Tuberculosis
1alpha,25-dihydroxyvitamin D inhibits matrix metalloproteinases induced by Mycobacterium tuberculosis infection.
Tuberculosis
Effect of 1, 25 dihydroxyvitamin D(3) on matrix metalloproteinases MMP-7, MMP-9 and the inhibitor TIMP-1 in pulmonary tuberculosis.
Tuberculosis
Mycobacterium tuberculosis, but not vaccine BCG, specifically upregulates matrix metalloproteinase-1.
Tuberculosis
Plasma levels of C-reactive protein, matrix metalloproteinase-7 and lipopolysaccharide-binding protein distinguish active pulmonary or extrapulmonary tuberculosis from uninfected controls in children.
Tuberculosis, Multidrug-Resistant
Matrix metalloproteinase-1 is regulated in tuberculosis by a p38 MAPK-dependent, p-aminosalicylic acid-sensitive signaling cascade.
Tuberculosis, Pulmonary
Effect of 1, 25 dihydroxyvitamin D(3) on matrix metalloproteinases MMP-7, MMP-9 and the inhibitor TIMP-1 in pulmonary tuberculosis.
Uremia
Matrix metalloproteinase-7 in platelet-activated macrophages accounts for cardiac remodeling in uremic mice.
Ureteral Obstruction
Matrilysin (MMP-7) expression in renal tubular damage: association with Wnt4.
Urinary Bladder Neoplasms
A multiplexed, particle-based flow cytometric assay identified plasma matrix metalloproteinase-7 to be associated with cancer-related death among patients with bladder cancer.
Urinary Bladder Neoplasms
Association of Matrix Metalloproteinase-7 Genotypes with the Risk of Bladder Cancer.
Urinary Bladder Neoplasms
Matrix metalloproteinase-7 as a marker of metastasis and predictor of poor survival in bladder cancer.
Urinary Bladder Neoplasms
MMP-7 Serum and Tissue Levels Are Associated with Poor Survival in Platinum-Treated Bladder Cancer Patients.
Urinary Bladder Neoplasms
Molecular basis for the involvement of thymidine phosphorylase in cancer invasion.
Urinary Bladder Neoplasms
Positive Correlation between Matrix Metalloproteinases and Epithelial-to-Mesenchymal Transition and its Association with Clinical Outcome in Bladder Cancer Patients.
Urinary Bladder Neoplasms
Preoperative levels of matrix metalloproteinase-7 and -9 and tissue inhibitor of matrix metalloproteinase-1 relation to pathologic parameters in bladder carcinoma patients.
Urinary Bladder Neoplasms
Serum Matrix Metalloproteinase-7 is an independent prognostic biomarker in advanced bladder cancer.
Urinary Bladder Neoplasms
The association between matrix metalloproteinase-7 genetic variant and bladder cancer risk in a Chinese Han population.
Urinary Bladder Neoplasms
Urinary matrix metalloproteinase-7 level is associated with the presence of metastasis in bladder cancer.
Urinary Bladder Neoplasms
Validation of Circulating MMP-7 Level as an Independent Prognostic Marker of Poor Survival in Urinary Bladder Cancer.
Urinary Bladder Neoplasms
[Siliconchiptechnology-based MMP-7 analysis in urine : An option for preoperative identification of lymph node metastasis in bladder cancer.]
Uterine Cervical Neoplasms
Association between expression of MMP-7 and MMP-9 and pelvic lymph node and para-aortic lymph node metastasis in early cervical cancer.
Uterine Cervical Neoplasms
Correlation of polymorphism of IL-8 and MMP-7 with occurrence and lymph node metastasis of early stage cervical cancer.
Uterine Cervical Neoplasms
Endothelium specific matrilysin (MMP-7) expression in human cancers.
Uterine Cervical Neoplasms
Matrix metalloproteinase-7 may serve as a novel biomarker for cervical cancer.
Uterine Cervical Neoplasms
MMP-7 (-181A>G) promoter polymorphisms and risk for cervical cancer.
Uterine Cervical Neoplasms
[Expression of ETV5 and MMP-7 in Early Stage Cervical Squamous Cell Carcinoma and Its Role in Lymphatic Metastasis.]
Vaccinia
The vaccinia virus G1L putative metalloproteinase is essential for viral replication in vivo.
Varicose Ulcer
Patterns of matrix metalloproteinase and TIMP-1 expression in chronic and normally healing human cutaneous wounds.
Varicose Veins
Pathogenesis of primary varicose veins.
Vascular Diseases
Optical Interference-Free Surface-Enhanced Raman Scattering CO-Nanotags for Logical Multiplex Detection of Vascular Disease-Related Biomarkers.
Vascular System Injuries
Protease-activated receptor-1 antagonist F 16618 reduces arterial restenosis by down-regulation of tumor necrosis factor ? and matrix metalloproteinase 7 expression, migration, and proliferation of vascular smooth muscle cells.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Quantin, B.; Murphy, G.; Breathnach, R.
Pump-1 cDNA codes for a protein with characteristics similar to those of classical collagenase family members
Biochemistry
28
5327-5334
1989
Homo sapiens, Rattus norvegicus
brenda
Netzel-Arnett, S.; Sang, Q.X.; Moore, W.G.I.; Navre, M.; Birkedal-Hansen, H.; van Wart, H.E.
Comparative sequence specificities of human 72- and 92-kDa gelatinases (type IV collagenases) and PUMP (matrilysin)
Biochemistry
32
6427-6432
1993
Homo sapiens
brenda
Zhang, Z.; Winyard, P.G.; Chidwick, K.; Murphy, G.; Wardell, M.; Carrell, R.W.; Blake, D.R.
Proteolysis of human native and oxidised alpha 1-proteinase inhibitor by matrilysin and stromelysin
Biochim. Biophys. Acta
1199
224-228
1994
Homo sapiens
brenda
Crabbe, T.; Smith, B.; O'Connell, J.; Docherty, A.
Human progelatinase A can be activated by matrilysin
FEBS Lett.
345
14-16
1994
Homo sapiens
brenda
Browner, M.F.; Smith, W.W.; Castelhano, A.L.
Matrilysin-inhibitor complexes: common themes among metalloproteases
Biochemistry
34
6602-6610
1995
Homo sapiens
brenda
Imai, K.; Yokohama, Y.; Nakanishi, I.; Ohuchi, E.; Fujii, Y.; Nakai, N.; Okada, Y.
Matrix metalloproteinase 7 (matrilysin) from human rectal carcinoma cells. Activation of the precursor, interaction with other matrix metalloproteinases and enzymic properties
J. Biol. Chem.
270
6691-6697
1995
Homo sapiens
brenda
Welch, A.R.; Holman, C.M.; Browner, M.F.; Gehring, M.R.; Kan, C.C.; van Wart, H.E.
Purification of human matrilysin produced in Escherichia coli and characterization using a new optimized fluorogenic peptide substrate
Arch. Biochem. Biophys.
324
59-64
1995
Homo sapiens, Rattus norvegicus
brenda
Crabbe, T.; Willenbrock, F.; Eaton, D.; Hynds, P.; Carne, A.F.; Murphy, G.; Docherty, A.J.P.
Biochemical characterization of matrilysin. Activation conforms to the stepwise mechanisms proposed for other matrix metalloproteinases
Biochemistry
31
8500-8507
1992
Homo sapiens
brenda
Marti, H.P.; McNeil, L.; Thomas, G.; Davies, M.; Lovett, D.H.
Molecular characterization of a low-molecular-mass matrix metalloproteinase secreted by glomerular mesangial cells as PUMP-1
Biochem. J.
285
899-905
1992
Homo sapiens
brenda
Soler, D.; Nomizu, T.; Brown, W.E.; Shibata, Y.; Auld, D.S.
Matrilysin: expression, purification, and characterization
J. Protein Chem.
14
511-520
1995
Homo sapiens
brenda
Woessner, J.F.
Matrilysin
Methods Enzymol.
248
485-495
1995
Homo sapiens, Rattus norvegicus
brenda
Bini, A.; Wu, D.; Schnuer, J.; Kudryk, B.J.
Characterization of stromelysin 1 (MMP-3), matrilysin (MMP-7), and membrane type 1 matrix metalloproteinase (MT1-MMP) derived fibrin(ogen) fragments D-dimer and D-like monomer: NH2-terminal sequences of late-stage digest fragments
Biochemistry
38
13928-13936
1999
Homo sapiens
brenda
Vargo-Gogola, T.; Crawford, H.C.; Fingleton, B.; Matrisian, L.M.
Identification of novel matrix metalloproteinase-7 (matrilysin) cleavage sites in murine and human Fas ligand
Arch. Biochem. Biophys.
408
155-161
2002
Homo sapiens
brenda
Cha, J.; Auld, D.S.
Site-directed mutagenesis of the active site glutamate in human matrilysin: Investigation of its role in catalysis
Biochemistry
36
16019-16024
1997
Homo sapiens
brenda
Windsor, L.J.; Steele, D.L.; LeBlanc, S.B.; Taylor, K.B.
Catalytic domain comparisons of human fibroblast-type collagenase, stromelysin-1, and matrilysin
Biochim. Biophys. Acta
1334
261-272
1997
Homo sapiens
brenda
Inouye, K.; Tanaka, H.; Oneda, H.
States of tryptophyl residues and stability of recombinant human matrix metalloproteinase 7 (matrilysin) as examined by fluorescence
J. Biochem.
128
363-369
2000
Homo sapiens
brenda
Oneda, H.; Inouye, K.
Effects of dimethyl sulfoxide, temperature, and sodium chloride on the activity of human matrix metalloproteinase 7 (matrilysin)
J. Biochem.
128
785-791
2000
Homo sapiens
brenda
Oneda, H.; Inouye, K.
Interactions of human matrix metalloproteinase 7 (matrilysin) with the inhibitors thiorphan and R-94138
J. Biochem.
129
429-435
2001
Homo sapiens
brenda
Oneda, H.; Shiihara, M.; Inouye, K.
Inhibitory effects of green tea catechins on the activity of human matrix metalloproteinase 7 (Matrilysin)
J. Biochem.
133
571-576
2003
Homo sapiens
brenda
Yu, W.H.; Woessner, J.F.Jr.
Heparan sulfate proteoglycans as extracellular docking molecules for matrilysin (matrix metalloproteinase 7)
J. Biol. Chem.
275
4183-4191
2000
Homo sapiens, Rattus norvegicus
brenda
Agnihotri, R.; Crawford, H.C.; Haro, H.; Matrisian, L.M.; Havrda, M.C.; Liaw, L.
Osteopontin, a novel substrate for matrix metalloproteinase-3 (stromelysin-1) and matrix metalloproteinase-7 (matrilysin)
J. Biol. Chem.
276
28261-28267
2001
Homo sapiens
brenda
Cheng, M.; De, B.; Pikul, S.; Almstead, N.G.; Natchus, M.G.; Anastasio, M.V.; McPhail, S.J.; Snider, C.E.; Taiwo, Y.O.; Chen, L.; Dunaway, C.M.; Gu, F.; Dowty, M.E.; Mieling, G.E.; Janusz, M.J.; Wang-Weigand, S.
Design and synthesis of piperazine-based matrix metalloproteinase inhibitors
J. Med. Chem.
43
369-380
2000
Homo sapiens
brenda
Mochizuki, S.; Shimoda, M.; Shiomi, T.; Fujii, Y.; Okada, Y.
ADAM28 is activated by MMP-7 (matrilysin-1) and cleaves insulin-like growth factor binding protein-3
Biochem. Biophys. Res. Commun.
315
79-84
2004
Homo sapiens
brenda
Muta, Y.; Oneda, H.; Inouye, K.
Anomalous pH-dependence of the activity of human matrilysin (matrix metalloproteinase-7) as revealed by nitration and amination of its tyrosine residues
Biochem. J.
386
263-270
2005
Homo sapiens
brenda
Muta, Y.; Oneda, H.; Inouye, K.
Inhibitory effects of alcohols on the activity of human matrix metalloproteinase 7 (matrilysin)
Biosci. Biotechnol. Biochem.
68
2649-2652
2004
Homo sapiens
brenda
Wang, F.; Reierstad, S.; Fishman, D.A.
Matrilysin over-expression in MCF-7 cells enhances cellular invasiveness and pro-gelatinase activation
Cancer Lett.
236
292-301
2006
Homo sapiens
brenda
Miyamoto, S.; Yano, K.; Sugimoto, S.; Ishii, G.; Hasebe, T.; Endoh, Y.; Kodama, K.; Goya, M.; Chiba, T.; Ochiai, A.
Matrix metalloproteinase-7 facilitates insulin-like growth factor bioavailability through its proteinase activity on insulin-like growth factor binding protein 3
Cancer Res.
64
665-671
2004
Homo sapiens
brenda
Harrell, P.C.; McCawley, L.J.; Fingleton, B.; McIntyre, J.O.; Matrisian, L.M.
Proliferative effects of apical, but not basal, matrix metalloproteinase-7 activity in polarized MDCK cells
Exp. Cell Res.
303
308-320
2005
Homo sapiens
brenda
Riccioli, A.; Dal Secco, V.; De Cesaris, P.; Starace, D.; Gandini, L.; Lenzi, A.; Dondero, F.; Padula, F.; Filippini, A.; Ziparo, E.
Presence of membrane and soluble forms of Fas ligand and of matrilysin (MMP-7) activity in normal and abnormal human semen
Hum. Reprod.
20
2814-2820
2005
Homo sapiens
brenda
Muta, Y.; Oyama, S.; Umezawa, T.; Shimada, M.; Inouye, K.
Inhibitory effects of lignans on the activity of human matrix metalloproteinase 7 (matrilysin)
J. Agric. Food Chem.
52
5888-5894
2004
Homo sapiens
brenda
Yamamoto, K.; Higashi, S.; Kioi, M.; Tsunezumi, J.; Honke, K.; Miyazaki, K.
Binding of active matrilysin to cell surface cholesterol sulfate is essential for its membrane-associated proteolytic action and induction of homotypic cell adhesion
J. Biol. Chem.
281
9170-9180
2006
Homo sapiens
brenda
Tan, X.; Egami, H.; Abe, M.; Nozawa, F.; Hirota, M.; Ogawa, M.
Involvement of MMP-7 in invasion of pancreatic cancer cells through activation of the EGFR mediated MEK-ERK signal transduction pathway
J. Clin. Pathol.
58
1242-1248
2005
Homo sapiens
brenda
Nemori, R.; Yamamoto, M.; Kataoka, F.; Hashimoto, G.; Arakatsu, H.; Shiomi, T.; Okada, Y.
Development of in situ zymography to localize active matrix metalloproteinase-7 (matrilysin-1)
J. Histochem. Cytochem.
53
1227-1234
2005
Homo sapiens
brenda
Bilousova, T.V.; Rusakov, D.A.; Ethell, D.W.; Ethell, I.M.
Matrix metalloproteinase-7 disrupts dendritic spines in hippocampal neurons through NMDA receptor activation
J. Neurochem.
97
44-56
2006
Homo sapiens
brenda
Shiomi, T.; Inoki, I.; Kataoka, F.; Ohtsuka, T.; Hashimoto, G.; Nemori, R.; Okada, Y.
Pericellular activation of proMMP-7 (promatrilysin-1) through interaction with CD151
Lab. Invest.
85
1489-1506
2005
Homo sapiens
brenda
Salmela, M.T.; Pender, S.L.; Karjalainen-Lindsberg, M.L.; Puolakkainen, P.; Macdonald, T.T.; Saarialho-Kere, U.
Collagenase-1 (MMP-1), matrilysin-1 (MMP-7), and stromelysin-2 (MMP-10) are expressed by migrating enterocytes during intestinal wound healing
Scand. J. Gastroenterol.
39
1095-1104
2004
Homo sapiens
brenda
Kawasaki, K.; Kawakami, T.; Watabe, H.; Itoh, F.; Mizoguchi, M.; Soma, Y.
Expression of matrilysin (matrix metalloproteinase-7) in primary cutaneous and metastatic melanoma
Br. J. Dermatol.
156
613-619
2007
Homo sapiens (P09237), Homo sapiens
brenda
Gershtein, E.S.; Korotkova, E.A.; Shcherbakov, A.M.; Prorokov, V.V.; Golovkov, D.A.; Kushlinskii, N.E.
Matrix metalloproteinases 7 and 9 and their types 1 and 4 tissue inhibitors in tumors and plasma of patients with colorectal cancer
Bull. Exp. Biol. Med.
143
459-462
2007
Homo sapiens (P09237), Homo sapiens
brenda
Remy, L.; Trespeuch, C.; Bachy, S.; Scoazec, J.Y.; Rousselle, P.
Matrilysin 1 influences colon carcinoma cell migration by cleavage of the laminin-5 beta3 chain
Cancer Res.
66
11228-11237
2006
Homo sapiens (P09237), Homo sapiens
brenda
Lynch, C.C.; Vargo-Gogola, T.; Martin, M.D.; Fingleton, B.; Crawford, H.C.; Matrisian, L.M.
Matrix metalloproteinase 7 mediates mammary epithelial cell tumorigenesis through the ErbB4 receptor
Cancer Res.
67
6760-6767
2007
Homo sapiens (P09237), Mus musculus (Q10738), Mus musculus, Mus musculus C57BL/6 (Q10738)
brenda
Miyamoto, S.; Nakamura, M.; Yano, K.; Ishii, G.; Hasebe, T.; Endoh, Y.; Sangai, T.; Maeda, H.; Shi-Chuang, Z.; Chiba, T.; Ochiai, A.
Matrix metalloproteinase-7 triggers the matricrine action of insulin-like growth factor-II via proteinase activity on insulin-like growth factor binding protein 2 in the extracellular matrix
Cancer Sci.
98
685-691
2007
Homo sapiens (P09237), Homo sapiens
brenda
Berton, A.; Selvais, C.; Lemoine, P.; Henriet, P.; Courtoy, P.J.; Marbaix, E.; Emonard, H.
Binding of matrilysin-1 to human epithelial cells promotes its activity
Cell. Mol. Life Sci.
64
610-620
2007
Homo sapiens (P09237), Homo sapiens
brenda
Miyata, Y.; Iwata, T.; Ohba, K.; Kanda, S.; Nishikido, M.; Kanetake, H.
Expression of matrix metalloproteinase-7 on cancer cells and tissue endothelial cells in renal cell carcinoma: prognostic implications and clinical significance for invasion and metastasis
Clin. Cancer Res.
12
6998-7003
2006
Homo sapiens (P09237), Homo sapiens
brenda
Kirimlioglu, H.; Kirimlioglu, V.; Yilmaz, S.; Sagir, V.; Coban, S.; Turkmen, E.; Hilmioglu, F.
Role of matrix metalloproteinase-7 in colorectal adenomas
Digest. Dis. Sci.
51
2068-2072
2006
Homo sapiens (P09237), Homo sapiens
brenda
Gorodeski, G.I.
Estrogen decrease in tight junctional resistance involves matrix-metalloproteinase-7-mediated remodeling of occludin
Endocrinology
148
218-231
2007
Homo sapiens (P09237), Homo sapiens
brenda
Ganguly, B.; Banerjee, J.; Elegbede, A.I.; Klocke, D.J.; Mallik, S.; Srivastava, D.K.
Intrinsic selectivity in binding of matrix metalloproteinase-7 to differently charged lipid membranes
FEBS Lett.
581
5723-5726
2007
Homo sapiens (P09237)
brenda
McCaig, C.; Duval, C.; Hemers, E.; Steele, I.; Pritchard, D.M.; Przemeck, S.; Dimaline, R.; Ahmed, S.; Bodger, K.; Kerrigan, D.D.; Wang, T.C.; Dockray, G.J.; Varro, A.
The role of matrix metalloproteinase-7 in redefining the gastric microenvironment in response to Helicobacter pylori
Gastroenterology
130
1754-1763
2006
Homo sapiens (P09237), Homo sapiens
brenda
Patraki, E.; Cardillo, M.R.
Quantitative immunohistochemical analysis of matrilysin 1 (MMP-7) in various renal cell carcinoma subtypes
Int. J. Immunopathol. Pharmacol.
20
697-705
2008
Homo sapiens (P09237)
brenda
Liu, D.; Nakano, J.; Ishikawa, S.; Yokomise, H.; Ueno, M.; Kadota, K.; Urushihara, M.; Huang, C.L.
Overexpression of matrix metalloproteinase-7 (MMP-7) correlates with tumor proliferation, and a poor prognosis in non-small cell lung cancer
Lung Cancer
58
384-391
2007
Homo sapiens (P09237), Homo sapiens
brenda
Sier, C.F.; Hawinkels, L.J.; Zijlmans, H.J.; Zuidwijk, K.; de Jonge-Muller, E.S.; Ferreira, V.; Hanemaaijer, R.; Mulder-Stapel, A.A.; Kenter, G.G.; Verspaget, H.W.; Gorter, A.
Endothelium specific matrilysin (MMP-7) expression in human cancers
Matrix Biol.
27
267-271
2008
Homo sapiens (P09237), Homo sapiens
brenda
Rome, C.; Arsaut, J.; Taris, C.; Couillaud, F.; Loiseau, H.
MMP-7 (matrilysin) expression in human brain tumors
Mol. Carcinog.
46
446-452
2007
Homo sapiens (P09237), Homo sapiens
brenda
Szklarczyk, A.; Conant, K.; Owens, D.F.; Ravin, R.; McKay, R.D.; Gerfen, C.
Matrix metalloproteinase-7 modulates synaptic vesicle recycling and induces atrophy of neuronal synapses
Neuroscience
149
87-98
2007
Homo sapiens (P09237)
brenda
Ito, T.K.; Ishii, G.; Chiba, H.; Ochiai, A.
The VEGF angiogenic switch of fibroblasts is regulated by MMP-7 from cancer cells
Oncogene
26
7194-7203
2007
Homo sapiens (P09237), Homo sapiens
brenda
Ichikawa, Y.; Ishikawa, T.; Momiyama, N.; Kamiyama, M.; Sakurada, H.; Matsuyama, R.; Hasegawa, S.; Chishima, T.; Hamaguchi, Y.; Fujii, S.; Saito, S.; Kubota, K.; Hasegawa, S.; Ike, H.; Oki, S.; Shimada, H.
Matrilysin (MMP-7) degrades VE-cadherin and accelerates accumulation of beta-catenin in the nucleus of human umbilical vein endothelial cells
Oncol. Rep.
15
311-315
2006
Homo sapiens (P09237), Homo sapiens
brenda
Ou, L.; Ma, J.; Zheng, X.; Chen, X.; Li, G.; Wu, H.
The expression and refolding of isotopically labeled recombinant matrilysin for NMR studies
Protein Expr. Purif.
47
367-373
2006
Homo sapiens (P09237)
brenda
Nishihara, S.; Someya, A.; Yonemoto, H.; Ota, A.; Itoh, S.; Nagaoka, I.; Takeda, S.
Evaluation of the expression and enzyme activity of matrix metalloproteinase-7 in fetal membranes during premature rupture of membranes at term in humans
Reprod. Sci.
15
156-165
2008
Homo sapiens (P09237), Homo sapiens
brenda
Martinez-Fernandez, A.; Garcia-Albeniz, X.; Pineda, E.; Visa, L.; Gallego, R.; Codony-Servat, J.; Auge, J.M.; Longaron, R.; Gascon, P.; Lacy, A.; Castells, A.; Maurel, J.
Serum matrilysin levels predict outcome in curatively resected colorectal cancer patients
Ann. Surg. Oncol.
16
1412-1420
2009
Homo sapiens (P09237), Homo sapiens
brenda
Yokoyama, Y.; Gruenebach, F.; Schmidt, S.M.; Heine, A.; Haentschel, M.; Stevanovic, S.; Rammensee, H.G.; Brossart, P.
Matrilysin (MMP-7) is a novel broadly expressed tumor antigen recognized by antigen-specific T cells
Clin. Cancer Res.
14
5503-5511
2008
Homo sapiens
brenda
Tsunezumi, J.; Yamamoto, K.; Higashi, S.; Miyazaki, K.
Matrilysin (matrix metalloprotease-7) cleaves membrane-bound annexin II and enhances binding of tissue-type plasminogen activator to cancer cell surfaces
FEBS J.
275
4810-4823
2008
Homo sapiens
brenda
Beeghly-Fadiel, A.; Shu, X.O.; Long, J.; Li, C.; Cai, Q.; Cai, H.; Gao, Y.T.; Zheng, W.
Genetic polymorphisms in the MMP-7 gene and breast cancer survival
Int. J. Cancer
124
208-214
2009
Homo sapiens (P09237), Homo sapiens
brenda
Tsunezumi, J.; Higashi, S.; Miyazaki, K.
Matrilysin (MMP-7) cleaves C-type lectin domain family 3 member A (CLEC3A) on tumor cell surface and modulates its cell adhesion activity
J. Cell. Biochem.
106
693-702
2009
Homo sapiens
brenda
Liu, H.; Huang, J.; Wu, B.; Zhou, Y.; Zhu, J.; Zhang, T.
Matrilysin inhibits proliferation and modulates sensitivity of lung cancer cells to FasL-mediated apoptosis
Med. Oncol.
25
419-430
2008
Homo sapiens
brenda
Liu, H.; Zhang, T.; Wu, B.; Huang, J.; Zhou, Y.; Zhu, J.
Chronic exposure to exogenous matrilysin induces chemoresistance and enhances Bcl-2 expression in A549 lung adenocarcinoma cells
Mol. Biol. Rep.
36
2099-2109
2008
Homo sapiens
brenda
Goswami, S.; Angkasekwinai, P.; Shan, M.; Greenlee, K.J.; Barranco, W.T.; Polikepahad, S.; Seryshev, A.; Song, L.Z.; Redding, D.; Singh, B.; Sur, S.; Woodruff, P.; Dong, C.; Corry, D.B.; Kheradmand, F.
Divergent functions for airway epithelial matrix metalloproteinase 7 and retinoic acid in experimental asthma
Nat. Immunol.
10
496-503
2009
Homo sapiens
brenda
Dilek, F.H.; Topak, N.; Aktepe, F.; Sahin, O.; Tuerel, K.S.; Sahin, D.A.; Dilek, O.N.
E-cadherin, beta-catenin adhesion complex and relation to matrilysin expression in pT3 rectosigmoid cancers
Pathol. Res. Pract.
204
809-815
2008
Homo sapiens
brenda
Dunn, K.M.; Lee, P.K.; Wilson, C.M.; Iida, J.; Wasiluk, K.R.; Hugger, M.; McCarthy, J.B.
Inhibition of hyaluronan synthases decreases matrix metalloproteinase-7 (MMP-7) expression and activity
Surgery
145
322-329
2009
Homo sapiens (P09237)
brenda
Gomes, E.G.; Juca, M.J.; de Menezes, H.L.; Nunes, B.L.; Costa, H.; Lima, F.d.e..O.; Matos, D.
Correlation between the immunohistochemical expressions of MMP-1, MMP-7 and VEGF and prognostic factors in colorectal adenocarcinoma
Acta Cir. Bras.
24
303-310
2009
Homo sapiens
brenda
Luukkaa, H.; Klemi, P.; Hirsimaeki, P.; Vahlberg, T.; Kivisaari, A.; Kaehaeri, V.M.; Grenman, R.
Matrix metalloproteinase (MMP)-7 in salivary gland cancer
Acta Oncol.
49
85-90
2010
Homo sapiens
brenda
Wang, X.Y.; Demelash, A.; Kim, H.; Jensen-Taubman, S.; Dakir, e.l..H.; Ozbun, L.; Birrer, M.J.; Linnoila, R.I.
Matrilysin-1 mediates bronchiolization of alveoli, a potential premalignant change in lung cancer
Am. J. Pathol.
175
592-604
2009
Homo sapiens
brenda
Park, H.I.; Lee, S.; Ullah, A.; Cao, Q.; Sang, Q.X.
Effects of detergents on catalytic activity of human endometase/matrilysin 2, a putative cancer biomarker
Anal. Biochem.
396
262-268
2010
Homo sapiens (P09237), Homo sapiens
brenda
Maruta, S.; Sakai, H.; Kanda, S.; Hayashi, T.; Kanetake, H.; Miyata, Y.
E1AF expression is associated with extra-prostatic growth and matrix metalloproteinase-7 expression in prostate cancer
APMIS
117
791-796
2009
Homo sapiens
brenda
Ulmer, T.A.; Keeler, V.; Andre, S.; Gabius, H.J.; Loh, L.; Laferte, S.
The tumor-associated antigen 90K/Mac-2-binding protein secreted by human colon carcinoma cells enhances extracellular levels of promatrilysin and is a novel substrate of matrix metalloproteinases-2, -7 (matrilysin) and -9: Implications of proteolytic clea
Biochim. Biophys. Acta
1800
336-343
2010
Homo sapiens
brenda
Zhao, C.; Bu, X.; Zhang, N.; Wang, W.
Downregulation of SFRP5 expression and its inverse correlation with those of MMP-7 and MT1-MMP in gastric cancer
BMC Cancer
9
224
2009
Homo sapiens
brenda
Leelawat, K.; Sakchinabut, S.; Narong, S.; Wannaprasert, J.
Detection of serum MMP-7 and MMP-9 in cholangiocarcinoma patients: evaluation of diagnostic accuracy
BMC Gastroenterol.
9
30-38
2009
Homo sapiens
brenda
Hartmann-Petersen, S.; Tammi, R.H.; Tammi, M.I.; Kosma, V.M.
Depletion of cell surface CD44 in nonmelanoma skin tumours is associated with increased expression of matrix metalloproteinase 7
Br. J. Dermatol.
160
1251-1257
2009
Homo sapiens
brenda
Takai, T.; Kanaoka, S.; Yoshida, K.; Hamaya, Y.; Ikuma, M.; Miura, N.; Sugimura, H.; Kajimura, M.; Hishida, A.
Fecal cyclooxygenase 2 plus matrix metalloproteinase 7 mRNA assays as a marker for colorectal cancer screening
Cancer Epidemiol. Biomarkers Prev.
18
1888-1893
2009
Homo sapiens
brenda
Yue, W.; Sun, Q.; Landreneau, R.; Wu, C.; Siegfried, J.M.; Yu, J.; Zhang, L.
Fibulin-5 suppresses lung cancer invasion by inhibiting matrix metalloproteinase-7 expression
Cancer Res.
69
6339-6346
2009
Homo sapiens
brenda
Thiolloy, S.; Halpern, J.; Holt, G.E.; Schwartz, H.S.; Mundy, G.R.; Matrisian, L.M.; Lynch, C.C.
Osteoclast-derived matrix metalloproteinase-7, but not matrix metalloproteinase-9, contributes to tumor-induced osteolysis
Cancer Res.
69
6747-6755
2009
Homo sapiens
brenda
Adachi, Y.; Li, R.; Yamamoto, H.; Min, Y.; Piao, W.; Wang, Y.; Imsumran, A.; Li, H.; Arimura, Y.; Lee, C.T.; Imai, K.; Carbone, D.P.; Shinomura, Y.
Insulin-like growth factor-I receptor blockade reduces the invasiveness of gastrointestinal cancers via blocking production of matrilysin
Carcinogenesis
30
1305-1313
2009
Homo sapiens
brenda
Williams, H.; Johnson, J.L.; Jackson, C.L.; White, S.J.; George, S.J.
MMP-7 mediates cleavage of N-cadherin and promotes smooth muscle cell apoptosis
Cardiovasc. Res.
87
137-146
2010
Homo sapiens, Mus musculus, Mus musculus C57/BL6J
brenda
Shi, M.D.; Lin, H.H.; Chiang, T.A.; Tsai, L.Y.; Tsai, S.M.; Lee, Y.C.; Chen, J.H.
Andrographolide could inhibit human colorectal carcinoma Lovo cells migration and invasion via down-regulation of MMP-7 expression
Chem. Biol. Interact.
180
344-352
2009
Homo sapiens
brenda
Yi, Y.C.; Chou, P.T.; Chen, L.Y.; Kuo, W.H.; Ho, E.S.; Han, C.P.; Yang, S.F.
Matrix metalloproteinase-7 (MMP-7) polymorphism is a risk factor for endometrial cancer susceptibility
Clin. Chem. Lab. Med.
48
337-344
2010
Homo sapiens
brenda
Anand, S.P.; Selvaraj, P.
Effect of 1, 25 dihydroxyvitamin D(3) on matrix metalloproteinases MMP-7, MMP-9 and the inhibitor TIMP-1 in pulmonary tuberculosis
Clin. Immunol.
133
126-131
2009
Homo sapiens
brenda
Ban, C.R.; Twigg, S.M.; Franjic, B.; Brooks, B.A.; Celermajer, D.; Yue, D.K.; McLennan, S.V.
Serum MMP-7 is increased in diabetic renal disease and diabetic diastolic dysfunction
Diabetes Res. Clin. Pract.
87
335-341
2010
Homo sapiens
brenda
Yeh, Y.C.; Sheu, B.S.; Cheng, H.C.; Wang, Y.L.; Yang, H.B.; Wu, J.J.
Elevated serum matrix metalloproteinase-3 and -7 in H. pylori-related gastric cancer can be biomarkers correlating with a poor survival
Digest. Dis. Sci.
55
1649-1657
2010
Homo sapiens
brenda
Achyut, B.R.; Ghoshal, U.C.; Moorchung, N.; Mittal, B.
Transforming growth factor-B1 and matrix metalloproteinase-7 promoter variants induce risk for Helicobacter pylori-associated gastric precancerous lesions
DNA Cell Biol.
28
295-301
2009
Homo sapiens
brenda
Galewska, Z.; Romanowicz, L.; Jaworski, S.; Ba?kowski, E.
Matrix metalloproteinases, MMP-7 and MMP-26, in plasma and serum of control and preeclamptic umbilical cord blood
Eur. J. Obstet. Gynecol. Reprod. Biol.
150
152-156
2010
Homo sapiens
brenda
Luukkaa, H.; Klemi, P.; Leivo, I.; Maekitie, A.A.; Irish, J.; Gilbert, R.; Perez-Ordonez, B.; Hirsimaeki, P.; Vahlberg, T.; Kivisaari, A.; Kaehaeri, V.M.; Grenman, R.
Expression of matrix metalloproteinase-1, -7, -9, -13, Ki-67, and HER-2 in epithelial-myoepithelial salivary gland cancer
Head Neck
32
1019-1027
2009
Homo sapiens
brenda
Hung, T.M.; Chang, S.C.; Yu, W.H.; Wang, Y.W.; Huang, C.; Lu, S.C.; Lee, P.H.; Chang, M.F.
A novel nonsynonymous variant of matrix metalloproteinase-7 confers risk of liver cirrhosis
Hepatology
50
1184-1193
2009
Homo sapiens
brenda
Miyata, Y.; Sagara, Y.; Kanda, S.; Hayashi, T.; Kanetake, H.
Phosphorylated hepatocyte growth factor receptor/c-Met is associated with tumor growth and prognosis in patients with bladder cancer: correlation with matrix metalloproteinase-2 and -7 and E-cadherin
Hum. Pathol.
40
496-504
2009
Homo sapiens
brenda
Matsuzaki, S.; Maleysson, E.; Darcha, C.
Analysis of matrix metalloproteinase-7 expression in eutopic and ectopic endometrium samples from patients with different forms of endometriosis
Hum. Reprod.
25
742-750
2010
Homo sapiens
brenda
Szarvas, T.; Becker, M.; Vom Dorp, F.; Meschede, J.; Scherag, A.; Bankfalvi, A.; Reis, H.; Schmid, K.W.; Romics, I.; Ruebben, H.; Erguen, S.
Elevated serum matrix metalloproteinase 7 levels predict poor prognosis after radical prostatectomy
Int. J. Cancer
128
1486-1492
2010
Homo sapiens
brenda
Ra, H.J.; Harju-Baker, S.; Zhang, F.; Linhardt, R.J.; Wilson, C.L.; Parks, W.C.
Control of promatrilysin (MMP7) activation and substrate-specific activity by sulfated glycosaminoglycans
J. Biol. Chem.
284
27924-27932
2009
Homo sapiens
brenda
Ryu, H.Y.; Lee, J.; Yang, S.; Park, H.; Choi, S.; Jung, K.C.; Lee, S.T.; Seong, J.K.; Han, I.O.; Oh, E.S.
Syndecan-2 functions as a docking receptor for pro-matrix metalloproteinase-7 in human colon cancer cells
J. Biol. Chem.
284
35692-35701
2009
Homo sapiens (P09237), Homo sapiens
brenda
Wilson, C.L.; Schmidt, A.P.; Pirilae, E.; Valore, E.V.; Ferri, N.; Sorsa, T.; Ganz, T.; Parks, W.C.
Differential processing of alpha- and beta-defensin precursors by matrix metalloproteinase-7 (MMP-7)
J. Biol. Chem.
284
8301-8311
2009
Homo sapiens
brenda
Fang, Y.J.; Pan, Z.Z.; Li, L.R.; Lu, Z.H.; Zhang, L.Y.; Wan, D.S.
MMP7 expression regulated by endocrine therapy in ERbeta-positive colon cancer cells
J. Exp. Clin. Cancer Res.
28
132
2009
Homo sapiens
brenda
Rand, L.; Green, J.A.; Saraiva, L.; Friedland, J.S.; Elkington, P.T.
Matrix metalloproteinase-1 is regulated in tuberculosis by a p38 MAPK-dependent, p-aminosalicylic acid-sensitive signaling cascade
J. Immunol.
182
5865-5872
2009
Homo sapiens
brenda
Kaner, R.J.; Santiago, F.; Crystal, R.G.
Up-regulation of alveolar macrophage matrix metalloproteinases in HIV1(+) smokers with early emphysema
J. Leukoc. Biol.
86
913-922
2009
Homo sapiens
brenda
Tilakaratne, W.M.; Kobayashi, T.; Ida-Yonemochi, H.; Swelam, W.; Yamazaki, M.; Mikami, T.; Alvarado, C.G.; Shahidul, A.M.; Maruyama, S.; Cheng, J.; Saku, T.
Matrix metalloproteinase 7 and perlecan in oral epithelial dysplasia and carcinoma in situ: an aid for histopathologic recognition of their cell proliferation centers
J. Oral Pathol. Med.
38
348-355
2009
Homo sapiens
brenda
Zeldich, E.; Koren, R.; Dard, M.; Weinberg, E.; Weinreb, M.; Nemcovsky, C.E.
Enamel matrix derivative induces the expression of tissue inhibitor of matrix metalloproteinase-3 in human gingival fibroblasts via extracellular signal-regulated kinase
J. Periodontal Res.
45
200-206
2010
Homo sapiens
brenda
Kitamura, T.; Biyajima, K.; Aoki, M.; Oshima, M.; Taketo, M.
Matrix metalloproteinase 7 is required for tumor formation, but dispensable for invasion and fibrosis in SMAD4-deficient intestinal adenocarcinomas
Lab. Invest.
89
98-105
2009
Homo sapiens, Mus musculus
brenda
Zohny, S.F.; Fayed, S.T.
Clinical utility of circulating matrix metalloproteinase-7 (MMP-7), CC chemokine ligand 18 (CCL18) and CC chemokine ligand 11 (CCL11) as markers for diagnosis of epithelial ovarian cancer
Med. Oncol.
27
1246-1253
2009
Homo sapiens
brenda
Scherer, R.L.; VanSaun, M.N.; McIntyre, J.O.; Matrisian, L.M.
Optical imaging of matrix metalloproteinase-7 activity in vivo using a proteolytic nanobeacon
Mol. Imaging
7
118-131
2009
Homo sapiens
brenda
Ansell, A.; Jerhammar, F.; Ceder, R.; Grafstroem, R.; Grenman, R.; Roberg, K.
Matrix metalloproteinase-7 and -13 expression associate to cisplatin resistance in head and neck cancer cell lines
Oral Oncol.
45
866-871
2009
Homo sapiens
brenda
Souza Freitas, V.; Ferreira de Araujo, C.R.; Alves, P.M.; de Souza, L.B.; Galvao, H.C.; de Almeida Freitas, R.
Immunohistochemical expression of matrilysins (MMP-7 and MMP-26) in ameloblastomas and adenomatoid odontogenic tumors
Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod.
108
417-424
2009
Homo sapiens
brenda
Almendro, V.; Ametller, E.; Garcia-Recio, S.; Collazo, O.; Casas, I.; Auge, J.M.; Maurel, J.; Gascon, P.
The role of MMP7 and its cross-talk with the FAS/FASL system during the acquisition of chemoresistance to oxaliplatin
PLoS ONE
4
e4728
2009
Homo sapiens
brenda
Amir, M.; Romano, S.; Goldman, S.; Shalev, E.
Plexin-B1, glycodelin and MMP7 expression in the human fallopian tube and in the endometrium
Reprod. Biol. Endocrinol.
7
152
2009
Homo sapiens
brenda
Koskensalo, S.; Mrena, J.; Wiksten, J.P.; Nordling, S.; Kokkola, A.; Hagstroem, J.; Haglund, C.
MMP-7 overexpression is an independent prognostic marker in gastric cancer
Tumour Biol.
31
149-155
2010
Homo sapiens
brenda
Oka, T.; Yamamoto, H.; Sasaki, S.; Ii, M.; Hizaki, K.; Taniguchi, H.; Adachi, Y.; Imai, K.; Shinomura, Y.
Overexpression of beta3/gamma2 chains of laminin-5 and MMP7 in biliary cancer
World J. Gastroenterol.
15
3865-3873
2009
Homo sapiens
brenda
Ohtani, H.; Maeda, N.; Murawaki, Y.
Functional polymorphisms in the promoter regions of matrix metalloproteinase-2,-3,-7,-9 and TNF-alpha Genes, and the risk of colorectal neoplasm in Japanese
Yonago Acta Med.
52
47-56
2009
Homo sapiens
-
brenda
Choi, S.; Kim, J.Y.; Park, J.H.; Lee, S.T.; Han, I.O.; Oh, E.S.
The matrix metalloproteinase-7 regulates the extracellular shedding of syndecan-2 from colon cancer cells
Biochem. Biophys. Res. Commun.
417
1260-1264
2012
Homo sapiens
brenda
Heinz, A.; Taddese, S.; Sippl, W.; Neubert, R.H.; Schmelzer, C.E.
Insights into the degradation of human elastin by matrilysin-1
Biochimie
93
187-194
2011
Homo sapiens
brenda
Muta, Y.; Yasui, N.; Matsumiya, Y.; Kubo, M.; Inouye, K.
Expression in Escherichia coli, refolding, and purification of the recombinant mature form of human matrix metalloproteinase 7 (MMP-7)
Biosci. Biotechnol. Biochem.
74
2515-2517
2010
Homo sapiens
brenda
Miyake, T.; Yasukawa, K.; Inouye, K.
Analysis of the mechanism of inhibition of human matrix metalloproteinase 7 (MMP-7) activity by green tea catechins
Biosci. Biotechnol. Biochem.
75
1564-1569
2011
Homo sapiens
brenda
Muta, Y.; Inouye, K.
Tyr219 of human matrix metalloproteinase 7 is not critical for catalytic activity, but is involved in the broad pH-dependence of the activity
J. Biochem.
150
183-188
2011
Homo sapiens
brenda
Yamamoto, K.; Miyazaki, K.; Higashi, S.
Cholesterol sulfate alters substrate preference of matrix metalloproteinase-7 and promotes degradations of pericellular laminin-332 and fibronectin
J. Biol. Chem.
285
28862-28873
2010
Homo sapiens
brenda
Rath, T.; Roderfeld, M.; Halwe, J.M.; Tschuschner, A.; Roeb, E.; Graf, J.
Cellular sources of MMP-7, MMP-13 and MMP-28 in ulcerative colitis
Scand. J. Gastroenterol.
45
1186-1196
2010
Homo sapiens
brenda
Samukange, V.; Yasukawa, K.; Inouye, K.
Effects of heparin and cholesterol sulfate on the activity and stability of human matrix metalloproteinase 7
Biosci. Biotechnol. Biochem.
78
41-48
2014
Homo sapiens (P09237), Homo sapiens
brenda
Liu, Y.; Tan, H.; Yan, H.; Song, X.
Design, synthesis and biological evaluation Of 3,9-diazatetraasteranes as novel matrilysin inhibitors
Chem. Biol. Drug Des.
82
567-578
2013
Homo sapiens (P09237)
brenda
Keles, D.; Arslan, B.; Terzi, C.; Tekmen, I.; Dursun, E.; Altungoz, O.; Oktay, G.
Expression and activity levels of matrix metalloproteinase-7 and in situ localization of caseinolytic activity in colorectal cancer
Clin. Biochem.
47
1265-1271
2014
Homo sapiens (P09237)
brenda
Yamamoto, K.; Miyazaki, K.; Higashi, S.
Pericellular proteolysis by matrix metalloproteinase-7 is differentially modulated by cholesterol sulfate, sulfatide, and cardiolipin
FEBS J.
281
3346-3356
2014
Homo sapiens (P09237)
brenda
Grindel, B.; Martinez, J.; Pennington, C.; Muldoon, M.; Stave, J.; Chung, L.; Farach-Carson, M.
Matrilysin/matrix metalloproteinase-7(MMP7) cleavage of perlecan/HSPG2 creates a molecular switch to alter prostate cancer cell behavior
Matrix Biol.
36
64-76
2014
Homo sapiens (P09237), Homo sapiens
brenda
Huang, Y.; Yu, H.; Lei, H.; Xie, C.; Zhong, Y.
Matrix metalloproteinase 7 is a useful marker for 5-fluorouracil-based adjuvant chemotherapy in stage II and stage III colorectal cancer patients
Med. Oncol.
31
824
2014
Homo sapiens (P09237), Homo sapiens
brenda
Fuksiewicz, M.; Kotowicz, B.; Rutkowski, A.; Kowalska, M.
The matrix metalloproteinase-7 and pro-enzyme of metalloproteinase-1 as a potential marker for patients with rectal cancer without distant metastasis
Tumor Biol.
36
3629-3635
2015
Homo sapiens (P09237), Homo sapiens
brenda
Xiao, Z.; Chen, C.; Meng, T.; Zhang, W.; Zhou, Q.
Resveratrol attenuates renal injury and fibrosis by inhibiting transforming growth factor-beta pathway on matrix metalloproteinase 7
Exp. Biol. Med. (Maywood)
241
140-146
2016
Homo sapiens (P09237), Homo sapiens
brenda
Ishikawa, T.; Kimura, Y.; Hirano, H.; Higashi, S.
Matrix metalloproteinase-7 induces homotypic tumor cell aggregation via proteolytic cleavage of the membrane-bound Kunitz-type inhibitor HAI-1
J. Biol. Chem.
292
20769-20784
2017
Homo sapiens (P09237)
brenda
Fu, H.; Zhou, D.; Zhu, H.; Liao, J.; Lin, L.; Hong, X.; Hou, F.F.; Liu, Y.
Matrix metalloproteinase-7 protects against acute kidney injury by priming renal tubules for survival and regeneration
Kidney Int.
95
1167-1180
2019
Homo sapiens (P09237), Mus musculus (Q10738)
brenda
Nukuda, A.; Sasaki, C.; Ishihara, S.; Mizutani, T.; Nakamura, K.; Ayabe, T.; Kawabata, K.; Haga, H.
Stiff substrates increase YAP-signaling-mediated matrix metalloproteinase-7 expression
Oncogenesis
4
e165
2015
Homo sapiens
brenda
Garalla, H.M.; Lertkowit, N.; Tiszlavicz, L.; Reisz, Z.; Holmberg, C.; Beynon, R.; Simpson, D.; Varga, A.; Kumar, J.D.; Dodd, S.; Pritchard, D.M.; Moore, A.R.; Rosztoczy, A.I.; Wittman, T.; Simpson, A.; Dockray, G.J.; Varro, A.
Matrix metalloproteinase (MMP)-7 in Barrett's esophagus and esophageal adenocarcinoma expression, metabolism, and functional significance
Physiol. Rep.
6
e13683
2018
Homo sapiens (P09237)
brenda
Li, M.; Zhang, Y.; Tian, H.; Zheng, M.; Yang, M.; Fang, H.; Xie, Y.; Jin, J.
Nitro-based selective inhibitors against matrix metalloproteinase-7 over matrix metalloproteinase-1
RSC Adv.
5
104725-104732
2015
Homo sapiens (P09237)
-
brenda
Jang, B.; Yun, J.H.; Choi, S.; Park, J.; Shin, D.H.; Lee, S.T.; Lee, W.; Oh, E.S.
Tyrosine 51 residue of the syndecan-2 extracellular domain is involved in the interaction with and activation of pro-matrix metalloproteinase-7
Sci. Rep.
9
10625
2019
Homo sapiens
brenda
Prior, S.H.; Fulcher, Y.G.; Koppisetti, R.K.; Jurkevich, A.; Van Doren, S.R.
Charge-triggered membrane insertion of matrix metalloproteinase-7, supporter of innate immunity and tumors
Structure
23
2099-2110
2015
Homo sapiens (P09237)
brenda
3.4.24.23 matrilysin
more
top
The reliability class of the localization prediction ranges from 1 (very reliable) to 5 (not reliable). 
